Protection of neuromuscular sensory endings by the WldS gene by Oyebode, Oyinlola R. O.
Protection of neuromuscular sensory endings by the Wld
S
 gene 
Oyinlola R. O. Oyebode MA (Cantab) 
 
PhD 




I hereby declare that the work described within, and the composition of, this thesis is 




I would like to say a big thankyou to my supervisor Richard Ribchester who found me 
a project, was encouraging all the way through and gratifyingly fell for an April fool 
in the middle. I would also like to acknowledge members of the Ribchester and 
Coleman laboratories, past and present, for protocols and technical assistance, with 
special thanks to Derek Thomson for keeping all the mouse records and knowing 
where everything is, Jasjot Singhota for piloting the spindle teasing and Adrianna 
Teriakidis for introducing me to neuroinformatics, the DTC and making lab-work so 
much fun. 
 
I would also like to thank my parents, Jan and Femi, and my little brother, Toks, for 
developing my interest in science and reasoning and for their support during the last 
three years. Lastly, thanks to all my friends for scientific discussion on a wide range 
of subjects, including my thesis, and welcomed distractions from science; in 
particular, L-staircase and co., Matthew Lyst and Nicholas Wilkie.
Abstract 
 
The compartmental hypothesis of neurodegeneration proposes that the neurone, long 
recognized to consist of morphologically and functionally distinct compartments, also 
houses distinct degeneration mechanisms for the soma, axon and nerve endings. 
Support for this hypothesis is provided by the phenomenon of the Wld
S
 (for Wallerian 
Degeneration, slow) mouse,  a mutant in which axons survive several weeks after 
transection, rather than degenerating within 24-48 hours as in wild type mice, by 
virtue of expression of a chimeric Nmnat1/Ube4b protein. In this thesis I used the 
Wld
S
-mouse to re-examine and extend the theory of compartmental neurodegeneration 
by focusing specifically on sensory axons and endings; and finally by considering a 
fourth compartment, the dendrites. 
 
The first part of this thesis reports that Ia afferent axons and their annulospiral endings 
are robustly protected from degeneration in Wld
S
 mice. Homozygous or heterozygous 
Wld
S
 mice crossbred with transgenic mice expressing fluorescent protein in neurones 
were sacrificed at various times after sciatic nerve transection. Fluorescence 
microscopy of whole mount preparations of lumbrical muscles in these mice revealed 
excellent preservation of annulospiral endings on muscle spindles for at least 10 days 
after axotomy.  No significant difference was detected in the protection with age or 
gene copy-number in contrast to the protection of motor nerve terminals, which 




In an attempt to explain the difference in motor and sensory protection by Wld
S
, 
examination of three hypotheses was undertaken: a) differences in protein expression, 
tested by western blot and immunohistochemistry; b) differences in the degree of 
neuronal branching, tested through examination of γ-motor axons and endings which 
have a degree of branching intermediate to motor and sensory neurons; and c) 
differences in the activity in the disconnected stumps, through primary culture of the 
saphenous and phrenic nerve, selected because they comprise largely pure sensory 
and motor axons respectively. The data suggest that none of these hypotheses 





The last part of this thesis attempts to extend the theory of compartmental 
degeneration. I examine a system for investigation of Wld
S
-mediated protection of 
dendrites. In preliminary experiments retinal explants from transgenic mice 
expressing YFP in a subset of retinal ganglion-cell neurones were cultured.  The 
dendritic arbours of these cells were shown to be amenable for repeated visualization 
and accessible to injury and monitoring of degeneration. 
 
Overall the data in this thesis suggest that the level of Wld
S
 -mediated protection 
conferred to an axon or axonal endings varies between different neuronal types. This 
has implications for the potential applications of Wld
S
 research to clinical problems. 
Specifically, the data imply that sensory neuropathies may benefit more than motor 
neuropathies from treatments based on the protective effects of Wld
S
.  These findings 
in sensory neurones also challenge some of the assumptions made about Wld
S
-
mediated protection of neurones, for example the extent of the age-effect on axonal 
endings. Further investigation of Wld
S
-mediated protection in the CNS could give 
renewed impetus to attempts to discover targets for treatment in common 
neurodegenerative diseases. Finally, a system for investigation of dendritic 
degeneration has been piloted, suggesting that molecules involved in the degeneration 
of dendrites or in protection from this degeneration may be amenable to investigation 
in this system, prospectively extending the compartmental hypothesis of neuronal 
degeneration. 
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I Introduction 
 
Understanding neural degeneration is one of the most important issues in clinical 
neuroscience. 
 
Classical neurodegenerative diseases include those diseases defined by progressive 
and irreversible loss of neurones from the nervous system. Neurodegenerative 
diseases are responsible for a major portion of the economic burden of ill health 
(Waldmeier and Tatton, 2004). These diseases effect tens of millions of people 
worldwide and dementias associated with neurodegenerative disease are expected to 
double between 2001 and 2040 in developed nations, and to increase by more than 
300 percent in India and China (statistics from the Alzheimer’s Research Trust).  
 
Alzheimer’s disease (AD), the most common of the neurodegenerative diseases, is a 
progressive neurodegenerative disorder associated with loss of cells from the cortex 
and hippocampus. Other common neurodegenerative diseases of the Central Nervous 
System (CNS) include Parkinson’s disease (PD), a neurodegenerative movement 
disorder characterized pathologically by the loss of dopaminergic neurones in the 
substantia nigra pars compacta and Huntington’s disease (HD), a genetic autosomic 
disease characterized by select degeneration of neurones in the striatum (reviewed in 
Okouchi et al, 2007). 
 
Amyotrophic lateral sclerosis (ALS) is a motor neurone disease characterized mainly 
by the degeneration of the anterior horn cells of the spinal cord (or motor neurones, 
historically known as lower motor neurones) and cortical neurones that project 
through the corticospinal tract to the anterior horn cells (historically known as upper 
motor neurones). In addition some ALS patients show degenerative signs in the 
front-temporal cortex, compounding their motor symptoms with dementia (Phukan et 
al, 2007). 
 
Neurodegeneration also has a key role in the pathogenesis of diseases not normally 
classed as neurodegenerative. For instance, while demyelination is responsible for 
the early signs of multiple sclerosis, neurodegeneration may play a role in 
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irreversible damage that occurs as the disease progresses (Bjartmar and Trapp, 2003). 
Neurodegeneration can also be a complication associated with diabetes (Toth et al, 
2007) and infection with human immunodeficiency virus (HIV) (Ozdener, 2005). 
Decreased hippocampal volume in patients with depression suggests there may even 
be a role of neurodegeneration in psychiatric disorders (Brink et al, 2006). 
 
Neurodegenerative diseases usually progress over an extended time frame, at the 
shortest 1-2 years (in the case of ALS) up to several decades (in AD, PD or HD). 
This extended time frame provides opportunity for intervention between diagnosis 
and death. Research into ways to delay or arrest degeneration in the nervous system 
could have a major impact on many diseases and therefore the quality of many 
peoples’ lives. 
 
Given the hallmark of neurodegenerative disease is loss of neurones; much research 
has focused on preventing neurones from undergoing programmed cell death. This 
continues today with a raft of drugs that interfere with neuronal death being trialed 
(Waldmeier and Tatton, 2004). However recent evidence suggests that before the 
neurone dies, changes occur, which may, more closely correlate with disease 
progression. Decreased neuronal size, atrophy of neuronal dendrites and reductions 
in axonal terminal fields have also all been identified in neurodegenerative disease 
(Waldmeier and Tatton, 2004). In AD there is evidence of synaptic alterations that 
predate neuronal death (Coleman et al, 2004; Selkoe, 2002; Terry et al, 1991; 
deKosky and Scheff, 1990). HD and HIV associated dementia also appears to begin 
with synaptic pathology and this pathology is closely correlated to disease 
progression (Smith et al, 2005; Bellizzi et al, 2006). Neuromuscular terminal and 
Axonal degeneration are major pathological features of ALS and occur before the 
death of motor neurones (Frey et al, 2000, Fischer et al, 2004; Fischer and Glass, 
2007). 
 
In the face of increasing evidence that degeneration of other neuronal compartments 
precedes cell death, the benefits of a focus on drugs that act to preserve neuronal cell 
bodies alone become questionable. Indeed, a number of experimental studies 
demonstrate that improving survival of neurones does not have an effect on the onset 
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of disease, for example in ALS (Sagot et al, 1995), or maintain neuronal function 
(Iyirhiaro et al, 2008). This suggests that therapies that concentrate on protection of 
the axon, dendrites and synapses in the nervous system must also be developed. 
 
I.1 The somatic Peripheral Nervous System 
 
All the spinal nerves that innervate the voluntary muscles and the skin are part of the 
somatic peripheral nervous system (PNS), on which this thesis is focussed. This 
comprises sensory (afferent) and motor (efferent) axons carrying information 
between the central nervous system (CNS) and the body. Here I will briefly review 
these components of the somatic peripheral nervous system, whose maintenance and 
degeneration are examined further in the following thesis. 
 
I.1.1 Overview 
In mammals, the skeletal musculature is innervated by somatic motor neurones 
which have cell bodies located in the ventral horn of the spinal cord grey matter. The 
axons of motor neurones bundle together to form ventral roots. The cell bodies of 
sensory neurones are located within the dorsal root ganglia (DRG), the axons of 
these unipolar neurones branch in dorsal root, one branch projecting into the spinal 
cord and the other projecting peripherally. Each ventral root joins a dorsal root to 
form a spinal nerve that exits the cord between the vertebrae. Sensory and motor 
neurones project to specific muscles. 
 
Motor neurones can be divided into two categories, according to morphology and 
function, as α- and γ-motor neurones. Sensory neurones can also be classified 
according to morphology and function. The smallest sensory neurones have 
unmyelinated axons (C-fibres or Group IV afferents) and receptors which mainly 
detect noxious stimuli, perceived as pain. Several intermediate myelinated axon sizes 
exist which respond to noxious or temperature stimuli (Aδ fibres, Group III), or non-
noxious touch sensations for example pressure (Aβ fibres, Group II) or vibration 
(Aα, Group I). The largest sensory neurones with large myelinated axons supply the 
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muscle spindle organs. The innervations of muscle spindle organs is a focus of the 
research described in much of this thesis. 
 
I.1.2 Peripheral nerve 
Axons travelling in peripheral nerve are protected by three layers. The endoneurium 
contains the axons and their associated Schwann cells along with endoneurial fluid 
and connective tissue. The perineurium is a dense connective tissue formed by up to 
15 layers of flat perineurial cells, interspersed with collagen fibrils and elastic fibres. 
This groups bundles of axons together to make fascicles and forms a diffusion barrier 
that protects the endoneurial space. The epineurium is another connective tissue layer 
which encircles both the fascicles and the entire nerve. 
 
Within the endoneurium, all axons are associated with Schwann cells. The myelin of 
each myelinated axon is formed from the plasma membrane of Schwann cell which is 
wrapped multiple times around the axon. A series of Schwann cells will be 
associated with an axon along its length and at the gap between adjacent Schwann 
cells is a gap known as the node of Ranvier which allows saltatory conduction along 
the myelinated axons. Unmyelinated axons are also enveloped by Schwann cell 
cytoplasm and plasma membrane, but a single Schwann cell may associate with 
several unmyelinated axons (reviewed in Topp and Boyd, 2006). 
 
I.1.3 α-motor neurones 
α-motor neurones innervate large diameter extrafusal muscle fibre and are therefore 
directly responsible for the generation of force by muscle. One α-motor neurone and 
all the muscle fibres it innervates are called one motor unit. Motor unit sizes range 
from a few to several hundred muscle fibres. Muscle contraction results from the 
individual and combined action of these motor units. 
 
The α-motor neurone causes muscle contraction through its innervations of muscle 
fibres at specialised chemical synapses known as neuromuscular junctions. Each 
muscle fibre is innervated by a single motor axon. At this site the membrane of the 
muscle fibre is invaginated forming the junctional folds (Roberts, 1963; Sanes and 
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Lichtman, 2001). Nicotinic acetylcholine receptors (AchR) are concentrated at the 
peaks of each fold. In the troughs are voltage-gated sodium channels responsible for 
triggering a muscle action potential in response to local depolarisation produced by 
activation of the AchRs (Wood and Slater, 2001). The terminus of the motor axon 
lies in register directly, opposing the junctional folds. Specialised active zones in the 
presynaptic terminal are in perfect alignment with the AchRs, separated by a 50nm 
gap, the synaptic cleft. The active zones are foci for clusters of synaptic vesicles, 
each packed with 1 quantum, or approximately 5000 molecules, of acetylcholine 
(Ach). The tight co-alignment of pre-synaptic motor axon terminal and post-synaptic 
junctional folds in the muscle fibre membrane ensures high fidelity transmission 
between the terminals of a motor neurone and contraction of the muscle fibres 
(Wood and Slater, 2001). 
 
I.1.4 Sensory innervation of muscle 
Muscle spindle organs are specialised to detect changes in muscle length and the 
associated sensory neurones conduct this information to the CNS where it is used in 
proprioception, the sense of where the body is in space. This organ is made up of 
specialised muscle fibres, known as intrafusal muscle fibres, supplied by one or more 
sensory neurones and γ-motor neurones mentioned below [Figure I.1]. 
 
There are 2 distinct types of intrafusal muscle fibre known as nuclear bag and 
nuclear chain fibres. These are contained in a fibrous capsule which is swollen and 
filled with endolymph in the equatorial region, conferring the characteristic shape of 
a spindle for which it is named. The muscle fibres are morphologically distinct from 
the extrafusal muscle fibres that make up the bulk of the muscle. Bag fibres contain a 
large cluster of nuclei in the equatorial region of the fibre, and chain fibres have them 
distributed along their length (Banks et al, 1978).  
 
Two types of sensory neurone innervate the muscle spindle; Group Ia and Group II. 
Group Ia neurones have larger axons (8-14 um diameter) which terminate in the 
equatorial region, forming annulospiral endings that wind around the intrafusal 
muscle fibres. These terminations are described as annulospiral. Group II neurones 
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have slightly smaller axons (6-12 um diameter) which terminate adjacent to the 
primary ending. The II termination is commonly described as having a flower spray 
appearance on contact with the intrafusal muscle fibres. Classical physiological 
studies show that Ia afferents respond partly to muscle length but respond more 
powerfully to changes in length. II afferents have a response that correlates to muscle 
length only (Barker and Scott, 1990; Banks et al, 1982). 
 
When a muscle is contracted the intrafusal muscle fibres change in length due to the 
forces exerted on them by the extrafusal muscle fibres. The sensory receptors signal 
this change, responding to the length or change in length of the muscle as they are 
specialised to do. If a muscle is stretched and then held at the new position, the 
primary endings discharge at high frequency during the change in length, while 
secondary endings will demonstrate a less marked increase in discharge during 
stretch. Once the muscle is being held at one length the primary ending adapts and 
the discharge returns to somewhere near baseline (although not quite, primary 
endings do have some sensitivity to muscle length). However, secondary endings 
will continue to fire at an increased rate while the muscle is held in a stretch (Kucera 
et al, 1991; Bear et al, 2001).  
 
As well as contributing to proprioception and kinesthesia, the muscle spindle organ 
can also regulate motor control. Ia and II afferents input on to the α-motor neurones 
supplying the same (ie: homonymous) muscle that contain the spindle. In the case of 
Ia afferents this input is direct, through one synapse in a pathway known as the 
monosynaptic reflex arc. Ia afferents can therefore powerfully excite the 
homonymous α-motor neurones. This is the basis of the classical stretch reflex where 
extension of a muscle causes a reflex contraction. Spindle afferents also 
monosynaptically and disynaptically innervate motor neurones that are synergistic in 
function to the homonymous motor neurone, and to interneurones that then synapse 
with antagonistic motor neurones (Windhorst, 2007; Hunt, 1990). 
  






Figure I.1 Diagram of a Muscle Spindle 
A diagram showing a simplified representation of a muscle 
spindle. Each component is shown; Bag and chain intrafusal 
fibres, with their characteristic shape and nuclear 
localisation, a Ia sensory axon with annulospiral termination 
within the capsule, a II sensory axon terminating with a 
flowerspray or incomplete annulospiral morphology beside 
the primary ending and γ-motor axons which terminate at 
the poles of the intrafusal muscle fibres. 
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I.1.5 γ-motor neurones 
In addition to the afferent sensory innervation of the intrafusal muscle fibres there is 
also efferent motor innervation by the γ-motor neurones. These small (3-8µm 
diameter), myelinated axons innervate intrafusal muscle fibres at neuromuscular 
junctions located at the poles of the muscle spindle. This input from the highly 
specialised small motor neurones is also known as fusimotor innervation. 
 
The γ-motor innervation of the muscle spindle provides additional control of α-motor 
neurones and muscle contraction. For instance, if the muscle spindle becomes slack 
as a consequence of α-motor discharge and muscle shortening, the afferent discharge 
is reduced and the spindle can no longer report subtle changes in the length of the 
muscle. Activation of the γ-motor neurones brings about contraction of the poles of 
the spindle, restoring spindle tone and sustaining sensitivity of the equatorial regions 
to changes in muscle length. There may be many other more complex roles that 
fusimotor innervation of the muscle spindles plays which are still to be investigated 
(Hunt, 1990). 
 
I.2 Wallerian degeneration 
 
In 1850 Augustus V. Waller published the paper “Experiments on the section of the 
glossopharyngeal and hypoglossal nerves of the frog, and observations of the 
alterations produced thereby in the structure of their primitive fibres.” He had shown 
that when an axon was disconnected from the neural cell body, the distal portion 
underwent degeneration, while the proximal segment remained intact.  
 
Three days after a lesion to the innervation of the tongue of the frog, Waller noted 
that there was a loss of muscular contraction and sensation. Examination of the nerve 
stump revealed discontinuous, fragmented and granulated axons (Waller, 1850). This 
axonal degeneration was subsequently named Wallerian degeneration, after him.  
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The histology of Wallerian degeneration is well established, although various factors 
can affect the speed of its completion. These factors include, for example, 
temperature (Tsao et al, 1999a) and the calibre of the axon including length, diameter 
and myelination (Lubinska, 1977; Weddel and Glees 1941; Friede and Martinez, 
1970). The age of the animal also affects the rate of Wallerian degeneration with 
older animals demonstrating a slower rate than young animals (Cook et al, 1974). 
The following description is based upon the electron microscopic study of rat sural 
nerve, by Ballin and Thomas (Ballin and Thomas, 1969). The first abnormalities 
include accumulation of organelles, including mitochondria, noticeable at 12 hours 
and plainly evident at 24 hours. Microtubules fragment and lose their orientation 
before axonal continuity is interrupted at 30 hours. The first changes in the myelin 
surrounding the axon can be seen at 24 hours after injury. The myelin sheath 
collapses and remains within the parent Schwann cell cytoplasm where it begins to 
be degraded (Ballin and Thomas, 1969). Phagocytosis of the remnants of the 
degenerating distal axon is initially undertaken by activated endoneurial 
macrophages (Leonhard et al, 2002) and later by monocytes and macrophages 
recruited from the blood stream (Mueller et al, 2001; Hirata and Kawabuchi, 2002). 
In the peripheral nervous system (PNS) the remnants are cleared 4 or 5 days after the 
injury occurs. However, in the CNS, though axons disintegrate over the same time 
course as in the PNS, hematogenous macrophages are not recruited to the distal 
stump and the clear up can take months (Perry et al, 1987). 
 
After Wallerian degeneration is complete, the severed neurones in the adult 
peripheral nervous system normally sprout new axons which will then re-establish 
connections. For this to occur, a growth permissive environment must be created 
(Kury et al, 2001). Schwann cells proliferate and align within basal lamina tubes 
forming what are known as Bands of Bungner. These appear to guide growing axons. 
Once the axons have contacted their targets, the proliferated Schwann cells align and 
re-myelinate them (Kury et al, 2001). 
 
Waller’s work led him to conclude that axons were dependent on the cell body for 
nourishment and that disconnection caused them to passively ‘starve’ to death. More 
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than 150 years later, this conclusion was challenged with the discovery of a mutant 
mouse in which axons survive several weeks after transection rather than 
degenerating with 24-48 hours as in wild type. This mouse is named WldS mouse for 
‘WaLlerian Degeneration Slow’ (Lunn et al, 1989; Mack et al, 2001), although it was 
previously referred to as “Ola” mouse, before the mutant gene was mapped (Lyon et 
al, 1993). 
 
Initially it was suggested the reason for the slow progression of Wallerian 
degeneration was due to a disruption in the recruitment of myelomonocytic cells to 
the distal portion of the axon (Lunn et al, 1989). However, transplant experiments 
(Perry et al, 1990a), graft experiments (Glass et al, 1993) and tissue culture 
experiments (Perry et al, 1990a; Deckwerth and Johnson, 1994; Glass et al, 1993) 
demonstrated that it was an intrinsic property of the axons/neurites. 
 
The discovery of inherently slow degeneration of axons in the nerves of the WldS 
mouse indicated that Wallerian degeneration is not simply a passive wasting away of 
the axon because it has been disconnected from its source of ‘nourishment’. Rather 
this suggests that Wallerian degeneration is a self-destructive mechanism that the 
disconnected axon undergoes in response to injury. Similarities between this process 
and another well known mechanism for self-destruction suggest that Wallerian 
degeneration may be similar in principle to apoptosis (Gillingwater and Ribchester, 
2001) [See I.7]. 
 
I.2.1 Mechanisms and molecules of Wallerian degeneration 
Little is known about what signals to the axon to self-destruct or how this self-
destruction occurs. 
 
Severed axons maintained in EGTA, a calcium buffer, degenerate more slowly than 
those in high-calcium media. Calpains, calcium dependent proteases, have been 
demonstrated to cleave the major axonal proteins (Schlaepfer and Bunge 1973). 
Using murine dorsal root ganglia in cell culture, George et al (1995) examined the 
role of calcium and the calpains in Wallerian degeneration.  
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When extracellular calcium levels were reduced by adding EGTA to the culture 
media after axotomy, the axons developed a beaded appearance but failed to 
degenerate within a week after axotomy, as opposed to complete degeneration by 48-
60 hours. Both A23187 and ionomycin, which elevate intra-axonal calcium, produce 
degeneration of uncut axons when added to dorsal root ganglia cultures. George et al 
demonstrated that the calcium entry in Wallerian degeneration is not simply due to 
disruption of the membrane, by showing that cobalt and manganese, non-specific 
calcium-channel inhibitors, effectively delayed axonal degeneration after axotomy. 
Conotoxin does not block axonal degeneration indicating that calcium enters through 
channels other than N-type calcium channels during axonal degeneration. Both 
leupeptin analogues and oxiranes, two classes of calpain inhibitor, preserve 
axotomised axons in a concentration dependent manner. This evidence gives a strong 
indication of an importance for calcium entry and calpain activity in Wallerian 
degeneration.  
 
De Jonge et al have shown that components of the complement system are produced 
in healthy peripheral nerve and activated during Wallerian degeneration (De Jonge et 
al, 2004). Depletion of C3 or C5 (extinguishing the complement cascade) causes 
delayed Wallerian degeneration (Dailey et al, 1998; Liu et al, 1999) as does 
deficiency of C6, highlighting the Membrane Attack Complex as important for 
normal Wallerian Degeneration (Ramaglia et al, 2007). Recently, Ramaglia et al 
have investigated the effects of inhibiting all arms of the complement cascade with 
treatment with a soluble form of Complement Receptor 1 (sCR1), and inhibition of 
specifically the classical and leptin pathways with a C1 inhibitor (Cetor). Treatment 
was started 1 day before crush injury of the sciatic nerve. They report that 3 days 
after crush injury sCR1 treated nerves showed more neurofilament and myelin 
staining as well as more axon profiles in electron micrographs, whereas Cetor treated 
nerves, though they had some preserved myelin did not have axon profiles. 
Phosphate Buffered saline (PBS)-treated nerves showed loss of axons as well as 
collapsed and degraded myelin. Seven days after injury axons in all animals were 
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degenerated, demonstrating that Wallerian degeneration is delayed but not 
completely blocked in complement inhibited animals. 
 
From the work described above, it would appear that calcium entry and calpain 
activation, followed by complement activation are necessary for Wallerian 
degeneration to proceed normally. However, what signalling originally causes the 






The slow Wallerian degeneration phenotype characteristic of WldS mice is caused by 
a spontaneous mutation in a line of C57/Bl6 mice originally supplied by commercial 
animal breeders and providers, Harlan-Olac laboratories. Superficially, these mice 
are not discernibly different from any other C57/Black mouse lines and behave and 
breed normally. What distinguishes them is the finding that Wallerian degeneration 
is significantly delayed in these mice after nerve injury. This phenotypic 
characteristic was discovered by chance during investigation into the role of the 
recruitment of myelomonocytic cells in Wallerian degeneration of mouse peripheral 
nerve by MC Brown, VH Perry and colleagues (Lunn et al, 1989). 
 
Wld
S animals exhibit slow Wallerian degeneration after nerve injury in both the 
peripheral and central nervous system including optic nerve and striatum of the 
mouse as well as delayed degeneration of motor nerve terminals (Gillingwater et al, 
2006b; Ludwin and Bisby, 1992; Ribchester et al, 1995). However, there are many 
subtleties to the phenotype which will be described below. 
 
1.3.1 Effect of age on the Wld
S
 phenotype 
Soon after the discovery of the WldS mouse, an effect of age on the phenotype was 
noted. During work to map the location of the gene through linkage testing, Lyon et 
al were confounded by the apparent shortage of mutants among the older animals. 
This weakening of the phenotype was investigated itself and described by Perry et al 
(1992).  
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Perry et al. reported that 5 days after section, sciatic nerve from 4 week old WldS 
mice exhibits compound action potentials, while sciatic nerve from 12 month old 
mice does not. They also report that using mice 8 weeks and older, they were only 
able to obtain neuromuscular transmission up to 2 days after sciatic nerve cut. 
However, in 4 week old animals they were able to elicit neuromuscular transmission 
5 days after nerve section. Electron microscopy confirmed their findings, nerves 
fixed 5 days after axotomy showed almost no abnormality in sciatic nerve from 4 
week old animals; however 27.3% and 36.3% of axons appeared abnormal in the 
nerves from 1 year old animals. (In any other mouse strain all axons would be 
completely degenerated by this point). 
 
Two years later Tsao et al (1994) confirmed this finding noting that compound action 
potentials, as well as neurofilament immunoreactivity, were both utterly extinguished 
at 2 days post transection in wild type mice, but could still be detected at 21 days 
post-transection in 1 month old WldS mice. However, these were barely detectable at 
14 days in 6 month old WldS mice or at 7 days in 12 month old WldS mice. 
 
A systematic morphological, histochemical and immunochemical study was 
published contesting these findings (Crawford, 1995). Crawford et al reported no 
difference in the degeneration rates of axons in 1, 3, 6 and 16 month old mice. Mice 
of all ages had similar numbers of surviving axons at 7, 14 and 21 days after injury 
and they had a similar amount of total axon area. They also found no difference in 
the number of innervated neuromuscular junctions 5 days post axotomy in the 
muscles of 1 and 7 month old animals (in the gastrocnemius muscle). 
 
The final published word on this (to date) is the paper by Gillingwater et al, 
published in 2002. Gillingwater et al reported that axonal protection is independent 
of age and therefore, agree with Crawford et al. However, they also provided 
compelling evidence that neuromuscular junctions are not protected in WldS mice 
over 7 months old, indicating some effect of age as previously described by both 
Perry, Tsao and colleagues. The Gillingwater et al (2002) paper does knit much of 
  
 - 14 - 
the earlier data together as degeneration of the neuromuscular junctions could have 
hidden robust survival of axons if assessment of degeneration was done by 
neuromuscular transmission. 
 
Taken together, the evidence favours some effect of age on WldS-mediated axonal 
and synaptic protection. WldS-protection appears to decrease with age with 
neuromuscular junctions being most susceptible to this possibly from as young as 8 
weeks and certainly by 7 months. If age has an effect on axonal protection it is likely 
that this occurs much later in an animal’s life than the effect on neuromuscular 
junction protection, probably not until at least 6 months of age and to no great extent 
even in animals older than that. 
 
It appears to be the age of the synapse rather than the age of the animal which is the 
factor important for neuromuscular junction protection. Gillingwater et al (2002) 
compared synaptic preservation of immature synapses at regenerated neuromuscular 
junctions in old WldS mice. In mice aged between seven and twelve months, the 
sciatic nerve was crushed on one side. Regenerating axons were allowed to re-
innervate the flexor digitorum brevis (FDB) muscle. Eight to ten weeks later 95% of 
fibres had regained synaptic activity from new synapses formed by the regenerated 
axons. Next the repaired synapses which could not have been more than eight weeks 
old were lesioned again, this time cutting the tibial nerve. The incidence of 
innervated FDB muscle fibres following the second lesion was then scored 
electrophysiologically and immunocytochemically. The first lesion produced rapid 
loss of synaptic transmission and morphology in these old mice; no fibres showed 
signs of activity three days post axotomy and fewer than 2% of endplates were 
contacted by nerve terminals. By contrast, synapses were consistently preserved after 
section of the regenerated axons: 33% of endplates still showed spontaneous 
miniature endplate potentials and or responded with end plate potentials to nerve 
stimulation. Immunocytochemistry labelled preparations showed that four or five 
days after axotomy 41% of endplates were contacted by nerve terminals. Therefore 
new synapses in old mice are better protected than the mature synapses innervating 
muscles without a prior conditioning lesion applied to the nerve. 
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I.3.2 Effect of Wld
S
 protein expression level on the Wld
S
 phenotype 
The WldS protein concentration effect on axon degeneration was studied by Mack et 
al (2001) who produced 4 transgenic lines expressing the WldS gene, each with a 
different number of copies of the gene. The level of protection exhibited by these 
mutants was reported to correlate with the number of copies of the transgene. Axons 
persisted longer than functional motor nerve terminals in these mice (Mack et al, 
2001). This result suggests that the degree of protection depends on the expression 
level of WldS protein. Mack et al, quantified this effect. They found that it is 
necessary for the expression level of WldS to reach a threshold level to exert a 
significant protective effect ie: the hemizygous mutant with the lowest copy number, 
though demonstrating detectable levels of WldS, exhibited Wallerian degeneration 
indistinguishable from wild type mice. Over the range tested they found no plateau 
of protection at the highest expression levels. Axons persisted longer than functional 
motor nerve terminals in these mice (Mack et al, 2001). 
 
Heterozygote WldS animals demonstrate a phenotype similar to the aged phenotype 
described by Gillingwater et al (2002). The axons are robustly protected; however 
the neuromuscular junctions degenerate at the same rate as those in wild type animals 
(Li Fan PhD Thesis, University of Edinburgh; F. Wong et al, in preparation). 
  
This finding is relevant to the future application of WldS-mediated protection 
therapeutically. It suggests that unless the critical threshold is reached, so that both 
axons and axon terminals are protected, clinical benefits may not be seen. Also, 
raising WldS expression could bring about even longer preservation of axons and 
their endings. 
 
The findings also provide information about the mechanism. The more WldS present 
in the cell, the greater the protection of the axon. This suggests that whatever WldS 
does to interfere with Wallerian degeneration, the ‘substrates’ or the other 
component molecules involved are present in abundance. Ie: WldS may regulate the 
rate limiting step in the production of a protective factor. Or if it is acting through a 
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dominant negative mechanism, whatever molecules it inhibits with must be present 
in ample quantities. 
 
Finally, this “gene-dose” effect, in conjunction with the age-effect has a third 
implication. In both heterozygotes and old homozygote WldS mice, the 
neuromuscular junction appears to degenerate despite the presence of WldS at levels 
able to fully protect the axon. This may suggest that the axon terminal has its own 
mechanism for destruction (see I.10). 
 
I.3.3 Sensory and motor differences 
The possibility of a difference between sensory and motor axon protection in WldS 
mice was first reported by Brown et al (1994). These authors found that the 
degeneration of axons in the saphrenous nerve, comprising only sensory axons, is 
slower than that in the phrenic nerve which largely comprises motor axons (Brown et 
al, 1994). This difference was apparent in mice aged 4 weeks of age. 
 
An alternative explanation for the data reported by Brown et al is that there are 
inherent difference in the strength of protection in axons of the saphrenous and 
phrenic nerves, independent of their respective sensory and motor functions. 
 
In 1995, Fruttiger et al reported a distinct difference in the speed of Wallerian 
degeneration between muscle and cutaneous branches of the femoral nerve in 16 
week old WldS mice as opposed to 6 week old WldS mice. They used an antibody 
against L2/HNK-1 to identify motor nerve associated myelinating Schwann cells. 
They report that in 16 week old WldS mice, 5 days post axotomy, 11 % of all 
L2/HNK-1-positive Schwann cells displayed neurofilament immunoreactivity in the 
centre of their myelin sheath. In contrast, 57% of all L2-HNK-1-negative Schwann 
cells showed neurofilament immunoreactivity. I.e.: 5 days post lesion almost all 
motor axons had degenerated but more than half of the sensory axons were still 
present (Fruttiger et al, 1995). 
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The issue of sensory/motor differences in WldS-induced axon protection is further 
examined in the present thesis. 
 
I.3.4 Other phenotypic differences 
Given the profound effect of the mutation on the response of neurones to injury, it is 
remarkable that there is apparently very little else to say about the constitutive 
phenotype of WldS mice. The mice have no overt behavioural abnormality which is 
why the axon-protection phenotype may have remained undiscovered until Brown 
and Perry’s serendipitous discovery in 1989. However, the following differences 
have been published. 
 
Brown et al (1991) reported that the soleus muscle in the mutant has an increase in 
intrinsic tension, fewer macrophages per muscle fibre and lower levels of Acetyl 
choline sensitivity. Tsao et al (1999b), report that there is altered cerebral 
metabolism. 
 
Two phenotypic characteristics reported to be specific to WldS mice, which I have 
examined further in the appendix of this thesis are decreased pain sensitivity (Zhong 
et al, 1999) and increased hair loss, which has not been published, but can be seen 
regularly in laboratory mice. 
 
The functional significance of these characteristics or the role of WldS in their direct 
causes remains unknown. However other characteristics, which the mutation is likely 
to have a role in, have also been published. 
 
Wishart et al (2008) report that WldS expression in mouse cerebellum and HEK293 
cells alters a number of cell-cycle related genes and proteins and suggest this may 
result in abnormal cell-cycle control in WldS animals. 
 
Brown et al (1994) investigated slow regeneration of axons in the peripheral nerve of 
Wld
S mice after crush injury. This appears to be due to the inappropriate environment 
that axonal sprouts find themselves in due to the persistence of the axonal stump. As 
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long as the myelinated axons in the distal stump remained intact, regeneration of 
axons did not occur, in spite of vigorous production of sprouts at the crush site. In 
addition, myelinated sensory axons regenerate very poorly in WldS mice, even in the 
presence of unmyelinated axons. However, this failure to regenerate is also explained 
by adverse local conditions confronting sprouts, as the cell bodies in the DRG 
respond normally to injury and if the saphrenous nerve is forced to degenerate more 
rapidly by multiple crush lesions, sensory axons regrow successfully. 
 
The lack of obvious complications to living with the WldS phenotype further 
increases the interest in this gene as a potential molecular basis for therapeutic 




 and axonal degeneration 
 
Wld
S protects axons from degeneration following axotomy. This has been 
demonstrated in the PNS, and also following injury in the CNS (Ludwin and Bisby, 
1992; Gillingwater et al, 2004). However, axonal degeneration does not only occur in 
response to nerve transection. Synaptic and axonal degeneration are recognised as 
early stages of many neurodegenerative diseases, for example in motor neurone 
diseases (Fischer and Glass, 2007) and Alzheimer’s disease (Selkoe, 2002). Axon 
degeneration can also occur as a result of exposure to neurotoxins such as taxol 
(Lipton et al, 1989), or cisplatin (Krarup-Hansen et al, 2007), agents which are used 
therapeutically, for instance in treatments for cancer. This raises the possibility that 
the downstream molecular action of the WldS gene might be exploited to prevent or 
alleviate neurodegeneration in these instances. 
 
Wld
S has been successfully used to protect axons challenged with neurotoxic 
chemicals in both cell culture studies and in vivo. Cultured superior cervical ganglion 
(SCG) neurites from WldS animals are resistant to degeneration induced by 
vinblastine, a micro-tubule disrupting agent (Ikegami and Koike, 2003). Cultured 
sympathetic neurones from WldS mice have neurites that are resistant to nerve growth 
factor deprivation (Deckwerth and Johnson 1994). Mice receiving three taxol 
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injections over the course of a week develop a highly reproducible sensory 
neuropathy. WldS mice are resistant to this neuropathy, as assessed by behavioural, 
electrophysiological and pathological means (Wang et al, 2002b). 
 
There has also been protection from neurotoxic insult in the CNS. 6-
hydroxydopamine (6-OHDA) is a catecholaminergic neurotoxin that, when injected 
into the forebrain, results in the loss of dopamine fibres in the nigrostriatal pathway. 
This is used as a model for Parkinson’s disease, where the same fibres are affected. 
To assess any WldS-mediated rescue of dopamine fibres, the nigrostriatal pathway of 
Wld
S mice was lesioned with 6-hydroxydopamine (6-OHDA), a catecholaminergic 
neurotoxin. Young WldS mice showed remarkable dopamine fibre protection in the 
striatum. Drug-induced rotational behaviour confirmed the nigrostriatal fibre ability 
to release dopamine (Sajadi et al, 2004). 
 
Results from crossbreeding WldS into other mouse models of disease have been 
mixed. The strongest WldS protection has been found in the progressive 
motoneuropathy mouse (pmn mouse), a model of early-onset motor neurone disease. 
Ferri et al, crossed pmn mice with WldS mice and found the WldS gene product 
attenuates disease signs, extends life span, prevents axon degeneration, rescues motor 
neurone number and size, and delays retrograde transport deficits (Ferri et al, 2003).  
 
Another disease model that has demonstrated benefits after cross-breeding with WldS 
mouse is the Protein zero deficient mouse (P0 -/-), a genetic model for myelin-related 
axonopathy. Samsam et al show WldS expression reduces axonal degeneration in 
peripheral nerves of 6 week old and 3 month old P0 -/- mice, and increases muscle 
strength. However axon loss at 6 months is comparable between p0 mice with and 
without the WldS mutation (Samsam et al, 2003). 
 
The promising results of neuroprotection against chemical injury in the CNS and 
PNS, and against disease in the pmn and P0 -/- mice indicate that there are some 
molecular or mechanistic similarities between the degeneration occurring in various 
neuropathies and the ‘pure’ Wallerian degeneration that occurs after a nerve is cut. 
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By studying WldS and Wallerian degeneration, other Wallerian-like degenerative 
processes and possible therapeutic targets may be better understood. 
 
However, WldS has not provided successful protection in all mouse models of 
disease. For examples Fischer et al (2005) investigated the SOD1-G93A mouse, an 
extensively used model of familial ALS. At 80 days SOD/WldS animals had 32.9% 
more innervated endplates than SOD/WT animals and they lived on average, 10 days 
longer. But at time points beyond 80 days, there was no significant difference in 
innervation of neuromuscular junctions, and the mice had no phenotypic 
improvements as measured behaviourally by a rotorod test. The authors conclude 
that ‘The WldS gene modestly prolongs survival in the SOD1-G93A mouse’ (Fischer 
et al, 2005). When Vande Velde et al investigated WldS protection in two more 
SOD1 mutants, SOD1G37R or SOD1G85R and found that WldS did not slow disease 
onset, ameliorate mutant motor neurone death, axonal degeneration, or preserve 
synaptic attachments (Vande Velde et al, 2004). Similarly, Kaneko et al found only a 
modest delay in axon degeneration and onset of symptoms in EAE mice (Kaneko et 
al, 2006). 
 
One fundamental problem in using WldS to try and treat neurodegenerative disease is 
the age-dependency of the phenotype. It is possible that the pmn mouse was the most 
successful case because this mouse model of disease displays signs of disease at a 
young age, when both motor axons and motor nerve terminals are protected by WldS. 
In disease models where symptoms do not appear until 12 weeks or more, WldS may 
be losing the capacity to protect neuromuscular junctions and so however long the 
motor axons remain intact, their function in mediating neuromuscular transmission 
and muscle contraction, will be lost.  
 
The gene-dose effect on the phenotype provides an additional hurdle when studying 
protection against disease. If protection of axonal endings is important, sufficient 
copy numbers of the gene must be delivered to their cell bodies. 
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The discovery of the WldS mouse suggested that Wallerian degeneration is not a 
passive wasting away of the axon as a consequence of disconnection from the cell 
body. Study of the mechanism of WldS protection from Wallerian degeneration might 
lead to insights about the mechanism and molecules involved in Wallerian 
degeneration. It could also lead to identification of new targets for drug development 
in neurodegenerative research. 
 
Perry et al (1990b) studied the inheritance of the phenotype in genetic outcrosses and 
backcrosses with the WldS mouse and as a result showed that the mutation segregates 
as a single autosomal dominant gene. Lyon et al (1993) narrowed down the locus. 
They employed chromosome mapping techniques in which mice are crossed with 
stocks carrying visible markers covering 80-90% of the genome and linkage was 
found with the locus of jerker on chromosome 4. This allowed molecular mapping to 
position the gene more precisely in a probable order with various microsatellites and 
restricted fragment length variants at the distal end of chromosome 4. 
 
An 85kb tandem triplication within the candidate region was discovered to be unique 
to WldS mice (Coleman et al, 1998). This 85 kb repeat sequence contains the exons of 
3 genes, each of which could have accounted for the WldS phenotype (Conforti et al 
2000). The first of these was named Retinal binding protein 7 due to homology with 
other known retinoid binding proteins. The remaining two genes, originally 
described as ubiquitin fusion degradation protein 2 (Ufd2) and a novel gene 
D4Cole1e, were reported to span the proximal and distal boundaries of the repeat 
unit, forming a chimerical gene encoding a 43 kDa fusion protein. It has since been 
shown that the novel sequence D4Cole1e incorporates the complete sequence 
encoding nicotinamide mononucleotide adenylyl transferase-1 (Nmnat-1), one of the 
enzymes responsible for synthesising Nicotinamide Adenine Dinucleotide (NAD) 
(Emanuelli et al, 2001) and also incorporating an N-terminal sequence of 18 amino 
acids that is not normally translated in Nmnat1. The novel chimerical gene includes 
this full sequence of Nmnat-1. The Ufd2 constituent is now referred to as 
Ubiquitination Factor E4 (Ube4B), which is the name given to the mammalian 
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homologue of the yeast Ufd2. Only a truncated N-terminal 70 amino acid coding 
sequence is included in the novel chimerical gene.  
 
Rbp7 was not expressed at sufficient levels in nervous tissue to be suspected of 
contributing to the phenotype leaving the chimerical gene as the most likely 
candidate responsible for the neuroprotection. This prediction was strongly supported 
when transgenic animals, expressing the chimerical gene exhibited the same 
protective phenotype as the naturally occurring mutant mouse (Mack et al. 2001) 
[Figure I.2]. 
  









Figure I.2 WldS protein is produced by a chimerical gene 
85 kb of DNA are triplicated in the WldS mouse giving rise to a 
chimerical gene. The gene contains 2 exons of Ube4B located 
within 30 kilobases of DNA, and the entire coding sequence of 
Nmnat1, which is four exons spanning about 11 kilobases of 
DNA. This translates to 70 amino acids of Ube4B and 302 of 
Nmnat1, including 18 amino acids which is normally 
untranslated, known as Wld18. A third gene is also triplicated in 
the mutant mice, this is known as Rbp7. However, transgenic 
mice expressing the chimera alone, demonstrate the WldS  
phenotype. 
Nmnat1 Rbp7 Ube4b 
 
N70 Wld18 Nmnat1 
WldS protein 
Chimerical WldS gene Chimerical WldS gene 
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Though the gene responsible for the phenotype has been identified, the mystery of 
how it interferes with Wallerian Degeneration remains. The WldS phenotype has been 
extended to neurones in both Drosophila and rats and it has been investigated in both 
CNS and PNS (Lunn et al, 1989; Mack et al, 2001; Adalbert et al, 2005; Gillingwater 
et al, 2006b; Hoopfer et al, 2006). This suggests the mechanism for Wallerian 
degeneration is ancient and conserved. However, we still have no conclusive 
evidence of molecules involved in the initiation of Wallerian degeneration or a 
mechanism by which WldS disrupts this process. 
 
WldS appears to act upstream of the calcium influx, calpain activation and 
complement activation in Wallerian Degeneration. WldS neurofilaments degenerated 
following incubation in media containing Calcium ionophore A23187 and 10 mM 
Calcium ions at the same rate as BALB/c neurofilaments (Tsao et al, 1994) and 
Calpain activity can be demonstrated in WldS axons (Glass et al, 1994; Glass et al, 
1998). This suggests that calpain activation and neurofilament degradation proceed 
as they do in wild type animals if the intra-axonal calcium is raised. 
 
Mack et al, 2001 reported that the protein is predominantly localised to the nucleus, 
with none detectable in the axons of the sciatic nerve, or in end-bulbs of 24-hour 
transected CNS and PNS axons, which normally accumulate other axonal proteins. 
Given that the nucleus is spatially distinct from the axon and, importantly, 
completely disconnected from the axons when they exhibit the phenotype, it is 
reasonable to hypothesise that other factors must mediate the effect of WldS on the 
axon. According to this view, these factors must already be present in the axon at the 
time-point of injury. 
 
If WldS somehow regulates other factors downstream, a further question is whether 
there is a specific domain of the WldS protein that is involved in this regulation. 
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Since the chimerical protein is made up of two proteins conserved in the normal 
animal; a plausible hypothesis is that one of these domains, either the full-length 
Nmnat1 or the 70amino acids of Ube4B has assumed a new function. This issue has 
not yet been resolved so I shall briefly discuss the evidence that has come to light so 
far. 
 
In the study by Mack et al, although it was demonstrated that brains from WldS mice 
show a fourfold increase in Nmnat1 enzymatic activity when compared to ordinary 
C57Bl6 mice, the amount of NAD in WldS nervous tissue was shown to be the same 
as that in wild type tissue (Mack et al, 2001). In addition, the ubiquitin-proteosome 
system has an important role in protein degradation and has been implicated in axon 
degeneration (see below), so the 70 amino acids of Ube4B seemed more promising 
to be causing the phenotype. 
 
I.6.1 The N70 Hypothesis 
The Ubiquitin Proteosome System (UPS) is responsible for degrading most cellular 
proteins and regulates a remarkably diverse group of cellular processes by 
conditionally degrading proteins that control or are essential to those processes 
(Glickman and Ciechanova, 2002). Deregulation of the UPS has been implicated in a 
wide range of neurodegenerative disorders. 
 
The gracile axonal dystrophy (gad) mouse is an autosomal recessive mutant that 
shows sensory ataxia, followed by motor ataxia at a later stage. Pathologically, the 
mutant is characterized by 'dying-back' type axonal degeneration and formation of 
spheroid bodies in nerve terminals. The gad mutation is caused by deletion of 2 
exons from the ubiquitin carboxy-terminal hydrolase isozyme (Uch-11), which is 
selectively expressed in the nervous system (and testes) (Saigoh et al, 1999). This 
mutation was published just 2 years prior to the WldS mutation along with the 
suggestion that altered function of the UPS directly causes neurodegeneration. 
 
The 70 amino acids of Ube4B (N70) that makes up part of the chimerical WldS 
protein does not include any part of the U-Box (which is located towards the C-
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terminus of the full length protein and is responsible for the polyubiquitination 
activity of Ube4b). Since this region is absent from WldS, it is unlikely that direct 
modulation of protein ubiquitination is responsible for the phenotype. However, N70 
could interact with other molecules normally involved in interactions with full-length 
Ube4B and perhaps, therefore, have a dominant negative effect on functioning of the 
UPS.  
 
There is evidence that inhibition of the UPS can delay Wallerian Degeneration. Zhai 
et al (2003), provide pharmacological evidence that UPS inhibition can delay 
Wallerian degeneration. They used two mechanistically different proteosome 
inhibitors: MG132, a peptide-based reversible proteasome inhibitor; and lactacystin, 
a synthetic irreversible proteasome inhibitor. Cultured superior cervical ganglia 
neurones were transected and control axons began developing signs of degeneration 
8 hours later. Those treated with both MG132 and lactacystin did not show 
degeneration until 16 hr post-axotomy. 24 hours post-axotomy, when most of the 
axon debris has detached from the culture surface in control cultures, proteasome 
inhibitor-treated explants still retained many axons with few signs of degeneration. 
In vivo, gelfoams pre-soaked with MG132 and applied to optic nerve which had been 
lesioned, slowed the breakdown of microtubules and neurofilaments compared to 
vehicle soaked controls. These results suggest that inhibiting UPS activity is able to 
delay Wallerian degeneration both in vitro and in vivo. MacInnis and Campenot 
(2005) achieved similar results using sympathetic neurones cultured in 
compartmentalised dishes. Treatment with Mg132 protected transacted axons from 
degeneration for at least 24 hours (up from 15-18 hours) and epoxomicin protected 
axons for 30 hours. 
 
Although it may be that the N70 acts in a dominant negative fashion and hence 
inhibits the UPS, the evidence presented above is not on the scale of the protection 
conferred to axons by WldS. On the basis of this evidence it seems unlikely that N70 
alone is responsible for the WldS phenotype. However, as described in the following 
section, it may be active in the phenotype. 
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I.6.2 The VCP hypothesis 
During a screen for WldS binding partners Valosin-containing protein (VCP) was 
established as a binding partner for N70 (Laser et al, 2006). VCP is involved in many 
cell maintenance and cycling functions as well as endoplasmic reticulum protein 
degradation, nuclear envelope reconstruction and suppression of apoptosis. 
 
Yeast Ufd2 is implicated in cell survival under stress (Koegl et al, 1999).  In Yeast 
Ufd2 interacts with cdc48 (Koegl et al, 1999). Mouse Ube4B interacts with VCP, an 
ortholog of yeast Cdc48 (Kaneko et al, 2003), suggesting this association has been 
conserved through evolution and may be functionally important (Okumura et al, 
2004). Kaneko et al suggest that the Mammalian Ube4B/VCP complex might 
function as an E3 chaperone in the response of neurones to stress (Kaneko et al, 
2003). 
 
WldS binding of VCP does not significantly alter steady-state levels of VCP in the 
brain; however it does alter the nuclear localisation of VCP. WldS clusters into 
intranuclear foci in some neuronal subtypes and cell lines. Laser et al found that 
WldS and VCP colocalised within these nuclear spots both in vitro (PC12 cells) and 
in vivo (in cerebellar granule cells and molecular layer neurones). In wild type 
cerebellum, there were no foci of VCP (Laser et al, 2006). 
 
Subsequent pull-down experiments with truncated WldS demonstrated that VCP 
bound to the N-terminal 16 amino acids (N16). Cells transfected with WldS lacking 
N16 were not able to affect VCP distribution in the nucleus. Importantly, WldS 
lacking N16 still formed the intranuclear foci (Laser et al, 2006). 
 
Though this interaction may be functionally important, which (if any) of VCP's 
functions is disrupted by WldS is unknown. RNAi of Drosophila VCP promoted an 
almost twofold accumulation of ubiquitinated proteins, a general indicator of 
inhibited UPS function (Wojcik et al, 2004). Perhaps WldS interaction with VCP 
decreases availability of the molecule for its normal interaction with Ube4B. This 
may result in inhibited UPS function.  
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Another possibility is that the high concentration of VCP in the intranuclear foci 
brings about a new function. Through the interaction with VCP, which binds long 
ubiquitin chains, WldS is also able to partially redistribute ubiquitin inside the 
nucleus (Laser et al, 2006). Perhaps VCP or ubiquitin are brought into proximity 
with other molecules (perhaps molecules involved in Nmnat1 functions) at higher 
concentrations that would normally occur, and this gives rise to interactions which 
cause WldS protection. 
 
I.6.3 The Nmnat1 Hypothesis 
In 2004, the possibility that it is Nmnat1 over-expression (due to the triplication in 
Wld
S) which causes the phenotype, resurfaced with a paper published by Araki et al 
(2004) demonstrating that transfection of cultured DRG neurones with Nmnat1 alone 
was sufficient to protect their axons from degeneration. 
 
Araki et al found that EGFP-Nmnat1 delayed axonal degeneration comparable to 
Wld
S gene itself whereas N70 had no effect whether targeted to the nucleus or 
cytoplasm. They then used the crystal structure of Nmnat1 to predict amino acids 
that might be mutated to alter substrate binding. This enabled them to create Nmnat1 
and WldS with a single codon mutation that caused an amino-acid substitution that 
severely limited the ability to synthesise NAD. Neurones expressing these 
enzymatically null mutants had no axonal protective effects. 
 
They then attempted to recreate the phenotype with exogenously applied NAD. They 
found that 0.1-1µM NAD added 8 or more hours before transection was enough to 
delay axonal degeneration, although to a lesser extent than lenti-virus mediated 
Nmnat1 expression. 
 
Araki et al conclude that WldS protection is mediated by NAD, overproduced by the 
triplicated Nmnat1 in WldS mice. Without the ability to produce NAD, there is no 
Wld
S protection. Nmnat1 and NAD could drive protection based on known 
biochemical pathways. In the 2004 Araki paper these were investigated. 
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Sirtinol added at the same time as NAD blocked the protection suggesting mediation 
through the sir2-pathway [Figure I.3, Diagram based on Revollo et al, 2004]. They 
next performed knock-down to the 7 SIRT proteins with the Sir2 domain and 
discovered that a knockdown of SIRT1 blocked axon protection as effectively as 
sirtinol. 
 
The same group claim in a later paper (Sasaki et al, 2006) to provide axonal 
protection with Nicotinamide phosphoribosyl transferase (Nampt) and nicotinic acid 
phosphroribosyl transferase (Npt), which convert the precursor molecules 
nicotinamide and nicotinic acid, to the respective mononucleotides. They also found 
that exogenous application of nicotinic acid mononucleotide (NMN) and 
nicotinamide riboside (NmR) promoted axonal protection to a similar extent as NAD 
itself. They conclude that stimulating the activity of the NAD biosynthetic pathway 
at multiple steps provides protection against axonal degeneration after axotomy. 
 
Further work showed that lentivirus transfection with Nmnat1 localised to different 
neuronal compartments also provides axonal protection. Nmnat1 localised to the 
cytoplasm provided strong axonal protection indistinguishable from wild-type 
Nmnat1. Nmnat3 expressed in the nucleus or in the mitochondria had the same 
effect. The changes had to be made 24 hours before transection or no protection was 
afforded. These results suggest that the subcellular location of Nmnat is not crucial 
for the phenotype (and therefore that the interaction with VCP is irrelevant). 
 
This evidence comes together to suggest that WldS protection is afforded through the 
increased production of NAD acting through the Sirtuin pathway. As well as the 
practical evidence for this, theoretically it is an exciting prospect. It is known that the 
Sirtuin pathway is involved in survival during starvation in yeast (Fabrizio et al, 
2005). Evidence is emerging that the Sirtuins have continued this function in 
multicellular organisms including Caenorhabditis elegans and Drosophila 
melanogaster (Michan and Sinclair, 2007). They are conserved in mammals and 
caloric restriction has extended the life of mice, and is currently being trialled in 
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primates who are already indicating delayed aging (Michan and Sinclair, 2007). It is 
easy to extrapolate that the sirtuin pathway may have been hi-jacked in the case of 
Wld
S axon protection. The sirtuins mediate a signal to produce adaptation in an 
organism facing calorie restriction. A severed axon is facing nutrient restriction, 
unable to receive the products of transcription produced in the cell body. Due to an 
over expression of NAD, working through the Sirtuins, biochemical changes that 
help a cell adapt to starvation might be present in WldS neurones that helps the 
isolated axon to survive for longer. 
 
The Araki group are not the only authors to claim the WldS phenotype is dependent 
on NAD production. Nmnat1 over expression in Drosophila can delay axon 
degeneration (Macdonald et al, 2006). Exogenously applied NAD or nicotinamide 
suppresses neurite degeneration induced through Zinc depletion (Yang et al, 2007). 
Suzuki and Koike (2007) found that basal levels of microtubule acetylation is 
increased in WldS granule cells and postulate that this acetylation is what increases 
axon stability. They found that they could increase the levels of acetylated α-tubulin 
through treatment with NAD. 
 
However, some reports, though also aligning with the Nmnat1 hypothesis, do not 
fully support Araki’s conclusion. For example, Zhai et al report that enzymatically 
null Nmnat1 can protect against retinal degeneration in Drosophila, caused by 
excessive neuronal activity (Zhai et al, 2006). Wang et al show that NAD levels 
decline in degenerating neurones and that application of NAD or nicotinamide can 
prevent degeneration of transected axons. However, the doses they use (up to 10mM) 
are high and maybe non-physiological, and they conclude that Nmnat1/NAD-
mediated protection is mediated locally rather than through a nuclear pathway (Wang 
et al, 2005). Watanabe et al generated WldS or Nmnat1-overexpressing Neuro2A cell 
lines and induced neurite elongation with retinoic acid. The over expression of WldS 
delayed the neurite degeneration by vincristine, whereas that of Nmnat1 did not 
delay it much. They conclude that Nmnat1 is considerably weaker than WldS for 
protection from toxic injury in vitro (Watanabe et al, 2007). 
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The hint that the neuroprotection might be due to Nmnat1 over expression has lead to 
optimistic trials of drugs that interfere with the Nmnat1-NAD-Sirt metabolism in a 
variety of animal models of disease. It has been reported that nicotinamide, the 
precursor to NAD reduces hypoxic-ischemic brain injury in the newborn rat (Feng et 
al, 2006) and that it protects against ethanol induced neurodegeneration in the 
developing mouse brain (Ieraci and Herrera, 2006). However, these studies look at 
apoptosis rather than axon degeneration and may be investigating a different 
phenomenon altogether. Nicotinamide was also used to protect mice with 
experimental autoimmune encephalomyelitis (EAE) from axonal degeneration. The 
authors found a profound protective effect of nicotinamide on neurological disability 
in the EAE model as opposed to a modest reduction of neurological disability of 
EAE in WldS mice (Kaneko et al, 2006). However, the nicotinamide treatment 
affected inflammation and demyelination as well as axonal loss, suggesting that 
again, the phenomenon might be slightly different from WldS protection. 
 
Despite the evidence and enthusiasm for the Nmnat1 hypothesis, there is significant 
data against a theory of axonal protection based purely on Nmnat1 overexpression. 
Conforti et al (2007) made Nmnat1 transgenics and despite matching the Nmnat 
activity of WldS heterozygotes, which have a robust slow Wallerian degeneration 
phenotype, Nmnat1 transgenic mice showed rates of Wallerian degeneration that 
were not discernibly different from wild type mice. They also demonstrated that 
Nmnat1 has significantly lower potency to protect neurites from traumatic or toxic 
injury in vitro. Although they do not rule out the possibility that Nmnat1 could delay 
Wallerian degeneration when expressed at very high levels, they conclude that the 
data demonstrates the ability of WldS to protect axons is greater than that of Nmnat1 
alone. Overexpression of Nmnat1 cannot therefore be the complete explanation for 
the WldS phenotype (Conforti et al, 2007). 
  










Figure I.3 The NAD biosynthesis pathways from nicotinamide, 
based on Revolla et al, 2004 
Mack et al demonstrated a 4 fold increase in Nmnat1 enzymatic activity 
but no increase in the amount of NAD in the nervous system in WldS 
mice. The theory that WldS protection is mediated by increased Nmnat1 
activity, argues that the increased Nmnat1 activity results in an increase 
in flux through the Sir2 pathway known to regulate survival during nutrient 
restriction in yeast.  
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I.6.4 Other mediators 
While one approach has been to ask which part of the WldS molecule causes the 
phenotype, another approach has been to look at differences in gene and protein 
changes between WldS and wild-type mice in order to identify downstream 
messengers. 
 
Gillingwater et al (2006a) performed a comparative gene expression profile 
(microarray) on three independently prepared and analysed preparations of mRNA 
extracted from WldS and wild type mice. Based on a stringency criterion of consistent 
two-fold or greater difference in expression level, 10 genes were identified, 6 
upregulated and 4 down-regulated, of which the largest changes were upregulation of 
Erythroid differentiation regulator 1 like-EST (Edr1l-EST) and down regulation of 
pituitary tumour transforming 1 (Pttg1). Gillingwater et al validated the microarray 
data using quantitative real time Polymerase Chain Reaction (PCR) to measure the 
mRNA expression levels of these candidate genes. 
 
HEK293 cells, transfected with a WldS-expressing plasmid, demonstrated that Pttg1 
and Edr1l-EST mRNA expression could be altered in human cells in vitro. They 
were also altered following transfection of the NSC34 neural cell line with the same 
construct. Exogenous application of NAD and expression of either of the WldS 
domains (N70 or Nmnat1) alone could also cause some of the mRNA levels to 
change suggesting that different components of the WldS regulate bidirectional gene 
transcription changes. 
 
There was no indication, from the data in the study by Gillingwater et al, as to how 
Wld
S regulates the mRNA expression of these other genes. It shows no homology to 
characterised transcription factors. The paper gives some preliminary evidence that 
WldS might regulate at least some of the genes through Nmnat1-NAD-sirtuin 
pathway. Down regulation of pttg1 mRNA was abolished when WldS transfected 
HEK293 cells were treated with sirtinol. 
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There is some indication that, at least some of the specific genes discussed in the 
paper may not turn out to be involved in the protective phenotype. Null-mutant 
(knock-out) mice without pttg1 do not show neuromuscular synaptic or axonal 
protection after axotomy (Gillingwater et al, 2006a). Interference in expression of the 
other genes has not yet been tested. 
 
Following up these investigations, Wishart et al (2007) carried out a differential 
proteomics analysis of synaptosomal preparations from WldS and wild type mice. 
They prepared these synaptosomes from the striatum since these synapses show a 
robust neuroprotective phenotype after traumatic brain injury (Gillingwater et al, 
2006b). This study resulted in identification of 16 proteins which had significantly 
different expression profiles in WldS and wild-type synaptosomes.  
 
Eight of the proteins identified by Wishart et al (2007) are known to be localised to 
mitochondria. The other eight have links to known neurodegeneration and 
neuroprotection. The eight mitochondrial proteins that were modified showed either 
elevated or reduced levels indicating that the number of mitochondria remains the 
same in WldS mice, but perhaps their state is altered. Subsequent screening showed 
that 3 more mitochondrial proteins are also altered in WldS animals (Wishart et al, 
2007). These changes may amount to priming the mitochondria to resist 
degeneration. How this comes about remains to be resolved. 
 
There is other evidence suggesting that mitochondria might be central to the WldS 
phenotype. Ikegami and Koike showed that while neurites of wild-type neurones 
experienced an early loss of mitochondrial membrane potential and subsequent 
Adenosine Triphosphate (ATP) depletion, when treated with vincristine, WldS 
neurites maintained both the mitochondrial membrane potential and ATP content 
(Ikegami and Koike, 2003). 
 
As well as highlighting mitochondria as a possible target in WldS protection. The 
authors also suggest some of the protein changes can be linked both to the Nmnat1 
and Ube4b components of the WldS gene. E.g.: One of the proteins identified in the 
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screen is UBE1. Changes in the expression levels of this gene (it was upregulated) 
could be seen to be linked to the expression of N70 in WldS. Another of the proteins 
is Aralar1, involved in the transfer of NAD(P)H into mitochondria. Alterations in the 
proteins in both NAD metabolism and the UPS indicate that both components of the 
Wld
S gene potentially affect the state of the synapses. However this does not indicate 
which of these changes are important for the phenotype. 
 
Interestingly none of the proteins flagged by the proteomic analysis coincided with 
any of the genes strongly up or down regulated at the mRNA level. None of the 11 
molecules found in the microarray were pulled up in the proteomics analysis. There 
are several possible explanations for this: Some of the proteins translated from the 
mRNAs maybe localised to the soma or axon rather than the synapse; due to the 
analysis of the 2D protein blot some proteins spots may have been occluded by larger 
protein spots or perhaps the spots were of too small an amount to be seen. 
 
In summary, whatever the mechanism for affecting transcription, and whether or not 
the most dramatically altered genes or proteins are involved in the WldS phenotype, it 
is conclusive that expression of WldS in neurones affects transcription of other genes 
and translation of synaptic proteins. This constitutes compelling evidence that 




Apoptosis is the well characterised (molecularly, mechanistically and 
morphologically) process by which cells are eliminated when they are damaged, 
dangerous or superfluous. It is an active, highly organised and regulated process 
characterised by cell shrinkage, chromatin condensation, DNA fragmentation, 
membrane blebbing and the formation of apoptotic bodies that are rapidly 
phagocytosed by macrophages (Wyllie, 1997).  
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Apoptosis can be triggered by either extrinsic or intrinsic signals. Both these 
pathways converge on activation of executioner caspases that cleave various 
substrates which bring about cell death. 
 
1.7.1 Caspases 
Caspases are cystine proteases that target aspartate residues of various substrates and 
are the main effectors of apoptosis. Caspases are normally present in the cell as 
inactive zymogens. 14 mammalian caspases have been described. However, not all 
of these participate in apoptosis; caspase-1 and caspase-11 are predominantly 
involved in the processing of pro-inflammatory cytokines. Depending on their mode 
of activation, the other caspases are categorised as either initiator or effector caspases 
(Freidlander, 2003).  
 
The initiator caspases are caspase-8 and caspase-9 which mediate the extrinsic and 
intrinsic pathways respectively. Protein complexes assembled in these pathways 
activate the initiator caspases; the death-inducing signalling complex (DISC) in the 
extrinsic pathway and the apoptosome, which consists of apoptotic protease-
activating factor-1 (APAF-1) and cytochrome-c in the intrinsic pathway. Several 
models for activation of initiator caspase-8 and caspase-9 have been proposed. 
 
Effector caspases such as caspase-3 and caspase-7 are activated by cleavage by 
initiator caspases and they subsequently cleave various substrates to induce cell 
death. Over 100 proteins have been identified as substrates. 
 
I.7.2 The extrinsic pathway 
The extrinsic or external pathway involves activation of a death receptor by a pro-
apoptotic ligand. Death receptors belong to the Tumour Necrosis factor (TNF)/nerve 
growth factor receptor superfamily. Among the best characterised are Fas and TNF 
receptor 1. The ligands that bind these belong to the TNF superfamily of cytokines 
and include TNFα and Fas ligand (FasL).When a death receptor binds its ligand this 
brings about a conformational change which sets in motion a cascade of protein-
protein interaction that leads to assembly of the DISC. Once the DISC activates 
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initiator caspases, apoptosis continues with or without involvement of the 
mitochondria (Okouchi et al, 2007). 
 
I.7.3 The intrinsic pathway 
The intrinsic pathway is activated by apoptotic stimuli such as DNA damage, 
reactive oxygen species or fas signalling. The central step involves the 
permeabilisation of the outer membrane of the mitochondria and subsequent release 
of pro-apoptotic factors that are normally based in the mitochondrial inter-membrane 
space, into the cytosol. Outer mitochondrial membrane permeability is governed by 
members of the Bcl-2 family (Danial, 2007; Wei et al, 2001).  
 
The Bcl-2 family comprises over 30 proteins and can be divided into anti-apoptotic 
proteins (eg: Bcl-2) and pro-apoptotic proteins (eg: Bad, bak and bax). The pro-
apoptotic proteins can be divided into multi-domain (eg: bad and bak) or Bh-3 
proteins (eg: bax). The pro-apoptotic Bh-3 proteins require a multi-domain protein to 
induce apoptosis. 
 
The anti-apoptotic proteins defend mitochondrial outer membrane integrity through 
interaction with the pro-apoptotic proteins. The susceptibility of a cell to apoptosis is 
directly related to the ratio of pro- and anti- apoptotic Bcl-2 family proteins. Cells 
that are deficient in both the two multidomain pro-apoptotic proteins, bax and bak, 
fail to release cytochrome-c and are resistant to all apoptotic stimuli that activate the 
intrinsic pathway (Wei et al, 2001). Similarly, over-expression of the anti-apoptotic 
protein Bcl-2 also protects cells from apoptosis (Martinou et al, 1994). However, 
once the mitochondrial apoptotic signalling process has been initiated, Bcl-2 proteins 
no longer exert any effect.  
 
The pro-apoptotic proteins, normally resident in the mitochondrial inter-membrane 
space include cytochrome-c and AIF, both normally involved in the electron 
transport chain. Released into the cytosol, these molecules trigger caspase-dependent 
or independent apoptotic death pathways. The caspase-dependent mechanism is 
mediated by caspase 9 via the apoptosome formed through interaction of 
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cytochrome-c and Apaf-1. For the caspase independent mechanism molecules such 
as AIF translocate to the nucleus and can induce DNA fragmentation and chromatin 
condensation. 
  
I.7.4 Apoptosis and neurodegenerative disease 
Apoptosis has a role in the normal development of the nervous system. Terminally 
differentiated neurones retain the normal full apoptotic machinery and ability to 
undergo apoptosis in response to various apoptotic stimuli (Okouchi et al, 2007). 
 
As described in I.1, what all neurodegenerative diseases have in common is the loss 
of neurones. Evidence for a role in apoptosis in the loss of neurones is extensive 
(Okouchi et al, 2007). For this reason many treatment strategies focus on preventing 
the neurone from undergoing apoptosis (Waldmeier and Tatton, 2004). 
 
However there is growing evidence that neurodegenerative diseases are correlated 
more directly with degeneration of neuronal processes, which precede neuronal 
apoptosis (Coleman et al, 2004; Smith et al, 2005; Fischer and Glass, 2007). 
 
Sagot et al (1995) investigated inhibition of apoptosis in the pmn mouse model of 
Motor Neurone Disease by crossing the pmn mouse with a transgenic mouse that 
over-expresses human Bcl-2. The pmn mouse is the same mouse model of ALS used 
by Ferri et al (2003) to test the potential protective benefits of WldS, as described in 
section I.4.  
 
The overexpression of Bcl-2 in the pmn mice rescued facial neurones, which 
demonstrated a normal soma size and expression of choline acetyltransferase. 
However, Bcl-2 over expression did not rescue the mice. Their symptoms (atrophy of 
the hind limbs and loss of grasp activity in the back paws) appeared at the same time 
as pmn mice without Bcl-2 over expression and progressed over the same time 
course, with death occurring in the sixth or seventh week. Sagot et al conclude that 
Bcl-2 overexpression cannot prevent disease progression in pmn mice. They noted 
that Bcl-2 over expression did not prevent degeneration of myelinated axons in the 
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facial and phrenic motor nerves. This contrasts sharply with the protective effects of 
Wld
S observed by Ferri et al and highlights the importance of the axonal impairment 
in the clinical manifestation of the disease. 
 
Perhaps regulation of apoptosis can be used to counteract neurodegenerative disease. 
However, what the above experiment demonstrates is that without axonal protection, 
increasing survival of neuronal cell bodies may have limited use.  
 
I.8 The compartmental theory of neurodegeneration 
 
There is plenty of evidence against the same key molecules being involved in 
Wallerian degeneration and in apoptosis. 
 
As described in I.7.4 Sagot et al found that protection of the cell body, through Bcl-2 
over expression, was not enough to retard onset or progression of one 
neurodegenerative disease (Sagot et al, 1995). This was explained through the 
observation that axon loss, which is more tightly correlated with clinical progression 
of the disease, occurred regardless, in these mice. Similarly, Bcl-2 does not prevent 
colchine-induced neurite degeneration although it delays apoptosis of the cell soma 
in cerebellar granule cell neurones (Volbracht et al, 2001). Bad and bax null mice 
exhibit no protection from Wallerian degeneration in explants of sciatic and optic 
nerve, though their retinal ganglion cell bodies are completely protected from 
apoptosis (Whitmore et al, 2003).  
 
Finn et al (2000) showed that caspase-3 is not activated in PNS or CNS axons during 
degeneration, although it is activated in the dying cell body of the same neurones. 
Caspase inhibitors (eg: zVAD-fmk) do not delay axon degeneration, although they 
inhibit apoptosis of the same neurones. The authors conclude that axon degeneration 
is molecularly distinct from caspase-dependent apoptosis in the same neurones. 
 
Just as those genes and proteins known to be involved in apoptosis do not seem to 
have similar roles in Wallerian degeneration, the corollary is also true. WldS does not 
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protect against somatic apoptosis in conditions where it protects neurites from 
degeneration (Deckwerth and Johnson, 1994). 
 
 
However, there are indications that Wallerian degeneration is analogous to 
apoptosis. Wallerian degeneration is a self destruction mechanism, executed in 
response to injury, which can be manipulated genetically. Where apoptosis is specific 
to the cell body, Wallerian degeneration is specific to the specialised processes of 
one cell type- the axon of a neurone. 
 
The pmn mouse, demonstrated by Sagot et al, to show signs that correspond, not to 
the loss of cells, but to the loss of axons belonging to those cells, might be expected 
to take greater benefit from a therapy that protects axons. Indeed Ferri et al, crossed 
the pmn mouse with the WldS mouse, as described in I.6, and found the WldS gene 
product attenuates signs of disease, extends life span, prevents axon degeneration, 
rescues motor neurone number and size, and delays retrograde transport deficits 
(Ferri et al, 2003). By contrast Bcl-2 over expression does not attenuate disease signs 
or increase life span in pmn mice (Sagot et al, 1995). 
 
Wld
S also protects axons in explants of sciatic and optic nerve from Wallerian 
degeneration where Bad and bax knock-outs failed (Whitmore et al, 2003) 
 
The compartmental neurodegeneration hypothesis, proposed by Gillingwater and 
Ribchester (2001), suggests that three compartments of a neurone, which we have 
long described as morphologically and functionally distinct, may also have distinct 
programmes of self destruction, governed by different molecular players. The 
controlled death of the cell body is regulated by a plethora of proteins such as the 
Bcl-2 family and the caspases. Wallerian degeneration of the axon is regulated by 
Wld
S and as yet unconfirmed additional molecules.  
 
The third putative compartment is the axon terminal. As explained in I.3, WldS 
protection of axon terminals is not as complete as its protection of axons. Though the 
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latter is robust, the former is eliminated with age, and with lower gene dosage. The 
fact that axon terminals are able to degenerate in the presence of both Bcl-2 
upregulation and WldS expression suggests that they also have their own mechanism 
for self destruction, though the molecules responsible are not yet known. 
 
I.8.1 Clinical relevance of the compartmental theory of neurodegeneration 
The consequences of this theory are important for neurodegenerative research. What 
has been demonstrated is that protection of the cell body can not diminish the 
severity of diseases where axon degeneration is what correlates with symptoms, as in 
Motor Neurone Disease.  
 
When an Alzheimer’s disease patient dies, neuronal loss is a prominent feature. 
However, evidence suggests that, like Motor Neurone Disease, what actually 
correlates with disease progression is axon and synapse loss in the brain (Selkoe, 
2002). Song et al (2006) describe a culture system in which the environment of the 
cell bodies and axons can be manipulated separately. Addition of amyloid peptide 
(Aβ), a peptide which accumulates and deposits in the brains of Alzheimer’s disease 
patients, to the axon compartment induces axonal degeneration followed by neuronal 
cell body degeneration. Inhibition of caspase activation blocks Aβ induced apoptosis 
but not the axonal degeneration. However, blocking the axonal degeneration with a 
calpain inhibitor blocks not only the axonal degeneration but also apoptosis of the 
cell body. This suggests that it might even be possible to prevent neuronal cell death 
through inhibition of axonal degeneration.  
 
Ultimately to battle a disease in which multiple neuronal compartments are involved 
it may be necessary to invoke a cocktail of substances that can combat both apoptosis 
and Wallerian degeneration, as well as protecting synapses from degeneration. 
 
I.9 Aims of the thesis 
 
Many questions remain to be answered on the subject of WldS and Wallerian 
Degeneration. For instance, important questions remain about the molecular 
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mechanism of protection by WldS protein, including the roles of Nmnat1 enzymatic 
activity, the VCP binding domain in the N-terminus, the precise cellular locus of the 
protein’s main effects, the signalling pathways involved and the ultimate molecular 
targets of the protective effects. However the phenotypic characterisation of WldS is 
also incomplete and arguably the unknowns here are at least as important to 
establish, since the phenotype defines the kinds of questions that must be addressed 
on a cellular and molecular level. For instance it is remarkable that a mutation having 
such a profound effect on the response of neurones to injury, apparently has no 
discernable constitutive phenotype, despite substantial accumulation of mutant 
protein in neurones. In general, bridging phenotype-genotype gaps in biology 
remains an important challenge in many areas of molecular genetics. This thesis, 
therefore, largely addresses the hypothesis of compartmental degeneration and the 
scope and utility of the WldS phenotype in exploring, testing and better defining it. 
 
Currently the compartmental degeneration hypothesis is based on extensive work 
with motor neurones. It explains the degeneration of neuronal cell somas by 
apoptosis and how interference in that may protect them. It explains the degeneration 
of axons by Wallerian degeneration and how interference in that may protect them. It 
also explains that neither of these degeneration mechanisms account for the 
degeneration of axonal terminals, pre-synaptic compartments, which exhibit 
degeneration in the presence of WldS (known to protect axons) and Bcl-2 (known to 
protect cell bodies). However, it is unknown if this compartmentalisation extends to 
all axonal endings, as most of the work has been carried out examining 




 protection differentiate between sensory endings and axons, as it does 
motor endings and axons? 
Should all axon terminals, or specifically pre-synaptic structures, be considered as a 
separate neurodegenerative compartment? 
 
To answer this question I have studied the degeneration of Ia afferent endings on 
muscle spindle organs in the muscles of WldS mice. 
  
 - 43 - 
 
Given the answer to this question, the second part of my thesis follows: 
 
Why are sensory axons and endings so much better protected than motor axons 
and endings? 
I have investigated hypotheses based on differences in protein expression through 
Western Blotting of dorsal root ganglia and spinal cord, and through immunostaining 
sensory and motor nerves. 
 
I also examined whether a difference in the branching patterns might distinguish the 
protection between sensory and motor neurones. This was achieved through study of 
the specialised γ-motor neurones that innervate the intrafusal muscle fibres of the 
muscle spindle and that branch less than α-motor neurones. I compared the 
degeneration of the terminals of these neurones in WldS mice, to that of motor 
neurones with larger motor unit sizes, which innervate the extrafusal muscle fibres. 
 
Finally, I tested whether a difference between motor and sensory axon stump could 
be due to endogenous the activity present. Tissue culture of sensory and motor nerve 
was used to eliminate this difference. 
 
The last part of this thesis attempts to extend the theory of compartmental 
degeneration. Though descriptions of the degeneration of cell body, axon and axon 
terminal have been discussed, another classical compartment of the neurone, the 




 protect against dendritic degeneration? 
Does this separate morphological and functional compartment have a self destruction 
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M. Methods  
 
M.1 Animals and animal care 
A transgenic mouse line that has become central to the study of Wallerian 
degeneration is one in which fluorescent protein is expressed in neurones driven by 
the thy1.2 promoter. 
 
Green Fluorescent Protein (GFP) from the Aequorean victoria jellyfish has proved 
invaluable to biological research because it is a protein and can be harmlessly driven 
in cells in an organism of interest. This was first shown to be useful in eukaryotes by 
Chalfie et al in 1994. They demonstrated that expression of the DNA in 
Caenorhabditis elegans produced a fluorescent product. The gene sequence has been 
altered to produce spectral variants, for example cyan fluorescent protein (CFP) and 
yellow fluorescent protein (YFP) that emit different wavelengths of light. This can be 
visualised in a variety of ways, most commonly by fluorescence microscopy or 
confocal microscopy (Shaner et al, 2005). 
 
In thy-1.2-XFP mice, the fluorescent protein, driven by the thy-1.2 promotor, labels 
the neurone in its entirety, however, despite using identical constructs, different 
subsets of neurones are labelled in each of the 25 lines generated (Feng et al, 2000). 
Of these 25 lines, there are 3 which have been used extensively throughout my PhD. 
These are the CFP-23, YFP-16 and YFP-H lines [Figure M.1, adapted from Feng, et 
al 2000]. All DRG sensory neurones and spinal motor neurones are reported to be 
labelled in the CFP and YFP16 lines, but only about 5% of them in the YFP-H line. 
However, I found that γ-motor axons and their terminals were usually not labelled in 
the CFP line. 
 
Mice from thy-1.2-XFP lines were mated with WldS homozygotes to produce thy-1.2 
XFP Wld
S heterozygote lines. Backcrossing to WldS homozygotes produced WldS 
homozygotes which also expressed fluorescent protein in neurones. Mice of each 
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genotype and at a range of ages between 8 and 88 weeks were examined for this 
thesis. 
 
All animals procedures reported in this thesis were performed according to Home 
Office regulations and with the necessary project and personal licences 
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Figure M.1 Table of expression of fluorescent protein in thy1.2-
XFP mice based on a figure by Feng et al (2000) 
Regulated by the thy1.2 promoter, very different expression profiles 
of yellow, green and cyan fluorescent proteins produced were 
produced in the nervous system of mice. The mouse lines I use 
have been highlighted: the YFP16, YFP-H and CFP-23 lines. 
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M.1.1 Animal sacrifice 
All animals were killed by either cervical dislocation or by exposure to increasing 
levels of CO2, in accordance with schedule 1 of the licensing regulations provided by 




M.2.1 Fluorescence microscopy 
Fluorescent molecules glow when their electrons are raised to an excited energy state 
by absorbing a high energy photon. Some energy is lost to other molecules as 
electrons return to their ground state. The rest of the energy is lost by emitting 
photons of light with lower energy (ie: a longer wavelength). The difference between 
excitation and emission wavelengths is called the Stokes shift and forms the basis for 
using separate emission, absorption filters and dichroic (or dichromatic) mirrors in 
fluorescent microscopy. 
 
In fluorescence microscopy, light from a source (often a mercury lamp) is reflected 
off a dichroic mirror toward the specimen. A dichroic mirror reflects short 
wavelengths, but allows longer wavelengths to pass through. The returning emitted 
fluorescence, now at a longer wavelength, is allowed to pass through the dichroic 
mirror to the eye-piece [Figure M.2, based on a figure by Semwogerere and Weeks, 
2005]. 
 
For confocal microscopy the mercury lamp is replaced by a laser. An argon laser is 
typically used to excite CFP, GFP or YFP; a helium-neon laser is used to excite red 
fluorescence, such as from rhodamine-conjugated proteins. Light from the laser is 
reflected on the dichroic mirror and is scanned across the specimen by scanning 
mirrors. Optical sectioning occurs after the light passes back through the dichroic 
mirror, when it enters a confocal pinhole on its way to the detector, comprising a 
sensitive photomultiplier. [Figure M.2, based on a figure by Semwogerere and 
Weeks, 2005]. The recorded photon energies are used to construct a two-dimensional 
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digital image. The confocal arrangement of excitation and emitted light maximises 
resolution and minimises blur from light emitted above and below the focal plane. 
Maximum brightness projection of a stack of confocal images obtained by 
systematic, sequential scanning through a vertical set of image planes in a specimen 
(Z-series) allows viewing of features of interest from different angles, rotating 
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Figure M.2 Diagrams of fluorescent and confocal microscopy 
based on Semwogerere and Weeks, 2005. 
A) In fluorescence microscopy, light is reflected off a dichroic mirror 
toward the specimen, this reflects short wavelengths, but allows 
longer wavelengths to pass through. The returning emitted 
fluorescence, now at a longer wavelength, is allowed to pass 
through the dichroic mirror to the eye-piece. B) For confocal 
microscopy the light source is replaced by a laser. The laser is 
reflected on the dichroic mirror and scanned across the specimen by 
the scanning mirrors. Optical sectioning occurs after the light passes 
back through the dichroic mirror, when it enters a pinhole on its way 
to the detector. 
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M.2.2 Sciatic Nerve Cuts 
Mice were anaesthetised by Halothane inhalation (Merial Animal Health Ltd.) at 2-
5% in Oxygen and Nitrous oxide (1:1). This was delivered using a Fluovac system 
(International Market Supply). Once a suitable level of anaesthesia had been 
achieved, examined by pinching the toe and noting the absence of a reflex response, 
the skin above the nerve was shaved and swabbed and the sciatic nerve on one side 
exposed. Approximately 1mm of the nerve was removed. Complete nerve transection 
was achieved with surgical scissors. The skin wound was closed with a single suture 
using 7/0 silk suture (Ethicon). 
 
M.2.3 Lumbrical Preparation 
Mice were sacrificed between 8 hours and 20 days after the sciatic nerve cut and the 
four deep lumbrical muscles from each hindfoot were dissected in oxygenated 
mammalian physiological solution (Ringer solution) with mM concentrations as 
follows: NaCl 120; KCl 5; CaCl2 2; MgCl2 1; NaHCO3 23.8; D-glucose 5.6. All 
chemicals used in the Ringer are purchased from VWR International Ltd and Fisher 
Chemicals, Fisher Scientific. 
 
Dissected preparations were pinned out in Sylgard (Dow Corning) coated Petri 
dishes containing oxygenated Ringer solution using minutien pins (fine science 
tools). 
 
Lumbricals were incubated with Tetramethyl rhodamine isothiocyanate conjugated 
α-bungarotoxin (TRITC-α-BTX; purchased from either Molecular Probes or 
Cambridge Bioscience) for 10 minutes followed by washes in Ringer solution, then 
fixed in 4% paraformaldehyde (PFA; purchased from Fisher Scientific) for 20 
minutes and washed in 1% phosphate buffered saline (1% PBS with the following 
micromolar concentrations; 137 NaCl, 2.76 KCl, 8.10 Na2HPO4 and 1.47 KH2PO4).  
 
The solutions were kept in constant motion by placing the dish on a rotating platform 
during incubations. 
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Lumbrical preparations were mounted on glass slides in glycerol with 2.5% 1, 4-
diazabicyclo [2.2.2] octane (DABCO) and covered with glass coverslips, to allow 
visualisation using fluorescence and confocal microscopy. 
 
M.2.4 Spindle teasing 
After dissection and preparation of lumbrical muscles, as described, the muscle was 
teased apart on a microscope slide in DABCO in glycerol. This was performed under 
the dissection microscope using a pair of pin vices. The position of the spindle was 
confirmed by visualisation of the preparation under a fluorescent microscope, as 
described below, during the process of teasing [Figure M.3]. When the intrafusal 
muscle fibres were isolated to the extent that their innervation was distinct from all 
the extrafusal innervation, a coverslip was applied to allow visualisation under the 
confocal microscope. 
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M.3 A teased muscle spindle 
A teased muscle spindle from a YFP16 mouse with α-BTX used to stain γ-
neuromuscular endplates: A) Transmitted light to show the intrafusal 
muscle fibres, B) Fluorescence microscope photo of the primary sensory 
ending (white arrow), secondary sensory endings (green arrow) as well as 
γ-motor innervation (red arrow) at the pole, C) Combined image. 
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M.2.5 FM1-43fx 
Lumbrical muscles were dissected as described above. Muscles were subsequently 
pinned in the sylgard coated Petri dish and incubated with a fixable form of the 
original vital aminostyryl dye FM1-43fx (Molecular Probes) diluted in oxygenated 
Ringer solution to give a final concentration of 4-10 µM. They were pinned under 
full tension for 20 minutes and then returned to resting length for a further 20 
minutes. This stretch followed by a relaxation of the muscles was repeated 3 times 
giving a total time of submersion in the FM1-43fx of 2 hours. The solutions were 
kept in constant motion by placing the dish on a rotating platform during incubations. 
Muscles were then given a few quick washes in oxygenated Ringer solution and one 
or two short washes then fixed in 4% PFA for 20 minutes.  After washing they were 





Muscles, nerves and dorsal root ganglia were dissected in oxygenated Ringer 
solution. They were then fixed in 4% PFA for 20-30 minutes and washed in 1% PBS. 
 
Tissue was then incubated in blocking solution (4% bovine serum albumin, 0.5% 
Triton-X in PBS) for 4 hours/overnight at 4ºC. Primary antibody (Anti-Wld18, 2/1000 
in blocking solution) was applied overnight at 4ºC. The tissue was washed in 1% 
PBS for 5-8 hours and secondary antibody applied overnight at 4ºC. After a final 
wash in 1% PBS the tissue was put on slides in DABCO and glycerol and a coverslip 
applied for visualisation. 
 
M.2.7 Antigen retrieval method 
In order to investigate whether WldS immunoreactivity was concealed by protein 
cross-linking caused by the fixation procedure, I examined whether it could be 
detected in axons or muscle treated with citraconic anhydride (Sigma Aldritch) and 
heat as described in Namimatsu et al (2005). 
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Tissue was treated as described above with an additional step. After fixation and 
before the application of the primary antibody, the tissue was heated to 98ºC in 
0.05% citraconic anhydride solution in PBS, for 45 minutes. 
 
M.2.8 Visualisation and image capture 
Slides were viewed under an Olympus BX50WI fluorescent microscope using Zeiss 
10x, 20x and 40x objectives and a mercury lamp. Fluorescein Isothiocyanate (FITC) 
excitation/emission block (450-490 nm excitation filter, 510 nm dichoric mirror and 
510-520 emission filter) was used for visualising YFP labelled axons and a 
customised excitation/emission block designed for visualisation of FM1-43 (435nm 
excitation filter, 455nm dichoric mirror and 515 IF emission filter) was used for 
visualising CFP labelled axons and FM1-43 labelled muscle spindles. A TRITC 
excitation/emission block (510-560nm excitation filter, 580 nm dichroic mirror and 
590 emission filter) was used for visualising TRITC labelled α-bungarotoxin. 
 
Images were captured using a colour chilled 3CCD camera (Hamamatsu C5810 or 
C4742-80) connected to an Apple G4 computer running Openlab (Improvision). 
 
Slides were subsequently viewed under a Biorad Radiance 2000 confocal microscope 
via a Nikon Eclipse E600 microscope. A 10x objective and 40 x and 60 x oil 
immersion objectives were used. Fluorophores were excited with an Argon, HeNe or 
Red Diode laser. Images were captured with Lasersharp 2000 software running on a 
Dell Poweredge 1400 computer. 
 
M.2.9 Spindle quantification 
The number of innervated spindles per muscle was counted under the fluorescent 
microscope described above. 
 
Morphology of innervated spindles was examined in confocal images. These were 
viewed using ImageJ and Adobe Photoshop from the Biorad source (.pic) files using 
the appropriate plug-ins. For measurements, the measuring tool provided by ImageJ 
was used. All data were entered into Microsoft excel 2001 worksheets for further 
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analysis. For Figures, Adobe Photoshop was used to reconstruct muscles or spindles 
that required multiple confocal or fluorescent images. Adobe Photoshop was used for 
image enhancement and files were exported as uncompressed tiffs files or 
compressed jpg files. 
 
The following data were collected; the number of intrafusal muscle fibres, the 
number of Ia, II and γ-motor axons innervating the intrafusal muscle fibres, the 
length of the primary ending (and the other endings, but this data was not used) and 
number of spirals in the primary endings. 
 
Ia and II axons were differentiated by width of the axon and position and 
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Figure M.4 Quantification of spindles 
A) In order to count the number of I, II and γ-axons I used confocal 
microscopy of teased YFP16 muscle spindles, like the one shown here. 
Figure M.3 used arrows to indicate the primary, secondary and γ-
endings. The I, II and γ-axons are the axons supplying each of these 
terminals, respectively.  
 
The identity of axons was judged according their diameter, and position 
and morphology of the ending on the muscle spindle. In the example 
shown the primary, secondary and γ-endings are easy to recognise and 
although higher magnification would be necessary to discriminate the 
number of II and γ-axons, it is possible to see that 2 axons supply the 
primary ending. I have indicated these with two white arrows. 
 
 B) In order to measure the length of the primary ending and to count the 
number of spirals (or transverse bands) I used confocal images of 
spindles situated within a lumbrical muscle preparations, as shown here. 
The distance measured to be the length of the primary ending, was taken 
along the length of the intrafusal muscle fibre, starting and finishing at the 
furthest boundaries of the annulospiral. This is illustrated with a double 
headed arrow in the figure. The parallel lines indicate the ‘top’ of each 
annulospiral counted, 15 in total. 
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M.3 Western blotting 
 
Unless otherwise stated, chemicals and reagents were obtained from Sigma Aldrich 
Company Limited.  
 
M.3.1 Protein extraction 
After sacrifice, spinal cords, between 6 and 8 DRG and dorsal and ventral roots were 
removed as quickly as possible, dipped in liquid nitrogen and put into eppendorfs on 
dry ice. During this process the mouse heads sat in dry ice. Once the other tissue was 
in dry ice the brains were removed either treated similarly (ie: frozen in liquid 
nitrogen and then transferred to dry ice) or homogenised directly into 1ml RIPA 
buffer (10mM HEPES, 150mM NaCl, 1mM EDTA, 1.1% SDS, 1% Triton X-100, 
1% sodium deoxycholate with 1% EDTA-free, Roche protease inhibitor) on ice, then 
homogenised with a fine bore pipette, centrifuged at 10000g and 4ºc and the 
supernatant collected and frozen in the -80º freezer until use. 
 
Brains were removed last as they gave a strong WldS signal at the appropriate 
molecular weight using a variety of protocols, whereas spinal cord and dorsal root 
ganglia samples often produced degradation bands. Data collected using two 
different protocols were used for analysis of WldS expression in cerebellum. 
 
Samples frozen in liquid nitrogen were subsequently homogenised in RIPA buffer 
each using a small glass pestle and mortar. The volume of RIPA used was equivalent 
to the weight of the sample. These were centrifuged and the supernatant collected. 
 
Samples were then mixed with sodium dodecyl sulphate-polyacrylamide gel 
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Gels for SDS-PAGE were purchased pre-cast from Novex, Invitrogen or prepared 
using stock solutions.  
 
When gels were purchased they were Nupage 4-12% Bis-tris, 1.0mm 12 well gels 
used in conjunction with Tricine SDS running buffer. 
 
Where gels were prepared, final concentrations were as follows: Resolving Gel, 
375mM Tris-HCL, 10% Acrylamide, 0.1% SDS, 0.1% NNN’N’- tetramethyl 
ethlylene diamine (TEMED), 0.01% Ammonium persulphate (APS); Stacking gel, 
125 mM Tris-HCL, 4% Acrylamide, 0.1% SDS, 0.1 % TEMED, 0.01 % APS and 
they were used with Biorad 10x Tris-glycine reservoir buffer. 
 
Samples were loaded along with a molecular weight marker, Precision Plus Protein 
marker (dual colour) (Bio-Rad) or SeeBlue pre-labelled standard (Invitrogen). The 
reservoir was filled with running buffer. Protein was then separated by 
electrophoresis at 150V for approximately one hour. 
 
M.3.3 Transfer 
Proteins were transferred to polyvinylidene difluoride (PVDF) membranes. This was 
done using a semi-dry method or a wet transfer as described. 
 
Semi-dry 
The membrane used for the semi dry blots was Millipore PVDF. The transfer was set 
at 13 V for 20 minutes using a semi-dry blotter (Bio-Rad) using a method adapted 
from Towbin et al (1979). PVDF was wetted briefly with methanol and washed with 
water prior to the transfer. The resolving gel, transfer membrane and Grade I filter 
papers (Whatman Laboratories), pre-soaked in transfer buffer made up from 0.192M 
Glycine, 25mM Tris and 20% Methanol, were assembled.  
 
Wet transfer  
Gels were placed onto Amersham Hybond-LFP PVDF membrane from GE 
Healthcare, and sandwiched between filter papers and sponges in an XCell II blot 
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module (Invitrogen), immersed in novex Tris-glycine transfer buffer and transferred 
overnight at 25 Volts. 
 
M.3.4 Immunoblotting 
Membrane was blocked for one hour in nonfat Marvel milk buffer (10% dried marvel 
milk in PBS-T PBS containing 0.2% Tween 20) to prevent non-specific binding of 
primary antibody. The membranes were then incubated with WldS18 antibody raised 
in rabbit (1/4000). Either Mouse anti-β-actin or mouse anti-β-tubulin monoclonal 
antibody was used as a loading control (1/4000) as stated. Following washes, the 
membranes were incubated with horse radish peroxidase (HRP) conjugated 
secondary antibodies. Signal of bound antibodies was developed by ECL 
chemiluminescence Western Blot detection reagent analysis system (GE Healthcare) 
according to the manufactorer’s instructions. Chemiluminescence was detected using 
hyperfilm-ECL (GE Helathcare) and films were processed using a hyperprocessor 
(GE Healthcare). 
 
M.4 Tissue Culture 
 
M.4.1 Nerve explant culture 
After sacrifice, mouse legs were immediately removed, skinned and placed in filtered 
oxygenated Ringer solution. Phrenic nerve was subsequently removed quickly and 
placed in a sterile dish containing culture medium (50% MEM-Earles + 25 mM 
HEPES <no L-glutamine>, 25% HBSS, 25% horse serum (heat inactivated), 1% 
5000:5000 penicillin streptomycin solution and 0.5 ml 100x L-glutamine (200mM 
solution); All invitrogen) warmed to 37ºc. 
 
Sterile tweezers were used to place membrane filters (Millipore; Biopore; CM PICM 
ORG50) in culture dishes containing 1ml of warmed culture media. Isolated nerve 
segments were subsequently transferred on to the membrane filter using a sterile 
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Tibial and saphenous nerves were dissected from mouse legs and treated as described 
for the phrenic nerve above. In dissection of all nerve, non-neuronal tissue was 
removed as much as possible and length of the nerve was cut at approximately 1cm. 
 
Dishes were incubated in a humid atmosphere at 37ºC and 5% CO2. Culture medium 
was replaced within half a day of culture and every 48 hours thereafter. Culture 
medium was warmed to 37ºC before the replacement. 
 
Visualisation of cultured nerves was undertaken periodically before the culture 
medium was due for refreshing. Dishes of cultured nerves were transported in a 
sterile, lidded dish to the alcohol swabbed platform of the fluorescence or confocal 
microscope and imaged as described in section M2.7. On returning to the tissue 
culture lab, culture media was exchanged before the dishes were returned to the 
incubator. 
 
M.4.2 Spinal cord culture 
Live spinal cord sectioning was performed by Carole Torsney in the Hugh Robson 
Building in George square. A 3 week old YFP-H WldS mouse was killed by 
decapitation and the spinal cord quickly removed. This was then stood upright in 
warm agar which was superglued to the cutting surface of a vibratome, and the 
chamber filled with oxygenated Ringer solution. The spinal cord was sliced at 
300µm, 8 sections of spinal cord were retrieved and I placed these in oxygenated 
retinal culture media as described below. These were then brought back to 1 George 
Square (approximately a 5 minute walk) where they were transferred onto a biopore 
membrane on a dish containing 1ml of culture media as described for phrenic nerve. 
  
M.4.3 Retinal culture 
After sacrifice eyes were removed as quickly as possible and placed in filtered 
oxygenated Ringer solution. Retinas was removed from eyes under a dissecting 
microscope in a sterile Sylgard-lined dish. Retinas were then treated exactly as 
described above for phrenic nerve, the only difference being the composition of the 
culture media which was as above but with 8% Glucose and 2% B-27. 
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M.4.4 Retinal injury 
Injury to the retinal explant was performed with a BD microlance or a Swann 
Motson razor blade.  
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Results Chapter 1: Does Wld
S
 protection differentiate between sensory endings 
and axons, as it does motor endings and axons? 
 
1.1 Introduction 
For decades the neuromuscular junction has been used as a model for studying form 
and function of synapses (Sanes and Lichtman, 2001). It is one of the easiest 
synapses to study as it is large and accessible to electrophysiological, morphological 
and molecular techniques. This has meant work on the neuromuscular junction has 
often guided research on other synapses, which has led to understanding of several 
general principles of synapse development, and neurotransmission. It seems likely 
that mechanisms of synaptic pathology might also be gleaned by appropriately 
designed studies of the neuromuscular junction. 
 
Extensive work has been done in the Ribchester laboratory on the effect of WldS on 
degeneration of neuromuscular junctions at the terminals of motor axons (Ribchester 
et al, 1995; Mack et al, 2001; Gillingwater et al, 2002; Adalbert et al, 2005). These 
studies clearly show that neuromuscular junctions are not protected by WldS to the 
same extent as motor axons. Axons are robustly protected for up to a month after 
axotomy in WldS mice, irrespective of age or gene dose, however, in heterozygotes 
and in mice beyond 4 months of age, neuromuscular junctions cease to be protected 
(Gillingwater et al, 2002; Li Fan, 2007, PhD Thesis, University of Edinburgh). This 
has prompted the hypothesis that motor nerve terminals at neuromuscular junctions 
have their own mechanism for self-destruction (Gillingwater and Ribchester, 2001).  
 
The finding that neuromuscular junctions are not protected by WldS in old and 
heterozygote animals implies, perhaps, that WldS does not protect any axonal ending 
in old or heterozygote animals. However in many ways the motor nerve terminal is a 
unique axonal ending. For example, it belongs to one of the largest neurones in the 
body, the motor neurone, which also projects further than most other neurones in the 
body (up to 5 cm in mice). The post-synaptic cell is non-neuronal and specific 
functional constraints have produced a number of adaptations, for example the 
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neuromuscular junction has very high fidelity transmission. ie: it is almost 
guaranteed that the post synaptic cell muscle fibre will respond and contract when 
the pre-synaptic axon fires. 
 
This chapter addresses whether WldS protection discriminates between axons and 
endings in sensory neurones.  I have focussed on the annulospiral sensory ending on 
the muscle spindle. This enables a direct comparison to the axonal terminals in 
muscle as the axons project similar distances and the environment of the endings is 
very similar. 
 
Muscle spindles are sensory organs that signal changes in muscle length. The 
annulospiral endings of Ia fibres are morphologically distinctive and can be readily 
identified in muscles from thy-1.2 XFP mice which express fluorescent protein in 
sensory as well as motor neurones (Feng et al, 2000). 
 
The possibility of a difference between sensory and motor axon protection in WldS 
mice has been reported previously (Brown et al, 1994). The degeneration of sensory 
axons in the sensory saphrenous nerve is slower than that in the phrenic nerve which 
contains mostly motor axons (Brown et al, 1994). In 1995, Fruttiger et al reported 
that they could see a distinct difference in the speed of Wallerian degeneration 
between muscle nerves and cutaneous nerves in 16 week old WldS mice. Five days 
post lesion almost all motor axons had degenerated but more than half of the sensory 
axons were still present (Fruttiger et al, 1995). 
 
With the investigation of sensory ending degeneration in WldS mice being the overall 
aim, three issues were addressed in passing. 
 
First, limited work has been undertaken on the mouse muscle spindle. The anatomy 
of the muscle spindle of the cat has been described in great detail (Banks et al, 1978; 
Banks et al, 1982; Barker and Scott, 1990). Descriptions of muscle spindles in the 
extra-ocular muscles of the cow (Blumer et al, 2003) and in various muscles of the 
rat and human have been published (Kim, 2007; Kararizou et al, 2005). However, 
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there appears to be a large variation in the anatomy of muscle spindles between 
species and possibly, within species from muscle to muscle (Edwards, 1975). Rosa P 
Edwards (1975) used electron microscopy to examine muscle spindles from the 
mouse biceps muscle in 3 month old mice. 7 muscle spindles were examined. Her 
primary aim was to study the capsule, as she was interested in the mode of entry of 
Mycobacterium leprae (that cause leprosy). For this reason, her observations of the 
sensory endings are concise. 
 
Having examined the muscle spindle in unoperated mice as a control for those 
degenerating after axotomy, I was able to draw some conclusions about its 
morphology as visualised by fluorescent protein expression. In the following work, I 
used descriptive statistics to illustrate the basic components of a muscle spindle, as I 
have found them in the mouse lumbrical muscles. 
 
Secondly, I asked whether spindle morphology changes with age. In humans, 
deterioration in gait, stability and both static and dynamic position sense occurs with 
aging (Madhavan and Shields, 2005). Functional and structural changes have been 
reported in the peripheral nerves of old subjects, for example: decreased nerve 
conduction velocity and demyelination. However, Kim (2007) suggests there may be 
age-related changes in the muscle spindles themselves. A physiological study has 
shown that dynamic and static length sensitivities of muscle spindle primary endings 
in response to ramp stretch were decreased in aged rats (Miwa et al, 1995). The 
possibility exists that this is due to morphological changes with age in the receptors 
on the muscle spindles. 
 
Kim studied 121 teased spindles from rat muscle using light microscopy. These were 
divided into 3 groups depending on the age of the rat they had come from. He found 
no difference in the mean number of primary and secondary endings per spindle, but 
did find a difference in length and number of spirals (Kim, 2007). 
  
This is important from the point of view of my WldS study, as any factor affecting 
spindle morphology would affect the quantification I undertook in order to examine 
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degeneration after axon transection. If spindle morphology changes with age, this 
must be taken into account when examining muscle spindles from animals in 
different age groups. For this reason, this question is addressed in mice as a control 
for my later experiments. 
 
Thirdly, the degeneration of axons and their endings in WldS mice is complete by a 
month after axotomy, as opposed to within 48 hours in wild type mice. Is this a 
reflection of a) Wallerian degeneration proceeding at a slower pace, or b) A delayed 
start to Wallerian degeneration or c) an alternative form of axonal degeneration that 
occurs in the absence of Wallerian degeneration? 
 
While quantifying the degeneration of Ia endings on muscle spindles it was possible 
to examine the pattern of degeneration of these spindles and compare this with the 
pattern of degeneration of wild type spindles. By comparing the pattern of 
degeneration in wild type and WldS mice it may be possible to discriminate between 
the options above. This adds information to the study of the mechanism of WldS-
mediated interference with Wallerian degeneration. 
 
1.2 Morphology of the muscle spindle 
 
I used confocal microscopy of 65 muscle spindles in lumbrical muscles, and 15 
teased muscle spindles to investigate the anatomy of the mouse muscle spindle and to 
test whether there was any change in this, due to aging. 
 
I counted the number of intrafusal fibres that were innervated, and the number of 
axons innervating those fibres, classifying them as Ia, II sensory or γ-motor. I 
measured the length of the primary ending and counted the number of spirals, 
described elsewhere as ‘transverse terminal bands’, that the primary endings made on 
contact with the intrafusal muscle fibres. More detailed description of these 
measurements is included in the Methods section. 
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I divided the analysed spindles into two groups, based on the age of the mouse from 
which they were taken. 
 
There was no significant difference between spindles from 8 week old mice and 
those from mice between 40 and 60 weeks of age when comparing the number of 
intrafusal muscle fibres innervated, or the number of Ia, II or γ-motor axons 
innervating the muscle spindle [Figure 1.1]. 
 
I also found no significant difference in the length or number of spirals of the muscle 
spindles in the two age categories. [Figure 1.1] 
 
I conclude, therefore, that over the age range I studied in mice there are no overt 
morphological changes in the innervation of lumbrical muscle spindles with age. 
 
Since there were no identifiable differences between the muscle spindles from older 
or younger mice, I used pooled the data in order to obtain a general description of the 
mouse lumbrical muscle spindle. 
 
I found that there are between 2 and 5 intrafusal muscle fibres, innervated by either 1 
or 2 Ia axons, with between 0 and 2 II axons. There were between 2 and 5 γ-motor 
axons supplying the poles with innervation [Figure 1.2]. The average length of the 
primary ending was 142.5+/- 43.11µm, and the lengths are distributed with a 
Gaussian distribution (Kolmogorov-Smirnov Test). The average number of 
annulospirals was between 22 and 23, and the number of spirals was also distributed 
normally (Kolmogorov-Smirnov Test) [Figure 1.2]. 
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Figure 1.1 No difference in spindle morphology with age 
Neither the length, nor the number of spirals, was significantly different 
between spindles from 8 week old animals (n=36) and 40+ week animals 
(n=8). The number of intrafusal muscle fibres and the numbers of axons 
innervating the spindles were not significantly different between the age 
groups either (8 week olds, n=7; 40+ week old, n=8). The box-whisker 
plots shown indicate the median, interquartile range and outliers of the 
data set. 
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Figure 1.2 The components of a mouse lumbrical muscle spindle 
Having examined 15 teased muscle spindles, the components of a 
mouse muscle spindle are presented here. Each dot represents a 
spindle. There are between 2 and 5, but most commonly 2 or 3, intrafusal 
muscle fibres; 1 or 2 primary axons in about equal proportions; up to 2 
secondary axons and between 2 and 5 γ-axons. The box-whisker plots 
summarise the data by indicating the median, interquartile range and 
range of the data set. 
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1.3 Controls 
 
Figure 1.3 shows that each lumbrical muscle contains a different number of spindles. 
The fourth deep lumbrical has the fewest muscle spindles, which might be expected 
due to its slightly smaller size, and the second and third have the most. Interestingly, 
instances were found where the fourth or first deep lumbricals appeared to contain no 
muscle spindles at all. Throughout my analyses I counted the number of innervated 
spindles per foot as a measure that could indicate degeneration of Ia endings. 
 
In order to be sure that the only factor affecting the number of innervated spindles 
per foot was degeneration due to axotomy, I tested for significant differences 
between the numbers of innervated spindles per foot in male/female, YFP16/CFP, 
left/right foot paired categories. These were all non-significant p=0.7127, 0.0942, 
0.7781 respectively (Mann Whitney test).  
 
I also tested for any effect of WldS gene expression on the number of muscle 
spindles. There was no significant difference between WldS homozygotes, 
heterozygotes or wild type animals in the number of muscle spindles located in the 
lumbrical muscles, p=0.8930 (Kruskal-Wallis, non parametric analysis of variance 
test) [Figure 1.4]. 
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Figure 1.3 The distribution of muscle spindles in the 
lumbrical muscle of the mouse foot 
I examined 48 mouse feet. Due to a significant difference 
in the number of innervated spindles per lumbrical muscle, 
I used totals from whole feet in the rest of my analysis. 
The box-whisker plots indicate the median, interquartile 
range and range of the data set. 
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Figure 1.4 Controls 
Box-whisker plots indicate the median, interquartiles and range of the 
data sets. Neither genotype, nor sex of the mouse affected the number of 
innervated muscle spindles per foot (male (n=37)/female (n=33) 
p=0.7127, YFP (n=41)/CFP (n=22) p=0.0942, WldShet (n=23)/ WldShom 
(n=21)/ WT (n=21) p= 0.8930). There was no difference between the 
number of muscle spindles in the left (n=8) and right feet (n=35) (p= 
0.7781) 
  




 strongly protects Ia annulospiral endings from degeneration after 
axotomy 
 
As expected, in 8 week old WldS mice, annulospiral endings are apparent in muscles 
2 days after axotomy, when wild type muscles are completely devoid of innervation. 
Remarkably, annulospiral endings could be identified in dissected lumbricals up to 
20 days after axotomy [Figure 1.5]. Therefore, muscle spindles in WldS mice remain 
innervated 10 times longer than they do in wild type mice after nerve injury [Figure 
1.6]. 
 
The number of innervated muscle spindles per foot was not significantly different 
from control feet, up to and including 5 days post axotomy [Figure 1.6]. 
 
I also noted that sensory axons innervating the muscle spindle survive intact up to 20 
days post axotomy, while the endings themselves do begin to degenerate, as can be 
observed from Figure 1.5.  
 
The length of the Ia ending in innervated spindles remains equivalent to control 
spindles up to 5 days post axotomy [Figure 1.7]. However, the number of spirals 
decreases within the same time frame. This pattern of losing spirals before losing 
length is examined further in section 1.7. 
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Figure 1.5 Confocal mircographs of preserved IA endings on muscle 
spindles in the muscles of WldS mice after axotomy 
Confocal micrographs of innervated muscle spindles found in the 
muscles of 8 week old WldS mice. Marked on each panel is the number 
of days after axotomy. Each picture features one annulospiral ending. 
 
This figure demonstrates that primary sensory endings are identifiable in 
the lumbrical muscles up to 20 days post axotomy. It shows the 
degeneration of IA endings with time post axotomy. It is also included in 
order that the reader can familiarise his/herself with the appearance of IA 
endings at various stags of degeneration as these are examined 
throughout this chapter. 
 
In these images it can be observed that the axons innervating the 
sensory ending are always intact (when present). It can also be noted 
that the Ia Spindle ending itself degenerates over these 20 days, so that 
by 5 days post axotomy, although the primary ending retains the length of 
an unoperated spindle the annulospiral features begin to be lost. From 5-
20 days length of the ending also decreases. These observations are 
explored further in later figures. Scale bars= 50µm. 
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Figure 1.6 Persistence of innervated muscle spindles in the 
lumbricals of WldS mice after axotomy 
 
The bar graph shows the number of innervated spindles counted per foot 
at the given number of days after axotomy in WT and WldS mice. 
Annulospiral endings could be identified up to 20 days post axotomy in 8 
week old WldS mice, in contrast no annulospiral endings could be 
identified in wild type muscle 2 days after axotomy. This suggests WldS 
preserves Ia sensory endings for about 10 times longer than they would 
survive in wild type animals. 
 
The number of innervated spindles per foot was not different in WldS 
mice in unoperated animals and up to and including 5 days post 
axotomy. However 10 days post axotomy and 20 days post axotomy 
there were significantly fewer innervated spindles per foot than in 
unoperated animals, p<0.01 and p< 0.001 respectively (Tukey’s multiple 
comparison test).  
 
For 8 week old WldS animals, n = 25, 4, 2, 8, 7, 8 for 0, 1, 3, 5, 10 and 20 
days post axotomy respectively. For wild type animals n= 21, 4, 4, 4, 3, 1 
for 0, 1, 3, 5, 10, 20 days post axotomy respectively. 
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Figure 1.7 Quantifying degeneration of Ia annulospiral endings in 
WldS mice 
There is no significant different between the length of the primary ending 
in WldS mice up 5 days post axotomy, and in unoperated animals. 
However, during the same time frame the number of spirals decreases. 
 
N= 29 for unoperated feet, n=7 for feet 5 days post axotomy. 
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1.5 Wld
S
 protects Ia endings better than motor endings 
 
In heterozygous WldS mice, and in mice as they age, motor endings lose the 
protection afforded by the gene. In order to investigate whether sensory endings have 
a similar phenotype, I examined innervation to the muscle spindle in old and 
heterozygote mice. 
 
Surprisingly, Ia Sensory endings persist up to 20 days in heterozygous WldS mice and 
also in mice at 16 weeks and older [Figure 1.8]. This is in contrast to the motor 
endings, which are not protected in heterozygote [Figure 1.9] or old homozygous 
Wld
S mice [Figure 1.10]. 
 
There is also evidence that sensory endings in young homozygote WldS mice are 
protected to a greater extent than motor endings, as they persisted in muscles which 
had lost all motor innervation [Figure 1.11]. 
 
Figure 1.12 shows the percentage of innervated neuromuscular junctions in the 
lumbrical muscles, 5 days post axotomy, divided into groups dependent on mouse 
age and genotype. In order to compare this information about the motor innervation 
to information on sensory innervation, I converted the data on sensory innervation to 
percentages also. I did this using the number of innervated spindles in unoperated 
muscles as the denominator. 
 
The oldest mouse I was able to investigate was 88 weeks old and 5 days after 
axotomy there were 4 innervated spindles one of which is pictured in Figure 1.13. 
 
These results demonstrate that muscle spindle endings have stronger protection from 
Wallerian degeneration post axotomy than motor endings do. 
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Figure 1.8 Protection of Ia annulospiral endings in heterozgous and 
aged WldS mice 
Confocal images of preserved IA annulospiral endings on muscle 
spindles in lumbrical muscle preparations. Marked on each panel are the 
number of days after axotomy. Top row, examples from aged WldS mice 
(32-58 weeks of age), Bottom row, examples from heterozygous WldS 
mice. 
 
As in Figure 1.5, this demonstrates that preserved annulospiral endings 
can be identified in muscles up to 20 days post axotomy. The 
degeneration of these spindles can be seen over time post axotomy. 
Features such as intact sensory axons supplying the endings, and 
degeneration of the annulospiral morphology occurring before reduction 
of the length of the primary ending can again be noted (but are the 
subject of later figures). 
 
Scale bars= 50µm 
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Figure 1.9 Ia annulospiral endings are protected to a greater extent 
than motor endings in heterozygous WldS mice.  
Confocal micrographs of lumbrical muscle from heterozygous WldS mice. 
Top row) 5 days post axotomy. Bottom row) 20 days post axotomy. 
Innervated muscle spindles and denervated neuromuscular junctions 
visualised with TRITC conjugated α-BTX are shown. Arrows indicate 
annulospiral endings which are shown in more than one panel. Scale 
bars= 50µm except where indicated to be 100 µm. 
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Figure 1.10 Ia annulospiral endings are protected to a greater extent 
than motor endings in aged WldS mice  
Confocal micrographs of lumbrical muscles showing innervated muscle 
spindles and denervated neuromuscular junctions visualized with TRITC 
conjugated α-BTX. This figure gives examples of the relative protection of 
the sensory endings in comparison to the neuromuscular endings in mice 
older than 8 weeks. Top row, 16 week old WldS mouse 5 days post 
axotomy, bottom row, 58 week old WldS mouse 10 days post axotomy. 
Arrows indicate annulospiral endings which are shown in more than one 
panel. Scale bars= 50µm except where indicated to be 100 µm. 
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F 5 days Post axotomy 
 
 
Figure 1.11 Ia annulospiral endings may be protected to a greater 
extent than motor endings in young WldS mice 
Figure extends over previous page. 
 
Confocal micrographs showing sensory and motor endings in 8 week old 
WldS mice. A and B) 5 days post axotomy, C, D and E) 10 days post 
axotomy.  
 
Although at 5 days both sensory and motor endings show some 
protection from degeneration, at 10 days post axotomy, the preservation 
of the sensory endings can be seen to be greater that the preservation of 
the motor endings. Sensory endings indicated with white arrows. (Motor 
endings can be recognised due to staining of the post synaptic receptors 
with TRITC-conjugated α-BTX) 
 
F) Reconstruction of part of a lumbrical muscle from an 8 week old WldS 
mouse, 5 days post axotomy. This shows intact axons (white arrow) 
leading to sensory endings and degenerating axons (yellow arrow) 
leading to motor endings. Scale bars= 50µm except where indicated to 
be 100µm 
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Figure 1.12 Ia annulospiral endings are protected to a greater extent 
than motor endings in old and heterozygote WldS mice.  
A graph that shows the percentage of innervated motor endplates 5 days 
post axotomy in young (n= 8), old (n= 10) and heterozygote (n= 12) WldS 
mice. In contrast the number of innervated sensory endings, expressed 
as a percentage of the number of innervated sensory endings in 
unoperated mice, is higher in all three groups, but particularly in old and 
heterozygote WldS mice 
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Figure 1.13 Preserved muscle spindles in the muscles 
of 88 week old WldS mice. 
I was able to examine the four lumbrical muscles of one 
foot from an 88 week old mouse, 5 days post axotomy and 
found four innervated muscle spindles and no motor 
innervation. One of the spindles is shown here. Scale bar= 
50µm. 
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It is clear from the measurements on lumbrical muscles of old and heterozygote 
mice, that WldS protects sensory endings better than motor endings. However, it is 
not obvious whether the protection of the Ia endings is dependent on the age of the 
animal or the number of copies of the gene. 
  
Figure 1.8 shows preserved spindles from old and heterozygote animals 2, 5, 10 and 
20 days post axotomy. These spindles look similar to the Ia endings shown in young 
homozygotes [Figure 1.5]. 
 
Figure 1.14 shows a comparison between the numbers of innervated muscle spindles 
at each time point post axotomy. An analysis of co-variance suggests that there is no 
significant difference between the rate of degeneration of muscle spindles in older or 
heterozygote mice and young homozygotes, p= 0.8175.  
 
Although there is no significant difference, the group that appeared superficially to 
lose protection of Ia endings first is the young homozygotes. Figure 1.14 shows that 
at 10 days post axotomy the number of innervated spindles in young homozygotes 
appears lower than the innervated spindles from heterozygote and old mice. 
However, this impression is likely to be an artefact due to the relative ease of 
counting spindles in lumbrical muscles where all the motor innervation has 
disappeared (such as in old and heterozygote WldS mice) in comparison to a 
lumbrical muscle with degenerating motor endings and axons that mask the 
degenerating Ia endings (as in young homozygote WldS mice). 
 
The surviving Ia endings appeared to degenerate at similar rates in old and 
heterozygote mice. There is no effect of group on the change in length or the change 
in number of spirals (Two-way ANOVA) [Figure 1.15]. Again, the observation can 
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be made that the length of the Ia ending does not change in the first 5 days post 
axotomy, while the number of spirals decreases. 
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Figure 1.14 There is no significant difference 
between the protection of Ia annulospiral 
endings in old, young or heterozygote WldS mice 
The graph shows the number of innervated spindles 
per foot at the given number of days post axotomy 
for each of the three groups of mice, young 
homozygotes (aged 8-12 weeks), old homozygotes 
(aged 32-58 weeks) and 8 week old heterozygote 
WldS mice. The table shows the n numbers for each 
group at each time point.  
 
Linear regression was used to plot the rates of 
decline for each group. The rates of decline in the 
numbers of innervated sensory endings were not 
significantly different between heterozygote, old and 
young WldS mice p = 0.8175 (ANCOVA). 
  
 - 100 - 
  
 - 101 - 
Figure 1.15 No significant difference between groups in the 
degeneration of annulospiral endings 
Graphs show the number of spirals and length of the primary ending in 
unoperated mice and mice 5 days post axotomy. There was no 
significant difference in the change in length (p= 0.2177) or no. of spirals 
(p=0.5998) between young, old and heterozygote WldS mice (Two-way 
ANOVA). As seen in young homozygotes, the degenerating spindles in 
all groups of WldS mice lost spirals before they lost length. 
 
For unoperated feet n= 29, 7, 8 and at 5 days post axotomy n= 7, 13, 10; 
for 8-12 week WldS mice, 30+ week old WldS mice and 8-12 week old 
heterozygote WldS mice respectively.  
  





protects axons more robustly than endings 
 
The previous data suggest that sensory endings are preserved irrespective of age and 
gene dose, which means they have more robust protection in old and heterozygous 
animals than neuromuscular junctions. However, they still appear to degenerate 
ahead of their parent axons. Figure 1.16 shows muscles containing Ia annulospiral 
endings that have nearly completely degenerated. However, the axons appear intact. 
 
In order to examine which compartment degenerates first, I examined 105 spindles 
and classified them as to whether they were fragmented or intact, and connected or 
disconnected (ie: whether the axons were unbroken). Figure 1.17 demonstrates that 
Wld
S Ia afferents lose their endings, before their axons begin to degenerate. 
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Figure 1.16 Sensory axons are better protected than 
sensory endings in WldS mice.  
Confocal microscope pictures of lumbrical muscle 
preparations from WldS mice 5-20 days after axotomy. These 
images show Ia annulospiral endings at various stages of 
degeneration (yellow arrows), but with strongly protected 
unbroken parent axons innervating them (white arrows). 
Neuromuscular endplates are also visible due to incubation 
with TRITC-conjugated α-BTX. All scale bars=100µm. 
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Figure 1.17 WldS sensory endings degenerate before their attached 
axons 
Figure to show percentage of spindles in different categories at given 
number of days after axotomy. Categories are designed to discriminate 
between annulospiral endings that are degenerating before or after their 
parent axon. Diameter of the circle at each vertex of the kite represents 
the percentage of spindles that fell within that category. 105 spindles 
were examined from more than 30 mice. No spindle at any time point, 
remained intact while its parent axon degenerated (ie: no annulopsiral 
ending examined was intact but disconnected). In addition no spindle at 
any time point degenerated alongside its parent axon (ie: no annulospiral 
ending was degenerated and disconnected). Instead all spindles 
examined were either intact and connected ie: neither the annulospiral 
ending nor the axon showed signs of degeneration, or fragmented and 
connected ie: the annulospiral ending was degenerating but the axon 
remained unbroken. This suggest Ia annulospiral endings spindles 
degenerate before their parent axon in WldS mice. The progress of the 
degeneration can also be seen in this figure, with the proportion of intact 
connected Ia afferents decreasing over time post-axotomy. 
 
N= 12, 4, 6, 11, 11, 4 for 0, 1, 3, 5, 10 and 20 days post axotomy 
respectively. 
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1.8 Pattern of degeneration 
 
In order to examine whether wild type Ia afferents degenerated with a similar pattern 
to WldS Ia afferents, I classified them in a similar manner to the WldS Ia afferents in 
1.6. In wild type mice there were more instances where an intact or near intact Ia 
ending was connected to an axon that contained breaks [Figure 1.18]. Examples of 
these are pictured in Figure 1.19. This suggests that Ia annulospiral endings in wild 
type mice degenerate alongside their axon after axotomy in wild type animals. This 
is qualitatively different to the pattern of degeneration in WldS mice where the 
endings degenerate first. 
 
Between 1 and 2 days post axotomy the number of innervated spindles in wild type 
muscle decreased [Figure 1.6], however the number of spirals and length of the 
remaining endings remained high [Figure 1.20]. This quantifies an observation I had 
noted; most wild type spindles that were innervated had well preserved morphology, 
unlike the WldS Ia endings which lost spirals as they degenerated over time. Wild 
type endings appear to remain intact after axotomy and must abruptly degenerate 
within a few hours. Figure 1.21 is a diagram to illustrate the differences in the pattern 
of degeneration between wild type and WldS Ia endings. 
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Figure 1.18 WT sensory endings degenerate alongside their 
attached axons 
Figure to show percentage of spindles in different categories at given 
number of days after axotomy. Diameter of the circle at each vertex of 
the kite represents the percentage of spindles that fell within that 
category. Unlike degenerating WldS spindles, spindles in lumbrical 
muscles from wild type animals, appear to degenerate alongside their 
parent axons giving rise to a number of spindles falling into both the 
intact, disconnected category and the fragmented, disconnected 
category. 
 
N= 3, 4, 6, 6, 3 for 0, 0.3, 0.6, 1 and 1.3 days post axotomy respectively. 
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Figure 1.19 WT sensory endings degenerate alongside their 
attached axons 
Confocal microscopy shows spindles in wild type animals during their 
degeneration 1-2 days after axotomy. Top image shows a spindle with 
intact morphology whose parent axon is broken. Remaining images show 
degenerating spindles attached to broken axons. Scale bars= 50µm. 
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Figure 1.20 Different pattern of degeneration in WT and WldS 
spindles after axotomy 
Graphs that show the number of spirals, or length of the primary endings, 
at given amount of time post axotomy. While WldS spindles lose spirals 
before they lose length after axotomy, which indicates that they do not 
retain normal morphology over time after disconnection, innervated wild 
type spindles retain their morphology with both length and number of 
spirals remaining high for innervated spindles in axotomised muscles. 
This suggests they must degenerate rapidly once degeneration is 
initiated. 
 
N= 6, 4, 10, 10, 3 for spindles from WT mice, 0, 0,3, 0.6, 1, 1.3 days post 
axotomy; and n= 31, 13, 16, 16, 20 for WldS mice 0, 1, 3, 5, 10 days post 
axotomy 
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Figure 1.21 Diagram to show pattern of degeneration of WldS and 
WT Ia sensory endings 
Three to 5 days after axotomy, WldS endings begin to show 
morphological degeneration while maintaining their length. Between 5 
and 10 days after axotomy the ending loses length and morphology and 
between 10 to 20 days after axotomy, the ending has completely 
degenerated. Breaks only begin to appear in the parent axon once 
degeneration of the ending is complete. 
 
WT endings maintain their morphology for up to 32 hours, but rapidly 
degenerate alongside the parent axon. 
  




In this chapter I have described the innervation of the lumbrical muscle spindle in the 




I characterised the innervation of the mouse muscle spindle and found that there were 
no changes with age over the age-range studied. 
 
I present evidence that suggests that slow Wallerian degeneration of sensory 
terminals, occurs with a qualitatively different pattern from Wallerian degeneration. I 
have found that wild type Ia endings degenerate rapidly after a latent phase in which 
they maintain their normal morphology. In WldS animals, however, the degeneration 
is gradual, over a longer time period and involves loss of spirals from the primary 
ending occurring before loss of length. 
 
I demonstrated that Ia afferent endings are protected by WldS to a much greater 
extent than neuromuscular junctions are, both in terms of length of survival after 
axotomy and also in terms of robust survival in older animals and in heterozygotes.  
 
I will review these findings and their implications and then discuss the contribution 
of this work to the compartmental hypothesis of neurodegeneration. 
 
1.9.1 Morphology of the mouse lumbrical muscle spindle 
There is very little literature on the anatomy of the mouse muscle spindle. Having 
studied numerous mouse muscle spindles as a control for my degeneration 
experiments I was able to use descriptive statistics to outline the components of the 
mouse muscle spindle in the lumbrical muscle. 
  
Edwards (1975) previously reported that the number of intrafusal muscle fibres in the 
mouse biceps muscle was 2, 3 and 4. When four were present two were nuclear bag 
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and two nuclear chain. I have found the range to be between 2 and 5, but this minor 
discrepancy may simply be due to either the different muscles studied or the 
difference in sample size as there was only one muscle spindle with 5 intrafusal 
muscle fibres out of the 15 that I examined and Edwards only studied 7 spindles in 
total. 
 
I found the average length of the primary ending to be 142.5 +/- 43.11 compared 
Kim’s finding in rats of 167.1 +/- 32.8 (Kim, 2007). This probably reflects their 
smaller body size. 
 
I also tested for any structural changes in the mouse muscle spindle that occurred 
during aging, but found no difference in any of the parameters measured between 
spindles from mice aged 8 weeks and those between 40 and 60 weeks of age.  
 
This was done as a control for my degeneration experiments, however, a change in 
spindle morphology has also been suggested to be a factor in the decline of postural 
stability with age (Kim, 2007), so to some extent, the result is interesting in its own 
right. Addition of a third, more elderly group of mice could perhaps elucidate any 
changes that may occur later in life. 
 
1.9.2 The pattern of Ia terminal degeneration 
My findings that Ia sensory terminals degenerate with a qualitatively different pattern 
in WldS mice than in wild type mice supports the conclusion made by Beirowski et al 
(2005) that WldS mutant mice undergo a fundamentally distinct process rather than 
simply following the same molecular pathway in slow motion. 
 
Beirowski et al (2005) studied degeneration of sciatic and tibial nerves from YFP-H 
mice. They found that delayed degeneration in individual WldS axons is directional 
with an exclusively anterograde pattern after either axon transection or crush injury. 
This pattern of degeneration was qualitatively different from what was observed in 
the nerve of wild-type mice. Wild type nerves degenerated with asynchronous, 
bidirectional fragmentation.  
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Indeed, even before 2005, differences in slow Wallerian degeneration and Wallerian 
degeneration in wild type mice had been noted. Gillingwater at al (2003) report that 
different ultrastructural events occur during degeneration of neuromuscular junctions 
in WldS mice and in wild type mice.  
 
In contrast the ultrastructural events in the degeneration of synapses in the brains of 
Wld
S mice after cortical ablation were delayed but indistinguishable from the 
degeneration in wild type mice (Gillingwater et al, 2006b). 
 
My results support the hypothesis that, rather than Wallerian degeneration 
proceeding at a slower pace, or a delayed start to Wallerian degeneration, Wallerian 
degeneration is abolished altogether and an alternative degeneration occurs in its 
absence. Electron microscopy of degenerating sensory endings in wild type and WldS 
mice could throw further light on this possibility. 
 
Beirowski et al (2005) suggest that this alternative degeneration may be passive 
degeneration due to disconnection from the cell body as Wallerian degeneration was 
once thought to be. Gillingwater et al suggest that there may be similarities between 
the degeneration of motor nerve terminals in WldS mice and the degeneration that 
occurs during development or in some diseases suggesting WldS mouse could be used 
as a model for these situations. 
 




The result that sensory endings are protected by WldS to a greater extent than motor 
endings has implications for the use of WldS in neurodegenerative therapies. 
 
Wld
S mice have been crossed with various mouse models of motor neurone disease. 
In these crosses, WldS has had variable success in improving the disease signs and 
lifespan of the animals. One factor that may affect how successful WldS is, in the 
treatment of these diseases, is that the protection of neuromuscular junctions is 
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reduced with age. Indeed the most promising study has come from the study of the 
progressive motoneuropathy mouse (pmn mouse) which develops disease very early 
in life. Ferri et al, crossed the pmn mouse with WldS mice and found the WldS gene 
product attenuates symptoms, extends life span, prevents axon degeneration, rescues 
motor neurone number and size, and delays retrograde transport deficits (Ferri et al, 
2003). However, the SOD1-G93A mouse, an extensively used model of familial 
ALS that develops disease later in life, demonstrated no benefits from a cross with 
the WldS mouse at time points beyond 80 days. There was no significant difference in 
innervation of neuromuscular junctions, and the mice had no phenotypic 
improvements as measured by rotorod (Fischer et al, 2005). 
 
The age-related decline in WldS-mediated protection of neuromuscular junctions may 
be a huge barrier to clinical application of WldS research in motor neurone disease 
and up until now the assumption has been made that any axonal ending would be 
similarly unprotected from degeneration in aged WldS mice. This renders WldS 
protection far less imminently useful, because age is a common risk factor to most 
neurodegenerative diseases. However recent studies suggest that other mutations can 
modify and enhance the strength of synaptic protection in WldS mice. These include 
point mutations in the WldS gene itself (B. Beirowski, M.P. Coleman, R. R. 
Ribchester et al, submitted) and random ENU-induced mutations at as-yet 
uncharacterised loci (F. Wong, G. Blanco and R. R. Ribchester, in preparation). This 
may be cause for optimism that the downstream signalling mechanism responsible 
for WldS protection might ultimately be translated into new treatments that could 
benefit humans with these neurodegenerative diseases. However, as things currently 
stand and given the result that sensory endings are protected to a far greater extent 
than motor endings and with no effect of age, perhaps neurodegenerative diseases or 
neuropathies that primarily effect sensory neurones stand to benefit more from 
therapies based on a mechanism of WldS protection. 
 
Sensory axons degenerate in response to chemotherapeutic drugs used in cancer eg: 
Paclitaxel (Lipton et al, 1989) and cisplatin (Krarup-Hansen et al, 2007). The 
neurotoxic side effects of these drugs limit doses and their therapeutic use (Lipton et 
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al, 1989). Sensory axon degeneration is also a complication in patients with diabetes 
(Muller et al, 2008), HIV (Keswani et al, 2006) or diseases such as chronic 
cholestasis, abetalipoproteinaemia, celiac disease or cystic fibrosis which lead to 
vitamin E deficiency (Aslam et al, 2004). There are also rare inherited or sporadic 
genetic sensory neuropathies. 
 
Wang et al (2002b) demonstrated that young homozygote WldS animals were less 
susceptible to the side effect of sensory axon degeneration in response to paclitaxel 
treatment using behavioral, physiological, and pathological measures. It would be a 
very interesting experiment to repeat this in heterozygotes and in older animals. 
Success could mean that those researching WldS for translational and clinical gains 
might switch attention from ALS to sensory disorders. 
 
Another important clinical implication is for other neurodegenerative diseases. 
Axonal endings in the brain have not been tested in mice over 8 weeks due to the 
presupposition that, like the neuromuscular junction, axonal endings in the brains of 
older WldS mice would degenerate rapidly. Perhaps the CNS experiments are now 
worth repeating in aged animals in order to assess whether synapses in the brain 
retain protection when neuromuscular junctions have lost it. This would demonstrate 
whether therapy based on WldS is worth pursuing for the common neurodegenerative 
diseases such as PD and AD. 
 
There are also scientific implications of the finding that different neuronal cells may 
have different degrees of axon and axon terminal protection due to WldS expression. 
Investigators work on the mechanism for WldS action in many different classes of 
neurones in vivo and in culture. Results may not be repeatable or comparable if one 
group are testing molecules on cultured DRG neurones, another group are working 
with cultured SCG neurones and a third group test in vivo by quantifying 
neuromuscular innervation after axotomy. 
 
1.9.4 The compartmental theory of neurodegeneration 
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The compartmental theory of neurodegeneration suggests that the separate 
compartments of the neurone which are morphologically and functionally distinct 
also have separate mechanisms of degeneration. 
 
If the same molecular mechanism was involved in the destruction of the axon and 
axon terminal, then it would be expected that any genetic intervention would have an 
equivalent effect on the destruction of both these compartments. However, in the 
case of WldS, aged or heterozygote WldS mice have robustly protected axons but the 
neuromuscular terminals proceed to degenerate on the same time scale as in wild 
type animals. 
 
The finding that there is strong protection of sensory endings in homozygote WldS 
mice independent of age, and that there is also equivalent strong protection in 
heterozygous WldS animals, suggest it may not be possible to generalise from the 
study of neuromuscular junctions to make assumptions about all axonal endings. 
This observation may therefore suggest that the compartmental theory of 
neurodegeneration, where the soma, axon and axon terminal are considered as 
separate compartments can only be specifically applied to motor neurones. 
 
However, despite the robust protection of sensory endings, I believe other evidence 
presented in this chapter supports more general application of the compartmental 
theory of neurodegeneration. 
 
Though the protection of sensory endings was more robust than that of motor nerve 
terminals, like motor nerve terminals, the axonal endings of sensory neurones were 
the first compartment to degenerate in WldS animals. Intramuscular sensory axons 
remained unbroken up to 20 days post axotomy, at a time point when all Ia endings 
had substantially degenerated. This suggests a retrograde pattern of degeneration 
occurring in the lumbrical muscle. 
 
Beirowski et al, 2005 reported that all degeneration in the injured nerves of WldS 
animals occurs anterogradely and proposed to rename slow Wallerian degeneration 
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as “slow anterograde axon decay”. The authors suggest two hypotheses to explain the 
anterograde degeneration that they observe. They note that the degeneration rate 
occurs at about the same speed as slow axonal transport. They suggest that a net 
anterograde gradient of cytoskeletal proteins could underlie the anterograde gradient 
of axonal atrophy as structural proteins are gradually depleted at the proximal end of 
the axon stump. The second explanation they propose is that a proximal-distal 
temperature gradient could be the cause of the difference in degeneration rate along 
the axon, as a decrease in temperature has been shown to delay degeneration in WldS 
axons after injury (Tsao et al, 1999a). 
 
If, in WldS animals, the axonal terminals were degenerating with the same 
mechanism as the rest of the axon, it would be expected that they would be last to 
degenerate. Instead I have observed that sensory terminals degenerate first. Given the 
observation that the axon degenerates anterogradely, there is a sharp contrast 
between the distal axon which lasts longest and the terminal which degenerates first. 
 
Taken together, the data from my own observations of sensory degeneration in WldS 
and the data from observations of axonal and neuromuscular terminal degeneration it 
appears that there is likely to be a separate axonal terminal compartment which 
undergoes its own molecularly distinct form of degeneration in WldS mice and 
therefore possibly in wild type mice under certain conditions. Whether or not there is 
a common mechanism which is responsible for both sensory and motor axon 
terminals is beyond the scope of the data presented here, but a question that would be 
interesting to tackle. 
 
Another question that arises is to find out where the first degenerative events happen 
after axon transection. To what extent is the degeneration in WldS animals 
bidirectional, given that there appears to be retrograde degeneration in the muscle 
and anterograde degeneration in the nerve?  
 
1.9.5 What causes the sensory-motor difference? 
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The difference in protection of sensory and motor axons and endings may affect 
clinical and scientific work in the future. However, the difference itself is also 
curious. Why is it that sensory axons and endings are protected to a greater extent 
than motor axons and endings? 
 
This question will be the subject of my following chapter. 
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In Chapter 1, I found that protection of sensory axonal endings was independent of 
age and gene copy number in WldS mice. In contrast, I confirmed that the protection 
of α-motor endings declines with age and there is no protection in heterozygote WldS 
animals. This means WldS protection of sensory endings is better than that of α-
motor endings in both homozygous animals over 16 weeks of age, and in those 
animals which are heterozygous for WldS. 
 
The present chapter examines three hypotheses which might explain this aspect of 
the WldS phenotype. These are protein expression levels, differences in the branching 
patterns of the axons and differences in activity experiences by sensory and motor 
axonal stumps. The results essentially rule out all three alternatives. 
 
2.2 Protein expression 
 
Given the similarity in phenotype for aged WldS and heterozygous WldS mice, I asked 
if decreased protein expression could be a common cause. Protein expression has 
been studied before using Western Blot. No differences were found in the amount of 
WldS protein in whole brain homogenate from mice between 2 and 12 months of age 
(Gillingwater et al, 2002). However, given the results of my first chapter, it seems 
possible that the age-effect is not specific to all the neurones in the brain. I 
investigated cerebellum, spinal cord and dorsal root ganglia to see whether there was 
a decline in WldS protein expression in these tissues, in older mice. The spinal cord 
samples were particularly important as these contain the cell bodies of motor 
neurones which we know to have an age-dependent phenotype. 
 
While running Western blots to detect WldS protein changes with age in the spinal 
cord, DRG and cerebellum, I also ran sciatic nerve, and dorsal and ventral roots and 
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detected WldS protein in these tissues. This result followed personal communication 
from Dr M. P. Coleman, whose group now has preliminary evidence that WldS 
works directly through a mechanism in the axon. Other recently presented data 
demonstrated that WldS is not required to be localised to the nucleus in order to cause 
the phenotype (Sasaki et al, 2006). Perhaps a difference in sensory and motor axons 
causes the difference in the level of WldS protection. For these reasons it also seemed 








I collected cerebella from wild type mice, young and old homozygote WldS mice and 
heterozygote WldS mice, extracted the protein and ran these samples for Western 
Blot. I detected no discernable difference in the amount of WldS protein extracted 
from the cerebellum of old and young WldS mice [Figure 2.1A]. In contrast, there is a 
striking difference in the amount of WldS extracted from heterozygote brains.  
 
I collected spinal cord samples from wild type mice and from young and old WldS 
mice. I found no apparent differences between the amount of WldS protein extracted 
from the spinal cords of young and old WldS mice [Figure 2.1B].  
 
I ran dorsal root ganglia samples from wild type mice and from young and old WldS 
mice. Again, I was unable to detect a difference in the amount of WldS protein 
extracted from old mice in comparison to that extracted from young mice [Figure 
2.1C]. 
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Figure 2.1 No detectable difference in WldS protein expression in 
cerebellum, spinal cord or dorsal root ganglia with age 
Western blots demonstrating no discernable difference in WldS protein 
levels in the nervous system of young and old WldS mice. A) Cerebella 
from WT, Young, old and heterozygous WldS mice. B) Spinal cord from 
WT, young and old WldS mice. C) DRG from WT, young and old WldS 
mice. 
  




 protein is readily detected in nerve preparations by Western blot 
While Western blotting, I also ran samples from sciatic nerve, dorsal and ventral 
roots. Although there were some unspecific bands and noise, probably due to the 
long exposure time necessary to detect the small amounts of protein extracted, I 
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Figure 2.2 WldS protein detected in sciatic nerve, ventral 
and dorsal roots. 
Western blot of sciatic nerve, ventral and dorsal root 
preparations from WT and WldS mice. These nerve 
preparations from WldS mice demonstrate immunoreactivity to 
WldS.  
  




 protein is not readily identified by immunohistochemistry in axons 
or their endings 
Given that WldS is present in the Western blot of nerve and roots, and given more 
evidence (M.P. Coleman and colleagues, unpublished observations) that WldS is 
present in axons; and given evidence that axonal WldS may have an effect (Sasaki et 
al, 2006), I considered the possibility that there might be a difference in WldS protein 
expression in the axons and endings of sensory in comparison to motor axons and 
endings. I examined tibial, phrenic and saphenous nerve as well as the motor and 
sensory endings in lumbrical muscles using DRG from WldS animals as a positive 
control. I was unable to detect immunoreactivity to WldS in any nerve examined 
[Figure 2.3].  
 
In order to thoroughly investigate axonal localisation of WldS, I repeated the 
immunoprotocol on nerves using an antigen retrieval method based on Namimatsu et 
al (2005). The idea behind this is that fixation in paraformaldehyde cross links 
proteins which then mask the antigen of interest. Again I was unable to detect 
immunoreactivity to WldS in either axon or axonal terminals in muscle. I was also 
unable to detect the fluorescence of the thy-1.2 YFP in these nerves or muscles after 
this treatment (data not shown). 
 
While I was unable to detect WldS immunoreactivity in nerves or nerve endings in 
lumbrical muscles, I did see specific WldS staining localised to the cytoplasm of the 
DRG cell somas, which I was using as controls [Figure 2.3]. 
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Figure 2.3 No sign of WldS immunoreactivity in nerve from WldS 
mice. 
Confocal microscopy showing WldS immunoreactivity in the nuclei of 
DRGs from WldS mice and none in the DRGs from WT mice. There is no 
WldS detectable in sciatic, tibial, phrenic or saphenous nerve from WldS 
mouse. Tibial nerve is shown; from a WldS mouse above and WT below. 
Interestingly there appears to be immunoreactivity to WldS in the 
cytoplasm of the WldS DRG neurones, indicated by a white arrow, as well 
as in the nuclei. Scale bars= 50µm. 
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2.3 Axonal branching 
 
Next, I asked whether the difference in protection might be associated with different 
degrees of axon branching. The axon of an α-motor neurone branches many times to 
innervate each endplate of a motor unit, in mouse lumbrical muscles the motor unit is 
between 35 and 80 muscle fibres with a mean of about 54. In contrast, a sensory 
neurone travels unbranched all the way to its target. 
 
It is plausible that axonal branching is somehow causal to the weakening of WldS 
protection, because although motor axons in the nerve are preserved in old and 
heterozygote mice, the intramuscular axons are not (Li Fan, PhD Thesis, University 
of Edinburgh). Given that WldS protection decreases at the point of intramuscular 
branching, there could be something about this branching that reduces the 
effectiveness of WldS protection. For instance, if there was a fixed amount of a 
neuroprotective molecule in the axon, its concentration would be diluted by 
distribution down several axon branches, but sustained in single axons with no 
branches, like Ia afferents. 
 
In order to investigate whether branching has an effect on WldS protection, I 
examined γ-motor units. These are motor neurones which innervate the poles of the 
muscle spindle. They have a small motor unit size of about 2 endplates per neurone, 
therefore they branch about 25 times less than α-motor neurones but at least twice as 
many times as sensory motor neurones. If the rate of axon degeneration were 
influenced by branching I would expect their terminals would degenerate at a rate 
intermediate to α-motor and Ia degeneration. I would expect the rate of γ-motor 
ending degeneration to more closely resemble the rate of Ia ending degeneration than 
that of α-motor endplate degeneration. 
 
2.3.1 γ -motor units are non-FP in CFP animals, FP in YFP16 animals 
Teased spindles from unoperated CFP mice revealed no fluorescent motor units, in 
contrast to teased spindles from YFP16 mice in which innervation to the γ-endplates 
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was visible in every spindle teased [Figure 2.4]. This contrasts with the data on this 
CFP line published by the creators, who state that all motor neurones are labelled in 
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This is part of Figure 2.4. The figure legend follows. 
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This is part of Figure 2.4. 
The figure legend follows. 
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Figure 2.4 γ-motor neurones are fluorescent in YFP16 mice, not 
fluorescent in CFP mice 
This figure extends over the previous three pages. 
 
Confocal microscopy of teased spindles from YFP16 and CFP mice show 
intramuscular γ-motor gamma motor axons and γ-motor nerve terminals 
on the intrafusal muscle fibres which are fluorescent in YFP16 (yellow 
arrows indicate a few of these) but not in CFP mice. The post-synaptic 
receptors on the γ-motor endplates are shown in red, due to incubation 
with TRITC conjugated α-BTX. Scale bars= 100µm 
 
Green arrows indicate the gamma endplates shown in scale with the 
teased muscle spindle at higher magnification. 
  




 protects γ-motor endings 
Seven teased spindles from 8 week old YFP16 WldS homozygotes, sacrificed 5 days 
post axotomy show protection of the γ-innervation of the intrafusal muscle fibres as 
was expected [Figure 2.5]. The percentage of innervated γ-endplates on muscle 
spindles from WldS mice 5 days post axotomy is not significantly different to the 
percentage of innervated γ-endplates in teased spindles from unoperated mice 
(p=0.4051 Mann Whitney U test) [Figure 2.5].  
  

























Figure 2.5 γ-motor endings are preserved in young homozygote 
WldS mice 
A) Confocal microscopy of teased muscle spindles from WldS mice 5 
days post axotomy showing innervated γ-motor endplates. Scale bars= 
100µm. B) Graph to show the percentage of innervated endplates from 
teased muscle preperations of unoperated (n=9) and 8 week old 

































 mice show no protection of γ-motor endings 
Teased spindles from WldS heterozygotes showed no γ-innervation at all at either 3 
(n=7), or at 5 days post axotomy (n= 6) [Figure 2.6]. 
 
This fast rate of degeneration is equivalent to the rate of degeneration of α-motor 
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Figure 2.6 γ-motor endings are not protected by WldS in 
heterozygote WldS mice 
Confocal microscopy of teased muscle spindles A) 3 days post axotomy, 
B) 5 days post axotomy showing completely dennervated γ-motor nerve 
terminals indicated with yellow arrows. Scale bars= 100µm. Graph to 
show the percentage of innervated γ-motor nerve terminals in teased 
muscle spindle preparations from unoperated (n=9) and heterozygote 
mice 5 days post axotomy (n=6).  
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2.3.4 Age effects Wld
S
 protection of γ-motor endings. However, γ-motor units 
are better protected than α-motor units in 16-42 week old animals 
15 teased spindles from mice up to 42 weeks of age, including seven from mice aged 
42 weeks, showed γ-innervation 5 days post axotomy. Three out of 6 teased spindles 
from mice aged 42 weeks showed some γ-innervation at 10 days post axotomy 
[Figure 2.7]. The percentage innervation of the γ-endplates was not significantly 
different between teased spindles from unoperated mice and teased spindles from 
Wld
S mice 5 days post axotomy, in the 8 week, 16 week or 32 week old age groups 
(Dunn’s Multiple Comparison test) [Figure 2.7]. 
 
However, there is a significant difference between the percentage innervation of γ-
endplates in 42 week old WldS animals, 5 days post axotomy, and from unoperated 
spindles (p< 0.05 Dunn’s Multiple Comparison test) and teased spindles from mice 
aged 58 weeks showed no γ-innervation at 3 (n=7) or 5 (n=7) days post axotomy 
[Figure 2.7]. 
 
Taken together, these data suggest that γ-innervation is preserved by WldS at ages 
when α-motor innervation is no longer robust. However, the WldS protection 
observed in these mice was not equivalent to the protection of sensory endings, 
which were robustly protected regardless of age. Here, there is an effect of age on the 
quality of WldS protection and no protection found at all in mice at 58 weeks. This 
means in mice aged 58 weeks that the protection of γ-motor endings is equivalent to 
the protection of α-motor endings. 
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This is part of Figure 2.7. The figure legend follows. 
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This is part of Figure 2.7. The figure legend follows. 
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This is part of Figure 2.7. The figure legend follows. 
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Figure 2.7 The protection of γ-motor endings depends on age in 
homozygote WldS mice 
Confocal microscopy of teased muscle spindles. This figure extends over 
the 4 preceding pages.  
 
A-C spindles from 32 and 42 week old animals, 5 days post axotomy. All 
of these still show some motor innervation of γ-motor endplates indicated 
by white arrows. D-F Spindles from 42 week old animals 10 days post 
axotomy with γ-motor innervation indicated by white arrows. G-J spindles 
from 58 week old WldS mice 5 days post axotomy showing no γ-motor 
innervation, empty γ-motor endplates visualised with TRITC conjugated 
α-BTX are indicated with yellow arrows. Scale bars= 100µm.  
 
Graph shows the percentage of γ-motor endings innervated 5 days after 
axotomy in various mouse age-groups. This declines with age. However 
there is no significant difference between the values in unoperated mice 
(n=9) and operated mice up to 32 weeks of age. N numbers = 8 week old 
(7), 16 week old (4), 32 week old (4), 42 week old (7), 58 week old (7). 
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In conclusion, it appears that there may be an effect of branching on the protection of 
axon terminals in WldS mice as in these experiments, γ-motor neurone terminals 
appear to be more robustly protected that α-motor neurone terminals. However, it is 
unlikely that branching alone is responsible for the improved protection of sensory 
endings as compared to α-motor endings in WldS mice as the protection of γ-motor 
endings declines with age and in 58 week old animals and heterozygotes the 
protection of these γ-motor terminals is equivalent to α-motor terminals while the 




The final factor I have investigated in this chapter is activity. Axons are not 
spontaneously active so a motor axon stump, having been disconnected from its 
inputs, most probably does not generate action potentials, although they are able to 
conduct them (Tsao et al, 1994). However, a sensory stump is still attached to its 
input; the sensory receptor, and could possibly still be generating potentials in that 
receptor during passive muscle stretching. These action potentials could propagate up 
the axon to the transection point. 
 
Neuronal activity is hypothesised to be protective in other systems. During synapse 
elimination in development more active inputs to a neuromuscular junction out 
compete inactive inputs (Ribchester and Taxt, 1983). One hypothesis is that the 
activity within the neurone promotes survival of its inputs to the synapse (Personius 
and Balice-Gordon, 2002). Increased mental activity decreases risk of 
neurodegeneration in the CNS (Valenzuela et al, 2007, 2008; Ickes et al, 2000) and 
exercise has suggested therapeutically for motor neurone disease sufferers 
(Kirkinezos, 2003). Although there are many factors that might mediate these 
benefits, it is possible that activity in the neurones is at least partially responsible for 
the neuroprotection. This could be mediated by activity-regulated genes such as c-fos 
which seems to be transcribed in response to synaptic activity in a neurone and 
  
 - 153 - 
neurotrophin, BDNF, also appears to be upregulated by neural activity (Flavell and 
Greenberg, 2008). Perhaps residual action potentials, in sensory axon stumps, cause a 
cascade of events that give the axon a better chance of survival.  
 
I attempted but was unable to obtain electrophysiological recordings from 
axotomised sensory endings to verify that disconnected sensory axons were 
functional so I used indirect methods to ascertain this. 
 
Ia sensory afferents terminating on muscle spindles contain 50nm clear vesicles 
which resemble synaptic vesicles in their morphology, association with synaptic 
vesicle proteins and FM1-43 uptake (Bewick et al, 2004). Bewick et al (2004) 
demonstrated that these vesicles under-go recycling in an activity and Ca 2+ 
dependent manner. I used FM1-43 to examine whether the preserved spindles in 
Wld
S animals after axotomy retained any normal activity. 
 
Next, in order to test the effect of activity on the survival of disconnected axons, I 
examined primary explant cultures of nerve. The nerves used to answer this question 
were the phrenic nerve, which supplies the diaphragm and is more than 90% motor 
axons and the saphenous which is 100% sensory axons. With no axonal endings of 
any kind in the primary culture, both nerves ought to have the same amount of 
activity. If activity were responsible for the differences in degeneration of sensory 
and motor nerve seen in vivo (Brown et al, 1994) then these cultured sensory and 
motor nerve explants should have degenerated at equivalent rates. 
 
2.4.1 Vesicle recycling occurs in sensory endings on lumbrical muscle spindles 
Following the protocol put together by Dr Guy Bewick (University of Aberdeen), I 
was able to demonstrate stretch-dependent labelling of sensory endings in mouse 
lumbrical muscle spindles using FM1-43fx [Figure 22.8]. 
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Figure 2.8 FM1-43 labels mouse lumbrical muscle spindles, 
Two examples of muscle spindles, in the lumbricals of CFP mice, 
showing that FM1-43 has been taken up by the IA endings. Confocal 
microscopy of the CFP (left) showing the structure of the ending, and the 
fixable fm1-43 (middle) showing where the styryl dye has been taken up, 
merged in the final panel. All scale bars = 50µm. 
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2.4.2 Vesicle recycling occurs in preserved sensory endings in Wld
S
 mice 
I used FM1-43fx to label sensory endings on muscle spindles in 8 week old, aged 
and heterozygous WldS mice, 5 days post axotomy.  This demonstrated that the 
vesicles are able to recycle in the ending even 5 days after the axon has been 
transected and suggests that at least one of the cellular processes continues to occur 
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Figure 2.9 FM1-43 is taken up by sensory endings in WldS mice after 
axotomy. 
Three examples of CFP WldS spindles, 5 days post axotomy. Confocal 
microscopy shows the CFP structure of the IA ending and the fixable  
FM1-43, which has been taken up by the annulospiral endings. Scale 
bars = 50µm. 
  





 phenotype is reproduced in culture 
Degeneration of tibial nerve from WldS mice is slower than that of wild type mice, in 
vitro [Figure 2.10]. Up to 11 days after the nerve was cultured (ie: 11 days post 
axotomy) WldS nerve the majority of axons appear to have long intact lengths and 
few breaks, while in WT nerve, axons were broken into short intact lengths four days 
after axotomy and these continued to be reduced. This result demonstrates that even 
after undergoing what is effectively a double axotomy, followed by tissue culture, 
Wld


















This is part of Figure 2.10. The figure legend follows. 
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Figure 2.10 WldS axonal phenotype is reproducible in culture 
This figure extends over the previous two pages. 
 
Confocal micrographs of tibial nerve from mice expressing yellow 
fluorescent protein, after increasing duration of time in culture. A) YFP-H 
tibial nerve, top row from a WldS mouse, bottom row from a wild type 
mouse, at given days post axotomy (Left to right 1, 9 ,11). B) YFP16 tibial 
nerve. Top row from a WldS mouse, Bottom row from a WT mouse, at 
given days post axotomy (Left to right 2, 6 and 11). The difference in the 
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2.4.4 There is differential Wld
S
 protection of the phrenic and saphenous nerve in 
culture 
Having demonstrated that it is possible to discriminate WT and WldS nerves in 
culture, I examined phrenic and saphenous nerve from WldS mice in order to see if 
there was a difference in their rates of degeneration in vitro. Phrenic nerve cultured 
from old WldS mice degenerates faster than that of saphenous nerve from the same 
mice [Figure 2.11]. Axon breaks appeared in phrenic nerve within a week, and by 11 
days axon fragments were considerably shorter, whereas saphenous nerve retained 
unbroken axons even at 11 days in culture. 
 
There was no discernable difference in the rate of degeneration between phrenic and 
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Figure 2.11: Motor axons degenerate faster than sensory axons in 
culture 
Confocal micrographs of peripheral nerves at increasing durations of time 
in culture. Top row phrenic nerves from YFP16 WldS mice, middle row 
saphenous nerves from YFP16 WldS mice. There are two examples of 
nerve at each time point. Bottom row: Examples of phrenic and 
saphenous nerve from YFP16 WT mice. From left to right, 2, 6 and 11 
days in culture. 
 
Both examples of WldS phrenic nerve contain many more broken axons 
than the examples of WldS saphenous at both 6 and 11 days post 









2.5.1 Protein expression 
The first part of this chapter examined the hypothesis that the amount of WldS 
protein decreases with age, potentially providing the age phenotype and the 
heterozygous phenotype with a common cause. Due to the reports in the literature 
that WldS protein is neuronally located I chose to examine cerebellum, as a region on 
CNS in which WldS protein expression is high; spinal cord, where the motor neurone 
somas are located and dorsal root ganglia which house the cell bodies of sensory 
neurones. The amount of WldS protein in each nervous tissue examined remained 
high in older animals. There was also no evidence to suggest that the amount of 
protein fell selectively in the motor neurones, as samples of spinal cord where the 
motor cell bodies are located, showed similar levels of WldS protein in young and old 
animals. Taken together, there is no evidence of differential protein expression in old 
Wld
S animals in the nervous system. 
 
During the final year of my studies, evidence has emerged that WldS protein may in 
fact be located in the axons of WldS animals at very low levels (M.P. Coleman, B. 
Beirowski, personal communication). There are also data that suggest WldS protein 
located in the axon may give rise to the protective phenotype (Sasaki et al, 2006; B. 
Beirowski et al, submitted). However, up until now there has been overwhelming 
evidence in the literature that WldS protein was all located in the nucleus and none in 
the cytoplasm (Mack et al, 2001; Fang et al, 2005; Gillingwater et al, 2006a).  
 
I detected WldS protein in Western blots of sciatic nerve, ventral and dorsal roots. 
However, this not unequivocal evidence for WldS protein in axons as there are many 
cell types that make up nerve. I also examined WldS protein expression in the axon 
using immunocytochemisty. I was unable to detect any protein in axons from sciatic, 
tibial, phrenic or saphenous nerve, with this method. However, I was able to see 
some specific WldS staining in the cytoplasm of DRG neurones that I was examining 
as controls. 
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Given the signal from Western blots, and the accidental observation of cytoplasmic 
WldS in the cytoplasm of DRG neurones that was noticed in confocal images 
designed to examine the nuclear staining, it is puzzling that cytoplasmic localisation 
of the protein was not reported before. 
 
Notwithstanding the above, I find no compelling evidence to suggest that a 
difference in the amount of WldS protein in axons is responsible for the differing 
motor and sensory phenotypes. However, investigation of cytoplasmic deposits of 
WldS in the soma of spinal motor neurones should be a priority, and perhaps 
improved techniques for detection of axonal proteins could allow re-examination of 
peripheral nerve. 
 
Given that there is no evidence in favour of a decrease in the amount of WldS protein 
in the nuclei or axons of neurones as an animal ages, neither generally, nor specific 
to motor neurones, it seems unlikely that the heterozygote and aged WldS phenotype 
share a common cause. 
 
2.5.2 Axon Branching 
The second hypothesis examined in this chapter was that branching reduced the 
effect of WldS. This was tested by examining the protection of γ-motor units, which 
branch intermediately between α-motor and sensory units.  
 
Here γ-motor endings demonstrated no protection in heterozygous WldS animals. 
There was an effect of age on the protection of γ-motor endings and WldS mice at 58 
weeks of age exhibited no protection of the γ-motor endings. However, protection of 
γ-motor endings was excellent up until 32 weeks of age, and WldS mice at 42 weeks 
of age still demonstrated some protection of γ-motor endings at 3, 5 and 10 days post 
axotomy.  
 
This suggests that there may be a mild effect of branching on the protection 
conferred by WldS on axonal endings. This could be investigated further with a 
comparison of WldS protection to endings in muscles with larger motor unit size 
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versus smaller motor unit size. Perhaps this effect on the WldS phenotype can tell us 
something about the mechanism of WldS protection.  
 
If there was a protective factor produced by WldS in the nucleus that was transported 
down the axon by anterograde axonal transport, at axonal branch points the factor 
could get diluted down each arm of the axon. This could explain why no protection 
was seen even with smaller γ -motor unit sizes in the heterozygous WldS mouse. With 
less WldS in the heterozygous mouse there may be less of the protective factor to 
start with, this may protect a single axon adequately, but dilution even over a few 
branches may reduce the effectiveness. 
 
The sensory endings appear to be disproportionately better protected than even the γ-




The third part of this chapter addressed the possibility that activity underlies the 
increased protection of sensory endings. Experiments on cultured nerves where 
neither sensory nor motor axons receive any stimulus and should not experience any 
activity (or if they do, for some reason, it should at least be equivalent) showed that a 
difference in the protection of sensory and motor axons still exists. This is 
compelling evidence that an intrinsic difference rather than activity is the cause of 
more robust protection of WldS sensory axons.  
 
2.5.4 Other explanations 
The conclusion from this chapter is that the amount of protein in the nuclei of motor 
neurones does not change sufficiently with age to explain the loss of protection of the 
neuromuscular synapse. Activity and branching are also probably not the main 
causes of the sensory/motor difference. 
 
Given that none of the hypotheses I have tested can completely explain the 
differences between the robust protection of sensory axons and endings in WldS mice 
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and the conditional protection of motor axons and endings which is weaker in aged 
or heterozygous WldS mice, what other explanations might there be? 
 
The differences between sensory and motor neurones are vast. WldS protection is not 
the only feature to discriminate between them. The selective death of motor neurones 
in amyotrophic lateral sclerosis (ALS) has not yet been satisfactorily explained. In 
10-20% of familial ALS, a mutant SOD1 has been demonstrated to be responsible 
for the disease. However this protein is expressed in neurones throughout the nervous 
system so why is it that motor neurones selectively degenerate in both humans and 
mice expressing the mutant SOD1? 
 
This question is echoed throughout neurodegenerative disease research. In 
Parkinson’s disease there is selective death of dopamine neurones, in Alzheimer’s 
disease the hippocampus is primarily affected, in fronto-temporal dementia the 
frontal lobes degenerate first. In all of these neurodegenerative diseases, 
degeneration is not necessarily restricted to one population of neurones; however it is 
one particular population that is affected to the greatest extent. As with most 
questions in biology, the explanation for this is likely to be genetic, environmental or 
a mixture of the two.  
 
Returning to the example of ALS, perhaps motor neurones have a particular genetic 
pre-disposition that interacts with the mutant SOD1 in such a way as to cause 
pathology unseen in other neurones in the nervous system. Raoul et al (2002) 
identified a novel Fas signalling pathway that requires transcriptional upregulation of 
neuronal NOS and no evidence for involvement of this pathway was found in cells 
other than motor neurones. Motor neurones from transgenic mice overexpressing 
SOD1 mutants displayed increased susceptibility to activation of this pathway. They 
were more sensitive to Fas- or NO-triggered cell death but not to trophic deprivation 
or excitotoxic stimulation. 
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Genetic death pathways restricted to specific neuronal classes could exist for precise 
control of developmental neuronal death and also underlie the selectivity of neuronal 
loss in neurodegenerative disease.  
 
Genetic factors, for example as yet unknown death pathways unique to the motor 
axon terminals, may explain why they degenerate where sensory axon terminals 
remain intact after injury in older or heterozygote WldS mice. However it may be that 
motor axons experience a particular environment conducive to degeneration in this 
situation while sensory axons experience a supportive environment. Environmental 
factors could include a different compliment of neurotrophins, different activity, or 
different energy requirements. 
 
Hoke et al, (2006) used RT-PCR to examine the expression levels of 11 growth 
factors and demonstrated that Schwann cells of cutaneous nerve and ventral root 
exhibit differing growth factor profiles at baseline and respond differently to 
denervation. 
 
Expression of vascular endothelial growth factor-1 (VEGF-1), insulin-like growth 
factor-1 (IGF-1), and pleiotrophin (PTN) was much higher in intact ventral root than 
in intact cutaneous nerve. In contrast, baseline expression of BDNF, neurotrophin-3 
(NT-3), hepatocyte growth factor (HGF), and GDNF was higher in cutaneous nerve 
than in ventral root. NGF, the prototypical sensory growth factor, was expressed 
similarly in both nerve types, as were IGF-2, fibroblast growth factor-2 (FGF-2), and 
ciliary neurotrophic factor (CNTF) (Hoke et al, 2006).  
 
Between 5 and 30 days after denervation of the femoral cutaneous nerve and the L4 
and L5 ventral roots, five of the growth factors, NGF, BDNF, IGF-1, HGF, and 
VEGF were significantly upregulated in denervated cutaneous nerve but minimally if 
at all in denervated ventral root. When viewed in light of baseline expression levels, 
the predominance of BDNF and HGF in sensory nerve is accentuated further and that 
of NGF is unchanged; the relative levels of VEGF and IGF-1 are lower (Hoke et al, 
2006). 
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The differing baseline state of neurotrophins experienced by the axons and the 
differing responses to injury could underlie the differing susceptibilities to 
degeneration in genetic disease, or after environmental insult, and differing responses 
to protection from that degeneration. 
 
Age is a risk factor in all neurodegenerative diseases. Therefore, it seems likely that 
something about the neural constitution changes as they mature. In the WldS mouse 
similar genetic and environmental factors that change or develop with age, may be 
responsible for the loss of the protective phenotype that appears to be specific for old 
motor nerve terminals. 
 
Discovering what causes motor neurones in aged and heterozygous WldS mice to be 
susceptible to degeneration even when sensory neurones demonstrate such robust 
protection, might highlight changes that occur as motor neurones age that also makes 
them susceptible to degeneration in ALS. This could lead to insights into the key 
difference between neurones underlying their differential sensitivity in different 
neurodegenerative conditions. 
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The theory of compartmental degeneration suggests that the morphologically and 
functionally distinct compartments of the neurone have specific molecular 
mechanisms responsible for their degeneration. A host of molecules have been 
shown to regulate apoptosis of the neuronal soma including key players such as Bcl-
2 and the caspases. WldS has been shown to interfere with the molecular mechanism 
responsible for Wallerian degeneration of the axon. The axon terminal may have its 
own distinct pathway that regulates its destruction.  
 
No evidence has been presented that indicates whether either of these destruction 
mechanisms (apoptosis or Wallerian degeneration) can occur within the dendrite, a 
fourth morphologically and functionally specialised neuronal compartment. 
 
The present chapter aims to investigate any evidence for WldS protection in dendrite 
degeneration. 
 
Dendrites and axons are both neuronal processes with a common developmental 
history. However they each perform different functions in the neurone and are 
morphologically specialized for these purposes, resulting in some key molecular 
differences. Some of the similarities and differences will be discussed below. 
 
3.1.1 The development of axons and dendrites 
Most evidence we have about the development of the axons and dendrites comes 
from the most commonly used system for examination of neuronal polarity; cultured 
hippocampal neurones. These develop one axon and several dendrites (as they would 
in situ) and maintain their characteristics at a structural and molecular level. 
 
Dendrites and axons have a common beginning as neurites, growing from the newly 
differentiated neurone. After plating, hippocampal neurones develop protrusions 
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which grow to be short neurites all roughly equal in length. At this point it is not 
possible to identify special characteristics that could allow a prediction of which one 
will become the axon. There are no significant differences among the processes in 
light microscopic morphology or behaviour, in ultrastructural characteristics, in 
microtubule density or orientation, or in their content of markers that distinguish 
axons and dendrites in mature neurones (Arimura and Kaibuchi, 2005). 
 
12- 24 hours after plating, one neurite will begin to grow rapidly (Esch et al, 1999) 
and will go on to become the axon. This growth immediately establishes the polarity 
of the neurone. A few days after the axon has begun its rapid growth, the remaining 
neurites elongate and acquire the characteristics of dendrites. About 7 days after 
plating, neurones form synaptic contacts and establish a neuronal network (Arimura 
and Kaibuchi, 2005). 
 
3.1.2 Differences between mature axons and dendrites 
Dendrites are often shorter than axons.  They are thicker near their origin, at the cell 
body, and taper off, unlike the axon which has a similar cross section all along its 
length. When axons branch, this happens distally, near their target area, however, 
dendrites branch at semi-regular intervals. 
 
Axons and dendrites differ further in the polarity of the microtubules they contain. In 
axons, the microtubules are uniformly oriented with the plus end pointed distally, 
whereas in dendrites, the orientation of microtubules is mixed (Craig and Banker 
1994). This has important implications in the microtubule-based intracellular 
transport of molecules and organelles. Other molecular differences exist. Various 
cytoskeletal proteins, motor proteins, transmitter receptors, and ion channels are 
found exclusively or preferentially in axons or dendrites (Craig and Banker, 1994). 
 
All of the organelles that are found in the soma, including ribosomes, endoplasmic 
reticulum (ER) and Golgi are also found in the dendrites. This allows protein 
synthesis to occur locally in dendrites. In contrast, ribosomes are scarce, if not 
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absent, in the axon and it is generally believed that there is no protein synthesis in the 
axon. 
  
Both axons and dendrites have specialized endings for making synaptic contacts. The 
axon terminals have the machinery for transmitter release. The dendrites usually have 
dendritic spines, shaped like mushrooms, which contain the post-synaptic density, as 
well as the receptors and signaling complexes required to receive and transduce 
information. 
 
3.1.3 Dendrite degeneration 
There is evidence that there may be a degeneration mechanism specific to dendrites.  
Iyirhiaro et al, 2008 found that treatment with flavopiridol and minocycline provided 
long-term protection for cell bodies following global ischemia but dendrites were not 
spared (Iyirhiaro, 2008). Dendritic loss may be a survival strategy to contain viral 
infection in neurones. Expression of shorthairpin RNA (shRNA) against luciferase 
(which is not in the rat genome) in hippocampal pyramidal neurones in rat 
organotypic slice cultures triggers dramatic loss of dendritic spines and 
simplification of dendritic arbours (Alvarez et al, 2006). In both these cases dendrites 
appear to have degenerated independently of their neuronal cell bodies. Dendritic 
retraction also occurs in synapse remodelling, which occurs throughout the life of an 
organism (Alvarez and Sabatini, 2007). These suggest there may be a mechanism 
allowing destruction of dendrites without affecting the cell body. 
 
Literature can be found supporting an apoptotic-like degeneration or a Wallerian-like 
degeneration of dendrites. 
 
M. P. Mattson has produced a body of work demonstrating that apoptotic proteins are 
present in dendrites. Studies of cultured neurones, synaptosomes and postmortem 
brain tissue have shown that essentially all of the “cell death machinery” can be 
activated locally in synaptic terminals and dendrites. Such apoptotic cascades can 
cause several different changes in synaptic terminals. For example, Par-4 induction 
and caspase activation promote mitochondrial dysfunction, further caspase 
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activation, and release of factors into the cytosol that are capable of inducing DNA 
condensation and fragmentation (Mattson and Gleichmann, 2005; Gilman and 
Mattson, 2002). Studies of cultured hippocampal neurones and adult rats exposed the 
seizure-inducing excitotoxin kainate, have shown that activation of synaptic 
glutamate receptors can induce apoptotic cascades that are initially localized to the 
postsynaptic dendritic compartments.  
 
Mattson argues that these components of apoptotic pathways have physiological 
roles in synaptic plasticity in the dendrites and synapses of neuronal cells. But given 
that all the components are there, in pathological situations, they might be activated 
and cause degeneration [Figure 3.1 based on Mattson, 2004]. 
 
Alternatively taking the view that dendrite degeneration is not molecularly distinct 
from axonal degeneration, T. Koike et al (Koike et al, 2007; Ikegami and Koike, 
2003; Yang et al, 2007; Touma et al, 2007) have produced a body of work which 
discusses axon and dendrite degeneration mechanisms in the same breath, referring 
to them collectively as neurites. Koike and colleagues work with cultured SCG 
neurones in which the axons and dendrites are not mature. They have described 
neurite death in response to disconnection from cell bodies, vinblastine treatment and 
cellular Zn+ chelation and demonstrated WldS protection against this neurite 
degeneration. This suggests that immature dendrites at least, may be susceptible to a 
form of degeneration that is not molecularly distinct from Wallerian degeneration in 
mature axons. 
  
 - 176 - 
 
  
 - 177 - 
Figure 3.1 Interactions of apoptosis pathways with calcium 
signaling and synaptic transmission  
 
This figure illustrates that molecules involved in apoptosis also have roles 
in normal synaptic function. 
 
Examples include:  
 
Par-4, which can transduce classical apoptosis pathways. However, Par-
4 also interacts with the D2 dopamine receptor at synapses to inhibit 
downstream dopamine signaling. This latter interaction is antagonized by 
calcium-activated calmodulin.  
 
Bcl-2, which inhibits apoptosis by regulating the permeability of the 
mitochondrial membrane. However it also enhances calcium leakage 
from the endoplasmic reticulum during synpatic transmission.  
 
Activated caspase-3, an effector of apoptosis, can cleave GluR1, an -
amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) receptor 
subunit, thereby modulating intracellular calcium levels.  
 
[D2DR, dopamine 2 dopamine receptor; NMDA-R, NMDA receptor; 
AMPA-R, AMPA receptor, atPKC, atypical PKC ( ), LTP, long term 
potentiation; IL-1, interleukin-1ß; casp 1, caspase 1; casp 3, caspase 3; 
PTP, mitochondrial permeability transition pore; NF- B, Nuclear factor-
kappaB.] 
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3.1.4 Aim of chapter 3 
My aim in this third chapter was to investigate whether mature dendrites were 
protected from degeneration by WldS. I first tried to do this using spinal cord slice 
cultures. This seemed to be the obvious choice as the motor neurone cell bodies are 
located in the spinal cord, and with characterisation of WldS protection of the motor 
neuronal soma (Bisby et al, 1995), axon (Lunn et al, 1989) and neuromuscular 
junction (Ribchester et al, 1995) it would complete the picture to look at motor 
neurone dendrites. However, although I was successful in culturing spinal cord for 
up to 14 days, the dendrites of the motor neurones were not clearly visible or 
amenable to injury in YFP-H mice. As an alternative I used retinal cultures where the 
dendritic trees of the few retinal ganglion cells (RGCs) that express YFP in the H-
line present a spectacular and accessible appearance [Figure 3.3]. 
 
3.2 Spinal cord culture 
 
Spinal cord survived for up to 14 days in culture. However, motor neurones appeared 
in slices rarely and the dendrites were difficult to identify. With these issues, and the 
effect of length on WldS protection to contend with (Ribchester et al, 1995), I did not 
continue to try and investigate the protection of motor neurone dendrites. 
 
3.3 Retinal culture 
 
I originally attempted to culture the retina of WldS and wild type animals using the 
same culture media I had used to culture nerves. This resulted in the death and 
degeneration of the RGCs and probably the rest of the retina also. For what it might 
be worth, there were no discernable differences between the rates or pattern of 
degeneration of the soma or dendrites of RGCs in WldS retina in comparison to the 
degeneration of wild type retina [data not shown]. 
 
Once B-27 and glucose were added to the culture media, retinal explants appeared to 
remain healthy for up to 14 days in culture. Figure 3.2A shows RGCs retaining 
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distinctive morphology over time in culture and imaged with both the fluorescence 
and confocal microscope. Figure 3.2B shows a retina fixed after 2 days in culture 
still with healthy intact neurones and retaining the normal morphology. Retinal 
culture allowed for repeated visualisation of neurones as show in figure 3.3. 
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A
This is part of Figure 3.2. The figure legend follows. 
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B
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Figure 3.2 Retinal morphology survives in culture  
This figure extends over the 2 proceeding pages. 
 
A) 5 images of RGCs in cultured retina. Two (top row) using conventional 
fluorescent microscope taken after 4 days in culture. Three images 
(bottom row) of fixed retina previously in culture for between 2 and 4 
days, taken with the confocal microscope, scale bars= 50µm. B) Confocal 
microscope images reconstructed to show an entire retina, fixed after 2 
days in culture. 
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Figure 3.3 Survival of retinal explants in tissue culture 
Three fluorescent microscope images showing two neurones surviving 
(from left to right) 2, 6 and 8 days in culture. The white arrow indicates the 
same neurone in each of the three pictures. Scale bars= 50µm 
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I attempted to injure retinal ganglion neurones with needles or to separate the cell 
soma from the dendrites using razorblades. However, usually I found either no injury 
could be detected or the retina ceased to resemble retina. In two instances I was able 
to injure the neural cell body and follow up the neurone at later time points. In both 
cases on re-visualising the neurone I was unable to identify the cell body or 
dendrites, however the disconnected axon was visible. The more successful of these 
instances is shown in Figure 3.4. This suggests that dendrites degenerate much more 
rapidly than axon following a lesion to the RGC cell soma and therefore that WldS 
does not protect dendrites. However, this can not be confidently concluded from such 
limited and few examples. 
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Figure 3.4 RGC dendritic protection after somal injury 
A) taken on day of culture. B,C) taken after the retina was in culture for 4 
days. B uninjured, C post injury. D,E,F) taken after 6 days in culture. No 
effect of injury was seen (D) so I attempted reinjury. This time damage to 
the cell body could be seen clearly (E,F). G, H) are taken after 8 days in 
culture. Here the neurone has vanished but the WldS protected axon 
remains. In G) the extent of the axonal protection can be seen. Scale 
bars on all picture equivalent to A, = 50µm. 
 
The white arrow points at the cell body in A and at where the cell body 
would have been in H. The yellow arrow points at the axon in both A and 
H, where in H it is preserved despite loss of the cell body. 
 
  




My preliminary work has suggested that WldS does not protect the dendrites of the 
RGC. However, further work needs to be undertaken in order to confirm this result. I 
have found a suitable culture system which is amenable to repeated visualisation, in 
which dendrites are accessible for injury. However the tools needed to injure the 
retina need to be refined. Laser microablation, for instance using a multiphoton 
microscope, could be a fruitful approach. Limited time and resources precluded any 
attempt at this during the course of the present PhD project. 
 
Identifying molecular players in dendrite degeneration is important clinically and 
scientifically. Dendritic membrane makes up a significant portion of any neurone. 
Different neurones vary significantly in their dendrite mass relative to axon mass 
(Craig and Banker, 1994) and for projection neurones such as motor neurones the 
axon mass may be several times larger than the dendritic mass.  However, more than 
80% of the cell membrane of a dentate granule cell (which has a short axon) is 
dendritic membrane (Craig and Banker, 1994).  
 
Dendrites degenerate or retract during normal physiology for example during LTP 
and LTD and possible as a survival strategy to contain viral infection in neurones.  
There are also instances on the boundary of physiology and pathophysiology in 
which dendrites are lost. One example of this is dendritic retraction during stress. 
Apical dendrites of pyramidal neurones of the medial prefrontal cortex and 
hippocampus are susceptible to degeneration after sustained exposure to 
corticosterone, perhaps suggesting that dendrite degeneration occurs as a result of 
stress (Cerqueira et al, 2007). 
 
Dendrites are lost in a range of diseases, both neurodevelopmental disorders, 
neurodegenerative and psychiatric diseases. Synaptic alterations in CA1 in mild 
Alzheimer’s disease suggest loss of dendritic spines is one of the first stages in 
developing the disease (Scheff et al, 2007). Post-mortem studies have revealed 
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dendritic abnormalities of pyramidal neurones in the prefrontal cortex of subjects 
with schizophrenia. These abnormalities include decreased dendritic arbour size and 
complexity and reduced dendritic spine density on subpopulations on pyramidal 
neurones (Hill et al, 2006). Spilman et al, 2008 suggest after abnormal prion protein 
accumulation dendritic degeneration is the first thing that happens before neuronal 
cell death. Chronic ethanol exposure may cause degeneration and withdrawal of 
dendrites in the purkinje neurones of the cerebellum (Dlugos, 2008). 
 
Understanding the mechanisms of dendrite degeneration and how to prevent it would 
enable therapeutic strategies to deal with dendrite loss in diseases where this is the 
correlate with clinical signs. In diseases where there is loss of entire neurones it may 
also be important to protect dendrites as protection of the cell body alone may not be 
enough to allow the neurone to retain its function. 
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This thesis has extended the compartmental theory of neurodegeneration by using the 
Wld
S mouse to examine mechanisms of degeneration in axon terminals and in 
dendrites [Figure D.1]. 
 
Firstly, I have found that sensory nerve terminals are much better protected from 
Wallerian degeneration than motor nerve terminals in the muscles of WldS mice. I 
have also provided evidence that supports the idea of the axon terminal as a separate 
neurodegenerative compartment, through examination of the pattern of degeneration 
after axotomy. Secondly, I examined three possible explanations for the difference in 
levels of protection between motor and sensory axons and endings but neither protein 
expression level, activity nor branching appear to offer a satisfactory explanation. 
Thirdly, I carried out some preliminary experiments, examining dendrite protection 
in WldS retina. The data tentatively suggests that WldS may not protect retinal 
ganglion cell dendrites from degeneration, at least not as strongly as their axons. 
Implications of this work affect both clinical and scientific research.  
 
Of interest to clinical research, it appears that sensory neuropathies may stand to 
benefit from therapy based on a WldS protective mechanism to a greater extent that 
motor neuropathies, particularly where age is an issue. The results also cast doubt on 
the assumption that axon terminals in the CNS would show decreased WldS 
protection in heterozygote and aged animals, as motor nerve terminals do. A 
demonstration that protection of nerve terminals in the brain was robust would make 
Wld
S research attractive to those working in CNS disorders. Also of interest to 
clinical researchers, it appears that the inhibition of Wallerian degeneration reveals a 
qualitatively different degeneration that may have more in common with the 
degeneration seen in some diseases. Finally, given the unexplained difference in 
Wld
S-mediated protection between the sensory and motor nerve terminals, this 
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increases evidence for a unique change in the constitution of motor nerve terminals 
as they age, and further examination of this might inform ALS research.  
 
The findings of this thesis also suggest that scientific methods used to investigate the 
mechanism of WldS protection should take into account differences that may be due 
to the use of different classes of neurone in the assays. Ie: the neurites of the DRG 
may show more robust protection under a variety of conditions, whereas motor nerve 
terminals in vivo may be more sensitive to the specifics of WldS protection. The 
components of the mouse muscle spindle have been described, allowing researchers 
of the sensory ending to perhaps consider working with this genetically versatile 
creature. A primary tissue culture method for repeated visualisation of both 
peripheral nerve and explanted retina has also been demonstrated. The explanted 
retina preparation may be useful in understanding mechanisms of degeneration of 
mature dendrites. 
 
Future directions suggested by this work include elucidating the difference between 
sensory and motor nerve terminal degeneration that is responsible for their differing 
levels of WldS protection after axotomy. That may also be key to understanding their 
different susceptibility to degeneration in a variety of disease and toxic insult 
scenarios. Examination of WldS protection of CNS synapses in old and heterozygote 
animals would be worthwhile. Further investigation into dendrite degeneration is 
necessary in order to confirm that WldS is not able to protect mature dendrites in the 
RGCs. Given the protection of WldS neurites in culture, it may be interesting to ask at 
what point the degenerative molecules become distinct and their relevance in 
development. 
 
Having discussed the above in greater detail in the relevant chapters, I will use this 
discussion to review the compartmental theory of neurodegeneration, examining the 
likelihood of its evolution and looking critically at the assumptions and 
simplifications it is based in. 
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Figure D.1 Diagram of WldS protection of the different 
compartments of a neurone 
The diagram shows the different neuronal compartments 
displayed in the reflex arc (based on Schade and Ford, 1965). 
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D.2 The compartmental theory of neurodegeneration revisited 
 
The compartmental theory of neurodegeneration, proposed by Gillingwater and 
Ribchester (2001), suggests that the morphologically and functionally distinct 
compartments of a neurone may also have distinct programmes of self destruction, 
governed by different molecular players. Dozens of proteins have been shown to 
control death of the cell body, examples include the Bcl-2 family and the caspases. 
Wallerian degeneration of the axon is regulated by WldS and as yet unconfirmed 
additional molecules.  
 
The fact that motor nerve terminals are able to degenerate in the presence of both 
Bcl-2 upregulation and WldS expression, as occurs in heterozygote and aged WldS 
mice, suggests a third putative neurodegenerative compartment; the axon terminal. 
 
My research has added support for the axon terminal as a separate neuronal 
compartment. Although sensory nerve terminals investigated in this thesis were 
protected to an equivalent degree in old and heterozygote mice, the information from 
pattern of degeneration suggests they do degenerate by a separate mechanism to the 
axons in these animals. Further, I have proposed that dendrites also have a distinct 
mechanism for degeneration and the observations I have made hint that they are not 
protected by WldS despite their common neuritic origins. 
 
D.3 Origins of compartmental degeneration of neurones 
 
It would be evolutionarily beneficial for a neurone to have a molecularly distinct 
process by which to eliminate dendrites, axons or synapses only. There are many 
situations during the life time of an organism, in which it might be necessary to lose 
these neuronal compartments; however, it would be a disaster for the organism if the 
same mechanisms that lead to clearing away damaged axons could also lead to 
degeneration of the neuronal cell bodies. Maintenance of mature neurones is a 
priority as most neurones are postmitotic and, with the exception of olfactory 
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neurones and some hippocampal neurones (Taupin and Gage, 2002), neuronal cell 
bodies are generally not able to be replaced from any resident or dormant population 
ie: once lost, a neurone is lost forever. 
 
D.3.1 As a mechanism for development 
During development of the nervous system, there are many more neural connections 
created than exist in the mature animal. In order to establish this mature pattern of 
precise connectivity, the initial axonal connections must be pruned through retraction 
or degeneration. 
 
For example, in an adult, one muscle fibre is innervated by an axon from a single 
motor neurone. However, during development multiple motor neurones make 
connections with single muscle fibres. The axon terminals compete at the 
neuromuscular junction on the muscle fibre and eventually all will retract except one. 
This process of synapse elimination is thought to occur throughout the nervous 
system. 
 
During synapse elimination, axon terminals retract, however larger scale pruning of 
entire axons also occurs during brain development. In the CNS, growing axons 
typically extend well past their target, axon collaterals then form and some of these 
innervate the target region. Inappropriate collaterals and the length of axon which 
overshot the target must subsequently be eliminated. The neural cell soma, however, 
remains intact (Luo and O’ Leary, 2005). 
 
D.3.2 Remodelling of connections throughout life 
It is now well-established that post-synaptic structures fluctuate throughout life 
(Alverez et al, 2007). Dendritic spines are constantly remodelled and although the 
dendritic arbour of most neurones is remarkably stable in the mature brain, there is a 
degree of remodelling which varies according to cell type (Alverez et al, 2007). This 
has been suggested as a mechanism that might encode experience in the brain; by 
altering connectivity in neuronal circuits. 
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There is also increasing evidence that there is some structural rearrangement of pre-
synaptic structures.  De Paola et al report that subpopulations of presynaptic 
terminals appeared or disappeared over a few days in a study using long-term 
organotypic hippocampal slice cultures, and that the extent of this turnover is 
enhanced by synaptic activity (De Paola et al., 2003). More recent studies have found 
evidence for these presynaptic terminal rearrangements in vivo (De Paola et al., 
2006; Stettler et al., 2006). The most recent of these studies is in functionally 
important presynaptic complexes formed by mossy fibre neurones in CA3 of the 
hippocampus. Galimberti et al, demonstrated that these pre-synaptic structures 
undergo rearrangement which occurs throughout the life of the animal and is 
influenced by experience (Galimberti et al, 2006). If it is necessary during adult life 
to structurally rearrange synapses, it is very important that the same molecules don’t 
lead to a shutdown of the whole cell.  
 
D.3.3 Response to stressors 
In the PNS after injury it makes sense to remove any disconnected or partially 
disconnected and damaged axons, to provide uncluttered avenues for new axons to 
sprout and grow to reinnervate their targets and restore functionality.  
 
As mentioned in chapter 3 it seems that dendritic retraction may occur in response to 
stressors as corticosteroids, toxic stress such as alcoholism and viral infection all 
have this effect. This dendritic retraction may occur in order to remove a neurone 
from a circuit when it is infected or incapable of normal function. It may also be to 
conserve resources, as the large membrane associated with a full arbour of dendrites 
requires a large amount of metabolic activity to maintain. 
 
It seems possible that axon loss is also a protective response of a neurone that is 
somehow compromised. Maintenance of an axon may be beyond the capacity of a 
neurone in the presence of some toxic/ hormonal stressor but without the axon the 
cell might be able to survive. Once better conditions exist, at least in the peripheral 
nervous system, the neurone might then sprout a new axon. 
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D.4 Limitations of the compartmental theory of neurodegeneration 
 
D.4.1 Polarity of the neurone 
The idea of morphologically, and functionally distinct compartments is not 
universally applicable within the mammalian nervous system. The standard neurone 
with a dendritic arbour whose function is to receive and integrate information, a 
neuronal soma where the nucleus is located and protein manufactured, and one axon 
that carries information contained in action potentials to its target is certainly an 
oversimplification.  
 
Functionally, it has been demonstrated that roles are not necessarily unique to one 
neuronal compartment. For example, there is now evidence for protein synthesis in 
all compartments of the neurone, although this is still contested in the case of the 
axon (Court and Alvarez, 2005). There are also examples of axo-axonic synapses 
which give axons the role of receiving input from other neurones. Also sensory 
axons receive signals which they then transmit towards the cell body. 
 
Morphologically, there are some neurones that lack axons altogether such as the 
granule cells of the olfactory bulb. Some neurones may have more than one axon 
such as certain classes of amacrine cell, which have as many as six axons arising 
from different dendrites. Others, including certain classes of horizontal and amacrine 
cells, have shapes so unusual that it is uncertain if the terms axons and dendrites 
apply at all (Craig and Banker, 1994).  
 
Even with classical polar compartmentalised neurones, there may be the potential 
within compartments to take on the morphology or function of another compartment. 
After injury some neurones can regrow their axon from a dendrite. Rose et al, 2001 
have shown that unusual processes originating from distal dendrites of cat neck 
motor neurones after axotomy have ultrastructural and molecular features that are 
typically attributed to axons (Rose et al, 2001). The same group went on to 
demonstrate this in other classes of neurone (Fenrich et al, 2007). 
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Given the blurring between distinct functions and morphologies of separate 
compartments in some neural cell types, it is possible that the idea of 
compartmentalised degeneration does not apply universally in the nervous system. 
 
D.4.2 Initiation may not occur in the same place as the destruction 
The first sign of degeneration that is seen in various neurodegenerative diseases, or 
after injury, may not be a reliable indication of which part of the neurone is initiating 
the degeneration.  
 
I showed in chapter one that axotomy in WldS mice caused degeneration of the 
sensory axon terminal, which occurred before the distal axon degenerated. This 
suggests that injury in the axon is able to cause degeneration in the terminal. Some 
molecular signalling must be involved in order for the spatially distinct nerve 
terminal to begin to undergo degeneration before the part of the axon directly 
connected to it.  
 
There are further examples in the literature of the first sign of degeneration being 
spatially distinct from where it may have been initiated.  
 
The induction of neuronal soma degeneration can be caused by excitotoxicity, ie: a 
signal received at the dendritic membrane. Similarly redundant neurones are lost 
during development seemingly by a “use it or lose it” mechanism. This suggests 
some signal generated at the post synaptic membrane must promote survival of the 
soma. 
 
If it were true that dendritic retraction or axonal loss was a defensive response of a 
cell experiencing some kind of challenge, for example viral infection. It would seem 
likely that the cell soma was initiating the degeneration of its processes. 
 
Perhaps, the signal might even be initiated in a different cell altogether. During 
synapse elimination it may be the post synaptic cell which signals to the innervating 
axon, either keeping it alive or bringing about its destruction. 
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So, just because the first sign of disease is degeneration of a particular compartment 
doesn’t mean that there isn’t something wrong elsewhere in the cell. If it were true 
that retraction or degeneration of processes was a protective mechanism for a 
neurone, then preventing the cell from shedding these processes might actually speed 
its demise. 
 
D.4.3 Multiple forms of cell death 
Up until now I have described Wallerian degeneration as an analogous form of self 
destruction for the axon as apoptosis is for the cell body. Though they appear to be 
molecularly distinct, there are similarities in principle. Firstly, each results in 
destruction of the neural compartment in response to a variety of insults, secondly 
each can be genetically manipulated.  
 
However, the exclusive position of apoptosis as the genetically regulated form of cell 
death has been challenged. It appears there are several forms of genetically regulated 
programmed cell death (PCD), known as apoptotic-like PCD, necrotic-like PCD and 
autophagy, which differ to greater and lesser extents both morphologically and 
molecularly. Indeed even necrosis, which used to be thought of as the opposite of 
apoptosis- a disordered, unregulated ‘accidental’ destruction of a cell, which results 
in release of the contents of the cell into the cellular environment  appears to 
sometimes occur after initiation of traditional apoptotic machinery and there are 
mechanisms which regulate this (Hetz et al, 2005). It seems likely that there are 
many ways for a cell to die, and much genetic machinery that could be involved. The 
precise form of cell death undertaken by a cell is likely to be related to the kind of 
event that has initiated the cell death, the type and maturity of the cell and the 
environment it is in. 
 
Similarly, it seems likely that there is more than one form of axonal death and 
possibly nerve terminal degeneration and dendrite degeneration also. It could also be 
contemplated that some forms of axonal/dendritic or terminal degeneration are 
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specific to particular classes of neurone. This may explain selective degeneration in 
certain types of neurones in various neurodegenerative disease. 
 
Evidence for more than one type of axonal death comes from Beirowski et al (2005). 
The evidence presented in this paper suggests that degeneration of the axon in WldS 
animals occurs by a qualitatively different pattern than Wallerian degeneration in 
wild type animals. Whether there are any situations in wild type mice when slow 
Wallerian degeneration occurs has not been shown. 
 
However, another alternative form of axonal degeneration maybe responsible for 
axon elimination discussed in D.3. It seems unlikely that the branch elimination 
occurring either during development or throughout life, possibly to encode 
experience, is by a Wallerian degeneration mechanism or one might expect it to be 
abnormal in WldS mice and their behaviour to be affected, but they appear to be 
normal. However, the percentage of de novo branch formation and elimination in 
CA3 over 1 month of imaging was only 4% and elongations and retractions were 
balanced to result in a constant average branch length (Galimberti et al, 2006). This 
suggests that mice with a deficit in this area might appear normal without tests for 
subtle differences in behaviour. Also WldS mice are often killed young and live in un-
enriched environments. 
 
It seems likely that there are at least four, possibly related, mechanisms of axon loss; 
developmental axon loss, Wallerian degeneration after injury, Wallerian-like 
degeneration which occurs in disease and toxic challenge situations, and a slow 
axonal degeneration which occurs in the absence of Wallerian degeneration. These 
may or may not turn out to have molecular pathways in common. 
 
Similarly, there is evidence for several mechanisms of axon terminal loss. The 
synchronous degeneration of terminals observed at wild-type denervated NMJs 
(Miledi and Slater, 1968) contrasts with the degeneration of WldS motor nerve 
terminals after axotomy. These withdraw in a piecemeal fashion ie: nerve terminals 
remove themselves from the endplate, bouton by bouton, until they form a bulbous 
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swelling at the distal end of the axon, detached from the endplate (Gillingwater and 
Ribchester, 2001; Ribchester et al, 1995). Similarly the degeneration of sensory 
terminals in WldS mice occurs progressively and retrogradely, with Ia annulospiral 
endings on muscle spindles degenerating before their parent axon. In contrast the 
degeneration of wild type endings is abupt after a latent phase. 
 
The ultrastructure of withdrawing neuromuscular terminals in axotomised WldS 
neurones is also distinctive (Ribchester et al, 1995; Gillingwater et al, 2000). 
However, the ultrastructure of degenerating nerve terminals in the CNS after cortical 
ablation appeared to be morphologically similar to that which occurs in wild type 
animals (Gillingwater et al, 2006b).  
 
Nerve terminals that withdraw during synapse elimination look similar to the 
degenerating motor nerve terminals seen in WldS mice (Gillingwater and Ribchester, 
2001). Developmental synapse elimination takes place at a normal rate in WldS mice, 
although axotomy in the neonate still delays degeneration (Parson et al, 1997). 
 
The evidence comes together to suggest there are several mechanisms of axon 
terminal degeneration which may or may not be mechanistically related. One occurs 
in wild type animals in response to injury, another is unmasked in WldS animals and 
this may differ between CNS synapses and peripheral axon terminals. There is also a 
developmental mechanism which may share some features with the degeneration of 
nerve terminals that occurs in WldS mice after axotomy. Nerve terminal degeneration 
that occurs in dying back disorders may also share some features with the 
degeneration of nerve terminals that occurs in WldS mice after axotomy 
 
Given the evidence for several distinct processes even within the compartmentalised 
model of neurodegeneration, it must be recognised that findings about degeneration 
of a particular compartment can’t necessarily be generalised to other neuronal types 
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There is increasing evidence supporting the compartmental theory of 
neurodegeneration. It is an evolutionarily viable theory with reasons for separate 
degenerative mechanisms for separate neuronal compartment that might explain their 
existence. It is important to understand the limits of this theory and that both 
simplifications and generalisations are examined. 
 
This thesis has extended the information on this theory, using the WldS mouse as a 
tool and left open questions to be answered by future study. 
 
Studies on PCD have demonstrated that it is difficult to obtain long lasting sustained 
neuroprotection in the face of chronic extrinsic stressor (Wang et al, 2002a). There is 
evidence that sustained inhibition of cell death in the continual presence of a chronic 
stressor can unmask alternative pathways of death (Iyirhiaro et al, 2008). Indeed, an 
alternative pathway of axonal and axon terminal degeneration is unmasked in WldS 
mice. This suggests that whatever compounds may be developed in the future to 
delay degeneration of different neuronal compartments, tackling whatever causes the 
harm to the neurone must be investigated.  
 
However, delaying degeneration of the specific neuronal compartments involved in 
disease pathology has the potential to delay onset of disability and prolong lifespan. 
It may also give clinicians the time to locate the cause of neurodegeneration and treat 
this before the neural functions are lost.  
 
It would be of great benefit in the study of neurodegenerative disease to make 
investigation into the degeneration of all compartments of the neurone central to the 
development of future therapies for these diseases. 
  




Given the profound effect of the WldS mutation on the response of neurones to injury, 
it is remarkable that there is apparently very little else to say about the constitutive 
phenotype of the mutant mice. The mice have no overt behavioural abnormality 
which is why the axon-protection phenotype may have remained undiscovered until 
Brown and Perry’s serendipitous discovery in 1989. However, two phenotypic 
characteristics reported to be specific to WldS mice, have been examined further in 
the appendix of this thesis. These are decreased pain sensitivity (Zhong et al, 1999) 
and increased hair loss, which has not been published, but can be seen regularly in 
laboratory mice. 
 
A.2 Hair loss 
Wld
S mice have bald patches especially around their eyes and nose but also behind 
their ears and on their backs. Having noticed what seemed to be decreased hair 
growth over the wound after by sciatic nerve transection in WldS mice compared to 
WT mice, I wondered if the loss of hair that has been noticed is due to a slower 
growth of hair in WldS mice. 
 
A.2.1 Shaving 
6 C57/Bl6 and 6 WldS mice were used. These were coded by ear punch and the 
genotype of the mice was kept secret until the experiment was over. Mice were 
anaesthetised by halothane inhalation and an area on the back of each of mouse was 
shaved with an approximate area of 2cm x 1.5 cm. Mice were photographed 
regularly up to 38 days after shaving. After 38 days when the majority of mice had a 
full covering of fur, the experiment was terminated and the identities of the mice 
revealed.  
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From qualitative examination of the photos, there was no discernable difference in 
the amount of hair regrowth in WT and WldS mice at any day after shaving. Figure 
A.1 shows 2 mice from each group 26 days after shaving. This demonstrates that 
there is equivalent variation in both genotypes in hair regrowth.
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Figure A.1 No discernable difference in hair growth in WldS mice 
Pictures to show 2 representative mice of each genotype 26 days after 
shaving. There was no discernable difference between the hair growth of 
WldS mice and WT mice 
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A.3 Pain sensitivity 
Zhong et al used a temperature sensitivity assay to look at sensory impairments in 
IL-6 knock out mice before and after nerve crush. WldS mice were used as a 
comparison for IL-6 knock out mice in this experiment, as another mouse with 
reduced sensory regeneration after crush. Sensitivity to heat was tested by letting the 
paws of mice touch an aluminum hot plate set to 60°C for no more than 20 sec. 
Before the nerve was crushed, the mean paw withdrawal time of wild type mice was 
just over 4 seconds, whereas WldS mice took more than double that time to react to 
the same heat exposure with a mean paw withdrawal time of nearly 11 seconds 
(Zhong et al, 1999). 
 
Nociceptors are bare nerve endings which are activated by stimuli which have the 
potential to cause tissue damage. These include strong mechanical stimulation, 
extremes of temperature and oxygen deprivation. In addition, chemicals released 
from damaged cells at the site of injury eg: ATP, proteases, and K+ ions can also be 
involved in pain. Elevation of extracellular K+ directly depolarises nociceptors, ATP 
causes depolarisation directly by binding to ATP-gated ion channels and proteases 
can break down an abundant extracellular peptide called kininogen into bradykinin  
which binds to receptor molecules and activates ionic conductance. Mast cells may 
be also cause nociception, when activated by exposure to foreign substances eg: bee 
venom. They release histamine which binds to receptors on nociceptors to cause 
depolarisation (Bear et al, 2001).  
 
It occurred to me that the chemical signals able to cause pain transduction may also 
be produced during Wallerian degeneration as this is a type of cellular injury. For 
this reason, it seems plausable that a mouse with inhibited Wallerian degeneration 
might have impaired pain transduction and therefore reduced sensitivity to pain. In 
addition, having demonstrated that the hair loss in WldS  animals is not due to slower 
hair growth, another explanation could perhaps be overgrooming perhaps because the 
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recipient of the grooming failed to react to pain cues that might normally result in the 
termination of the activity before hair was lost. 
 
A.3.1 P.A.M 
I was unable to try the heat sensitivity assay, but was able to borrow equipment from 
another lab in the building who work on rheumatoid arthritis ie: joint pain, called the 
Pressure Application Measurement (P.A.M). 
 
To use the P.A.M the mouse is scruffed and pressure is applied to the mouse knee 
joint with the experimenters finger and thumb through a transducer worn on the 
thumb. When the mouse is uncomfortable it withdraws its foot and the P.A.M gives a 
reading of the maximum pressure applied. 
 
I did two experiments each with 12 mice, 6 WldS mice and 6 C57/Bl6 WT mice. 
These were coded by ear punch and their genotypes kept secret until the experiment 
was finished. In each trial I repeated the P.A.M three times. For each mouse I did 6 
trials over the course of a few weeks. 
 
A.3.2 Individual mice appear to have different sensitivities to pressure 
In the first experiment each mouse the average standard deviation between trials in 
an individual mouse was much smaller than the standard deviation of all trials in all 
mice. This suggests that the P.A.M is able to detect individual differences in pressure 
sensitivity. 
  






















Figure A.2 Data from individual mice examined in experiment one 
Data from the individual mice examined in experiment 1, shows that the 
P.A.M device can detect difference in individuals sensitivity to pressure. 
The range and standard deviations for each mouse over x trials is lower 
than the overall range and standard deviation of all trials. 
Experiment 1: Individual data
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A.3.3 No difference in pain sensitivities in Wld
S
 mice 
The first twelve mice gave a highly significant difference between groups with 
p=0.003 and WldS mice appearing to have more sensitivity to applied pressure 
[Figure A.3]. This was surprising given that the Zhong paper reported a decrease in 
sensitivity to heat in WldS mice (Zhong et al, 1999). However, a repeat experiment 
gave no significant difference between groups and a non-significant difference in the 
opposite direction [Figure A.4]. 
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Figure A.3 Grouped data demonstrating a difference in pain reactions 
in WldS and WT mice  
Grouped data from the twelve mice examined in experiment 1, shows a 
difference in the maximum pressure needed to cause a withdrawal of the 
foot in WT and WldS mice, p=0.003 
  

















Figure A.4 Grouped data demonstrating no difference in pain 
reactions in WldS and WT mice  
Grouped data from the twelve mice examined in experiment 2, shows no 
difference in the maximum pressure needed to cause a withdrawal of the 
foot in WT and WldS mice, p=0.2925. In addition there is a non-significant 
trend in the opposite direction from that in experiment 1. 
Experiment 2: Group data































From the results presented about it appears that slow hair growth is not the reason for 
Wld
S alopecia. It also appears that there is no consistent difference between the 
sensitivity to pressure in WldS mice as compared to WT mice. 
 
Further experiments that might be worth considering, include investigation of other 
possible reasons for the hair loss in older WldS animals. Perhaps this is a social 
problem due to over-grooming. It would also be interesting to repeat Zhong et al’s 
(1999) heat sensitivity test, particularly as this was only done as a control in their 
experiment and was not examined. 
 
The lack of obvious complications to living with the WldS phenotype further 
increases the interest in this gene as a potential molecular basis for therapeutic 
intervention in diseases in which axonal degeneration is important. 
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